Tag | Content |
---|---|
Uniprot ID | P21802; B4DFC2; E7EVR6; E9PCR0; P18443; Q01742; Q12922; Q14300; Q14301; Q14302; Q14303; Q14304; Q14305; Q14672; Q14718; Q14719; Q1KHY5; Q86YI4; Q8IXC7; Q96KL9; Q96KM0; Q96KM1; Q96KM2; Q9NZU2; Q9NZU3; Q9UD01; Q9UD02; Q9UIH3; Q9UIH4; Q9UIH5; Q9UIH6; Q9UIH7; Q9UIH8; Q9UM87; Q9UMC6; Q9UNS7; Q9UQH7; Q9UQH8; Q9UQH9; Q9UQI0; |
Entrez ID | 2263 |
Genbank protein ID | AAC41937.1; BAC45037.1; AAK94206.1; AAH39243.2; AAC41936.1; AAD31565.1; CAA37014.1; AAK94208.1; BAA89301.1; AAD14392.1; AAC41933.1; AAA52449.1; AAA68514.1; AAM74056.1; AAA59471.1; AAC41934.1; BAA89297.1; AAD31561.1; CAA76643.1; AAA59472.1; AAK94209.1; AAD31562.1; BAA89300.1; AAA36152.1; AAA36147.1; ABE96832.1; CAA39654.1; AAA61188.1; CAA96492.1; BAA89298.1; BAA89299.1; AAK94205.1; AAD31567.1; AAF43273.1; BAA89296.1; AAC41938.1; AAD31560.1; AAF43274.1; AAC41935.1; AAK94207.1; BAG57383.1; AAA59470.1; |
Genbank nucleotide ID | NM_001320658.1; NM_023029.2; NM_001144917.1; NM_001144914.1; NM_001144916.1; NM_001144918.1; NM_001320654.1; NM_022970.3; NM_001144919.1; NM_001144915.1; NM_000141.4; NM_001144913.1; |
Ensembl protein ID | ENSP00000358052; ENSP00000358057; ENSP00000351276; ENSP00000263451; ENSP00000348559; ENSP00000353262; ENSP00000350166; ENSP00000352309; ENSP00000358056; ENSP00000410294; |
Ensembl nucleotide ID | ENSG00000066468 |
Gene name | Fibroblast growth factor receptor 2 |
Gene symbol | FGFR2 |
Organism | Homo sapiens |
NCBI taxa ID | 9606 |
Cleft type | |
Developmental stage | |
Data sources | Manually collected |
Reference | 25704602 |
Functional description | Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1. |
Sequence | MVSWGRFICL VVVTMATLSL ARPSFSLVED TTLEPEEPPT KYQISQPEVY VAAPGESLEV 60 RCLLKDAAVI SWTKDGVHLG PNNRTVLIGE YLQIKGATPR DSGLYACTAS RTVDSETWYF 120 MVNVTDAISS GDDEDDTDGA EDFVSENSNN KRAPYWTNTE KMEKRLHAVP AANTVKFRCP 180 AGGNPMPTMR WLKNGKEFKQ EHRIGGYKVR NQHWSLIMES VVPSDKGNYT CVVENEYGSI 240 NHTYHLDVVE RSPHRPILQA GLPANASTVV GGDVEFVCKV YSDAQPHIQW IKHVEKNGSK 300 YGPDGLPYLK VLKAAGVNTT DKEIEVLYIR NVTFEDAGEY TCLAGNSIGI SFHSAWLTVL 360 PAPGREKEIT ASPDYLEIAI YCIGVFLIAC MVVTVILCRM KNTTKKPDFS SQPAVHKLTK 420 RIPLRRQVTV SAESSSSMNS NTPLVRITTR LSSTADTPML AGVSEYELPE DPKWEFPRDK 480 LTLGKPLGEG CFGQVVMAEA VGIDKDKPKE AVTVAVKMLK DDATEKDLSD LVSEMEMMKM 540 IGKHKNIINL LGACTQDGPL YVIVEYASKG NLREYLRARR PPGMEYSYDI NRVPEEQMTF 600 KDLVSCTYQL ARGMEYLASQ KCIHRDLAAR NVLVTENNVM KIADFGLARD INNIDYYKKT 660 TNGRLPVKWM APEALFDRVY THQSDVWSFG VLMWEIFTLG GSPYPGIPVE ELFKLLKEGH 720 RMDKPANCTN ELYMMMRDCW HAVPSQRPTF KQLVEDLDRI LTLTTNEEYL DLSQPLEQYS 780 PSYPDTRSSC SSGDDSVFSP DPMPYEPCLP QYPHINGSVK T 821 |
Abbreviation :
CLO : cleft lip only. CPO : cleft palate only.
CLP : cleft lip and palate. CL/P : cleft lip with/without cleft palate.
For humans: CL/P, CLO, CPO, and CLP. For mice: CLO, CLP, and CPO.
Relation | Gene symbol | Entrez ID | UniProt ID | Cleft type | Developmental stage | Species | Evidence | Details |
---|---|---|---|---|---|---|---|---|
1:1 ortholog | FGFR2 | 102170938 | A0A452F370 | Capra hircus | Prediction | More>> | ||
1:1 ortholog | FGFR2 | 2263 | P21802 | Homo sapiens | Publication | More>> | ||
1:1 ortholog | Fgfr2 | 14183 | P21803 | CPO | E13.5, E14.0, E14.5, E16.0, E16.5 | Mus musculus | Publication | More>> |
1:1 ortholog | FGFR2 | A0A2I3S3S0 | Pan troglodytes | Prediction | More>> | |||
1:1 ortholog | A0A480U9V2 | Sus scrofa | Prediction | More>> | ||||
1:1 ortholog | FGFR2 | 100009417 | G1SSB0 | Oryctolagus cuniculus | Prediction | More>> | ||
1:1 ortholog | Fgfr2 | 25022 | F1LSG7 | Rattus norvegicus | Prediction | More>> | ||
1:1 ortholog | fgfr2 | A4JYI8 | Danio rerio | Prediction | More>> |
ID | Variant | Type | Disease | Chromosome\Coordinate | Evidence |
---|---|---|---|---|---|
rs1271629959 | p.Ser3Thr | missense variant | - | NC_000010.11:g.121593810C>G | TOPMed |
rs1346210003 | p.Gly5Cys | missense variant | - | NC_000010.11:g.121593805C>A | gnomAD |
rs3750819 | p.Arg6His | missense variant | - | NC_000010.11:g.121593801C>T | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs3750819 | p.Arg6Pro | missense variant | - | NC_000010.11:g.121593801C>G | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs3750819 | p.Arg6Pro | missense variant | - | NC_000010.11:g.121593801C>G | UniProt,dbSNP |
VAR_017258 | p.Arg6Pro | missense variant | - | NC_000010.11:g.121593801C>G | UniProt |
rs141724446 | p.Arg6Cys | missense variant | - | NC_000010.11:g.121593802G>A | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs141724446 | p.Arg6Cys | missense variant | - | NC_000010.11:g.121593802G>A | NCI-TCGA,NCI-TCGA Cosmic |
RCV000554983 | p.Arg6Pro | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121593801C>G | ClinVar |
RCV000121060 | p.Arg6Pro | missense variant | - | NC_000010.11:g.121593801C>G | ClinVar |
RCV000360397 | p.Arg6Pro | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121593801C>G | ClinVar |
RCV000271967 | p.Arg6Pro | missense variant | Saethre-Chotzen syndrome (SCS) | NC_000010.11:g.121593801C>G | ClinVar |
RCV000265971 | p.Arg6Pro | missense variant | Isolated coronal synostosis | NC_000010.11:g.121593801C>G | ClinVar |
RCV000354781 | p.Arg6Pro | missense variant | Acrocephalosyndactyly type I | NC_000010.11:g.121593801C>G | ClinVar |
RCV000299960 | p.Arg6Pro | missense variant | Levy-Hollister syndrome (LADD) | NC_000010.11:g.121593801C>G | ClinVar |
RCV000260043 | p.Arg6Pro | missense variant | Cutis Gyrata syndrome of Beare and Stevenson (BSTVS) | NC_000010.11:g.121593801C>G | ClinVar |
RCV000305951 | p.Arg6Pro | missense variant | Crouzon syndrome | NC_000010.11:g.121593801C>G | ClinVar |
RCV000366350 | p.Arg6Pro | missense variant | - | NC_000010.11:g.121593801C>G | ClinVar |
RCV000321039 | p.Arg6Pro | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121593801C>G | ClinVar |
rs147307031 | p.Ile8Ser | missense variant | - | NC_000010.11:g.121593795A>C | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
RCV000121062 | p.Ile8Ser | missense variant | - | NC_000010.11:g.121593795A>C | ClinVar |
rs1287624070 | p.Ile8Val | missense variant | - | NC_000010.11:g.121593796T>C | gnomAD |
RCV000655422 | p.Ile8Ser | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121593795A>C | ClinVar |
rs1479661228 | p.Cys9Gly | missense variant | - | NC_000010.11:g.121593793A>C | TOPMed |
rs370122049 | p.Leu10Val | missense variant | - | NC_000010.11:g.121593790G>C | ESP,ExAC,gnomAD |
rs143978938 | p.Val12Met | missense variant | - | NC_000010.11:g.121593784C>T | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
RCV000432180 | p.Val12Met | missense variant | - | NC_000010.11:g.121593784C>T | ClinVar |
rs143978938 | p.Val12Met | missense variant | - | NC_000010.11:g.121593784C>T | NCI-TCGA,NCI-TCGA Cosmic |
rs753987054 | p.Thr14Ile | missense variant | - | NC_000010.11:g.121593777G>A | ExAC,gnomAD |
rs1451094453 | p.Met15Leu | missense variant | - | NC_000010.11:g.121593775T>G | gnomAD |
rs984992964 | p.Ala16Thr | missense variant | - | NC_000010.11:g.121593772C>T | TOPMed |
rs766435280 | p.Thr17Ser | missense variant | - | NC_000010.11:g.121593768G>C | ExAC,TOPMed,gnomAD |
rs1417346628 | p.Thr17Ala | missense variant | - | NC_000010.11:g.121593769T>C | TOPMed,gnomAD |
rs766435280 | p.Thr17Ile | missense variant | - | NC_000010.11:g.121593768G>A | ExAC,TOPMed,gnomAD |
rs1417346628 | p.Thr17Ser | missense variant | - | NC_000010.11:g.121593769T>A | TOPMed,gnomAD |
rs760903123 | p.Ser19Phe | missense variant | - | NC_000010.11:g.121593762G>A | ExAC,TOPMed,gnomAD |
rs760903123 | p.Ser19Cys | missense variant | - | NC_000010.11:g.121593762G>C | ExAC,TOPMed,gnomAD |
rs773358865 | p.Ala21Val | missense variant | - | NC_000010.11:g.121593756G>A | ExAC,gnomAD |
rs189010277 | p.Arg22Gln | missense variant | - | NC_000010.11:g.121593753C>T | NCI-TCGA,NCI-TCGA Cosmic |
rs189010277 | p.Arg22Gln | missense variant | - | NC_000010.11:g.121593753C>T | 1000Genomes,ExAC,gnomAD |
rs377570596 | p.Arg22Trp | missense variant | - | NC_000010.11:g.121593754G>A | ESP,ExAC,TOPMed,gnomAD |
rs774554190 | p.Pro23His | missense variant | - | NC_000010.11:g.121593750G>T | ExAC,gnomAD |
rs1309596973 | p.Pro23Thr | missense variant | - | NC_000010.11:g.121593751G>T | TOPMed,gnomAD |
rs774554190 | p.Pro23Leu | missense variant | - | NC_000010.11:g.121593750G>A | ExAC,gnomAD |
rs1466576334 | p.Ser26Arg | missense variant | - | NC_000010.11:g.121593740A>C | gnomAD |
rs1379302733 | p.Ser26Asn | missense variant | - | NC_000010.11:g.121593741C>T | gnomAD |
rs1294518519 | p.Leu27Val | missense variant | - | NC_000010.11:g.121593739A>C | gnomAD |
rs775194870 | p.Thr32Ala | missense variant | - | NC_000010.11:g.121593724T>C | ExAC,gnomAD |
rs1298138650 | p.Leu33Ile | missense variant | - | NC_000010.11:g.121593721A>T | TOPMed |
rs373546701 | p.Glu34Gln | missense variant | - | NC_000010.11:g.121593718C>G | ESP,ExAC,gnomAD |
rs775973432 | p.Pro38Ser | missense variant | - | NC_000010.11:g.121565702G>A | ExAC,gnomAD |
rs1248875226 | p.Pro38Leu | missense variant | - | NC_000010.11:g.121565701G>A | gnomAD |
rs1488994705 | p.Pro39Ser | missense variant | - | NC_000010.11:g.121565699G>A | gnomAD |
rs746629822 | p.Thr40Ile | missense variant | - | NC_000010.11:g.121565695G>A | ExAC,gnomAD |
rs1212310813 | p.Lys41Glu | missense variant | - | NC_000010.11:g.121565693T>C | gnomAD |
rs1333561230 | p.Tyr42Phe | missense variant | - | NC_000010.11:g.121565689T>A | gnomAD |
rs777638930 | p.Gln43Lys | missense variant | - | NC_000010.11:g.121565687G>T | ExAC,TOPMed,gnomAD |
rs771790476 | p.Gln43His | missense variant | - | NC_000010.11:g.121565685T>G | ExAC,gnomAD |
COSM1346350 | p.Ile44Leu | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121565684T>G | NCI-TCGA Cosmic |
rs748117555 | p.Gln46His | missense variant | - | NC_000010.11:g.121565676T>G | ExAC,TOPMed,gnomAD |
RCV000415491 | p.Gln46His | missense variant | Craniosynostosis, nonspecific | NC_000010.11:g.121565676T>G | ClinVar |
rs1367082521 | p.Pro47Ser | missense variant | - | NC_000010.11:g.121565675G>A | TOPMed |
rs200700308 | p.Glu48Ala | missense variant | - | NC_000010.11:g.121565671T>G | ExAC,TOPMed,gnomAD |
rs1372877545 | p.Val49Gly | missense variant | - | NC_000010.11:g.121565668A>C | gnomAD |
RCV000678347 | p.Tyr50Phe | missense variant | - | NC_000010.11:g.121565665T>A | ClinVar |
rs1398842143 | p.Tyr50Phe | missense variant | - | NC_000010.11:g.121565665T>A | TOPMed |
rs1307462454 | p.Val51Met | missense variant | - | NC_000010.11:g.121565663C>T | TOPMed |
rs371358242 | p.Ala53Val | missense variant | - | NC_000010.11:g.121565656G>A | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs151126801 | p.Pro54Ser | missense variant | - | NC_000010.11:g.121565654G>A | ESP,ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Pro54Gln | missense variant | - | NC_000010.11:g.121565653G>T | NCI-TCGA |
rs971937812 | p.Gly55Arg | missense variant | - | NC_000010.11:g.121565651C>T | TOPMed |
rs1158629849 | p.Ser57Ala | missense variant | - | NC_000010.11:g.121565645A>C | gnomAD |
rs56226109 | p.Ser57Leu | missense variant | - | NC_000010.11:g.121565644G>A | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs56226109 | p.Ser57Leu | missense variant | - | NC_000010.11:g.121565644G>A | UniProt,dbSNP |
VAR_042204 | p.Ser57Leu | missense variant | - | NC_000010.11:g.121565644G>A | UniProt |
RCV000121064 | p.Ser57Leu | missense variant | - | NC_000010.11:g.121565644G>A | ClinVar |
rs1354205157 | p.Arg61Cys | missense variant | - | NC_000010.11:g.121565633G>A | gnomAD |
rs199575491 | p.Arg61Leu | missense variant | - | NC_000010.11:g.121565632C>A | 1000Genomes,ExAC,TOPMed,gnomAD |
rs199575491 | p.Arg61His | missense variant | - | NC_000010.11:g.121565632C>T | 1000Genomes,ExAC,TOPMed,gnomAD |
rs1468387033 | p.Cys62Tyr | missense variant | - | NC_000010.11:g.121565629C>T | gnomAD |
rs760115258 | p.Lys65Glu | missense variant | - | NC_000010.11:g.121565621T>C | ExAC,gnomAD |
rs148514974 | p.Asp66Asn | missense variant | - | NC_000010.11:g.121565618C>T | ESP,ExAC,TOPMed,gnomAD |
rs145746586 | p.Ala67Val | missense variant | - | NC_000010.11:g.121565614G>A | ExAC,gnomAD |
rs374996878 | p.Ala68Thr | missense variant | - | NC_000010.11:g.121565612C>T | ESP,ExAC,TOPMed,gnomAD |
rs374996878 | p.Ala68Pro | missense variant | - | NC_000010.11:g.121565612C>G | ESP,ExAC,TOPMed,gnomAD |
rs537841180 | p.Ala68Val | missense variant | - | NC_000010.11:g.121565611G>A | 1000Genomes,ExAC,TOPMed,gnomAD |
rs371714070 | p.Val69Met | missense variant | - | NC_000010.11:g.121565609C>T | ESP,ExAC,TOPMed,gnomAD |
rs1428037640 | p.Val69Ala | missense variant | - | NC_000010.11:g.121565608A>G | TOPMed |
rs768650541 | p.Ile70Val | missense variant | - | NC_000010.11:g.121565606T>C | ExAC,gnomAD |
NCI-TCGA novel | p.Trp72Cys | missense variant | - | NC_000010.11:g.121565598C>G | NCI-TCGA |
COSM6128294 | p.Asp75Asn | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121565591C>T | NCI-TCGA Cosmic |
NCI-TCGA novel | p.Gly76Arg | missense variant | - | NC_000010.11:g.121565588C>T | NCI-TCGA |
rs757219761 | p.Val77Met | missense variant | - | NC_000010.11:g.121565585C>T | ExAC |
rs1376151869 | p.Val77Glu | missense variant | - | NC_000010.11:g.121565584A>T | TOPMed |
NCI-TCGA novel | p.His78Asn | missense variant | - | NC_000010.11:g.121565582G>T | NCI-TCGA |
COSM3434816 | p.Leu79Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121565577C>A | NCI-TCGA Cosmic |
rs753179677 | p.Pro81Leu | missense variant | - | NC_000010.11:g.121565572G>A | ExAC,gnomAD |
rs1172232293 | p.Asn82Ser | missense variant | - | NC_000010.11:g.121565569T>C | gnomAD |
rs1378298459 | p.Asn82Lys | missense variant | - | NC_000010.11:g.121565568G>T | TOPMed |
rs765682593 | p.Asn83Asp | missense variant | - | NC_000010.11:g.121565567T>C | ExAC,gnomAD |
rs748315048 | p.Asn83Ser | missense variant | - | NC_000010.11:g.121565566T>C | gnomAD |
rs144714823 | p.Arg84Met | missense variant | - | NC_000010.11:g.121565563C>A | - |
rs779848635 | p.Arg84Ser | missense variant | - | NC_000010.11:g.121565562C>A | ExAC,TOPMed,gnomAD |
rs1315026296 | p.Thr85Ala | missense variant | - | NC_000010.11:g.121565561T>C | TOPMed,gnomAD |
rs1396687223 | p.Val86Met | missense variant | - | NC_000010.11:g.121565558C>T | TOPMed,gnomAD |
COSM3434813 | p.Leu87Pro | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121565554A>G | NCI-TCGA Cosmic |
rs200369248 | p.Ile88Thr | missense variant | - | NC_000010.11:g.121565551A>G | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
COSM4012203 | p.Glu90Ala | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121565545T>G | NCI-TCGA Cosmic |
rs1277734487 | p.Gly96Val | missense variant | - | NC_000010.11:g.121565527C>A | TOPMed,gnomAD |
rs372430349 | p.Ala97Thr | missense variant | - | NC_000010.11:g.121565525C>T | ESP,ExAC,TOPMed,gnomAD |
COSM4012198 | p.Ala97Val | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121565524G>A | NCI-TCGA Cosmic |
RCV000592272 | p.Ala97Thr | missense variant | - | NC_000010.11:g.121565525C>T | ClinVar |
rs1041970177 | p.Thr98Arg | missense variant | - | NC_000010.11:g.121565521G>C | TOPMed,gnomAD |
rs1041970177 | p.Thr98Met | missense variant | - | NC_000010.11:g.121565521G>A | TOPMed,gnomAD |
rs1483189961 | p.Thr98Ala | missense variant | - | NC_000010.11:g.121565522T>C | TOPMed |
COSM4921717 | p.Pro99Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121565519G>A | NCI-TCGA Cosmic |
rs774193926 | p.Arg100Lys | missense variant | - | NC_000010.11:g.121565515C>T | ExAC,gnomAD |
rs1324769001 | p.Arg100Gly | missense variant | - | NC_000010.11:g.121565516T>C | gnomAD |
COSM1152154 | p.Asp101Tyr | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121565513C>A | NCI-TCGA Cosmic |
rs775253363 | p.Leu104Phe | missense variant | - | NC_000010.11:g.121565504G>A | ExAC,gnomAD |
rs1434545235 | p.Tyr105Cys | missense variant | - | NC_000010.11:g.121565500T>C | gnomAD |
RCV000531359 | p.Tyr105Cys | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121565500T>C | ClinVar |
RCV000762805 | p.Tyr105Cys | missense variant | Acrocephalosyndactyly type I | NC_000010.11:g.121565500T>C | ClinVar |
RCV000522502 | p.Tyr105Cys | missense variant | - | NC_000010.11:g.121565500T>C | ClinVar |
rs1188185824 | p.Thr108Ala | missense variant | - | NC_000010.11:g.121565492T>C | TOPMed |
COSM1584811 | p.Thr108Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121565491G>C | NCI-TCGA Cosmic |
NCI-TCGA novel | p.Ser110Arg | missense variant | - | NC_000010.11:g.121565484A>T | NCI-TCGA |
rs1055824076 | p.Thr112Ala | missense variant | - | NC_000010.11:g.121565480T>C | TOPMed |
NCI-TCGA novel | p.Val113Ala | missense variant | - | NC_000010.11:g.121565476A>G | NCI-TCGA |
rs867109770 | p.Ser115Asn | missense variant | - | NC_000010.11:g.121565470C>T | TOPMed,gnomAD |
rs1170178043 | p.Ser115Cys | missense variant | - | NC_000010.11:g.121565471T>A | gnomAD |
rs139263005 | p.Trp118Leu | missense variant | - | NC_000010.11:g.121565461C>A | ESP,ExAC,TOPMed,gnomAD |
rs139263005 | p.Trp118Ter | stop gained | - | NC_000010.11:g.121565461C>T | ESP,ExAC,TOPMed,gnomAD |
rs139263005 | p.Trp118Ser | missense variant | - | NC_000010.11:g.121565461C>G | ESP,ExAC,TOPMed,gnomAD |
rs758751243 | p.Phe120Leu | missense variant | - | NC_000010.11:g.121565454G>T | ExAC,gnomAD |
rs748322657 | p.Met121Thr | missense variant | - | NC_000010.11:g.121565452A>G | ExAC,TOPMed,gnomAD |
rs910002462 | p.Met121Leu | missense variant | - | NC_000010.11:g.121565453T>A | TOPMed,gnomAD |
rs779423644 | p.Val122Met | missense variant | - | NC_000010.11:g.121565450C>T | ExAC,gnomAD |
rs375935265 | p.Asn123Ser | missense variant | - | NC_000010.11:g.121565446T>C | ESP,ExAC,TOPMed,gnomAD |
rs1337077719 | p.Asp126Gly | missense variant | - | NC_000010.11:g.121564579T>C | gnomAD |
rs1057523040 | p.Asp126Asn | missense variant | - | NC_000010.11:g.121565438C>T | gnomAD |
NCI-TCGA novel | p.Asp126Tyr | missense variant | - | NC_000010.11:g.121565438C>A | NCI-TCGA |
RCV000435241 | p.Asp126Asn | missense variant | - | NC_000010.11:g.121565438C>T | ClinVar |
rs1271274434 | p.Ile128Thr | missense variant | - | NC_000010.11:g.121564573A>G | gnomAD |
NCI-TCGA novel | p.Ser129Leu | missense variant | - | NC_000010.11:g.121564570G>A | NCI-TCGA |
rs780458049 | p.Gly131Arg | missense variant | - | NC_000010.11:g.121564565C>T | ExAC,gnomAD |
rs1281483681 | p.Asp133Asn | missense variant | - | NC_000010.11:g.121564559C>T | gnomAD |
rs373155033 | p.Asp133Glu | missense variant | - | NC_000010.11:g.121564557A>C | ESP,ExAC,TOPMed,gnomAD |
rs750876096 | p.Asp133Val | missense variant | - | NC_000010.11:g.121564558T>A | ExAC,gnomAD |
rs751236652 | p.Glu134Val | missense variant | - | NC_000010.11:g.121564555T>A | ExAC,gnomAD |
NCI-TCGA novel | p.Asp136Tyr | missense variant | - | NC_000010.11:g.121564550C>A | NCI-TCGA |
rs1267514450 | p.Thr137Ile | missense variant | - | NC_000010.11:g.121564546G>A | TOPMed,gnomAD |
rs1435487500 | p.Asp138Gly | missense variant | - | NC_000010.11:g.121564543T>C | TOPMed |
rs938460066 | p.Asp138Asn | missense variant | - | NC_000010.11:g.121564544C>T | TOPMed |
rs1324703247 | p.Gly139Asp | missense variant | - | NC_000010.11:g.121564540C>T | gnomAD |
rs927047637 | p.Gly139Ser | missense variant | - | NC_000010.11:g.121564541C>T | TOPMed,gnomAD |
rs762636391 | p.Ala140Thr | missense variant | - | NC_000010.11:g.121564538C>T | ExAC,gnomAD |
rs752501698 | p.Ala140Val | missense variant | - | NC_000010.11:g.121564537G>A | ExAC,TOPMed,gnomAD |
rs759550441 | p.Glu141Lys | missense variant | - | NC_000010.11:g.121564535C>T | ExAC,gnomAD |
COSM3866663 | p.Asp142Asn | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121564532C>T | NCI-TCGA Cosmic |
rs1195425758 | p.Val144Ile | missense variant | - | NC_000010.11:g.121564526C>T | gnomAD |
rs776668623 | p.Glu146Gly | missense variant | - | NC_000010.11:g.121564519T>C | ExAC,gnomAD |
NCI-TCGA novel | p.Asn147Asp | missense variant | - | NC_000010.11:g.121564517T>C | NCI-TCGA |
rs772298926 | p.Ser148Arg | missense variant | - | NC_000010.11:g.121564514T>G | ExAC,TOPMed,gnomAD |
rs772298926 | p.Ser148Gly | missense variant | - | NC_000010.11:g.121564514T>C | ExAC,TOPMed,gnomAD |
rs1236074902 | p.Asn149Lys | missense variant | - | NC_000010.11:g.121564509G>C | TOPMed |
NCI-TCGA novel | p.Asn149Asp | missense variant | - | NC_000010.11:g.121564511T>C | NCI-TCGA |
rs762030875 | p.Asn150Ser | missense variant | - | NC_000010.11:g.121564507T>C | ExAC,gnomAD |
rs774538633 | p.Lys151Asn | missense variant | - | NC_000010.11:g.121564503C>G | ExAC |
rs775743948 | p.Ala153Thr | missense variant | - | NC_000010.11:g.121551457C>T | ExAC,TOPMed,gnomAD |
rs775743948 | p.Ala153Pro | missense variant | - | NC_000010.11:g.121551457C>G | ExAC,TOPMed,gnomAD |
rs1429393695 | p.Tyr155Cys | missense variant | - | NC_000010.11:g.121551450T>C | gnomAD |
rs1314297833 | p.Thr157Ser | missense variant | - | NC_000010.11:g.121551444G>C | gnomAD |
rs1314297833 | p.Thr157Ile | missense variant | - | NC_000010.11:g.121551444G>A | gnomAD |
rs770169545 | p.Thr157Ala | missense variant | - | NC_000010.11:g.121551445T>C | ExAC,TOPMed,gnomAD |
rs866357501 | p.Glu160Ala | missense variant | - | NC_000010.11:g.121551435T>G | gnomAD |
rs1374572387 | p.Met162Thr | missense variant | - | NC_000010.11:g.121551429A>G | gnomAD |
COSM2056326 | p.Glu163Lys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121551427C>T | NCI-TCGA Cosmic |
rs146244307 | p.Arg165Gln | missense variant | - | NC_000010.11:g.121551420C>T | ESP,ExAC,TOPMed,gnomAD |
rs1171095092 | p.Arg165Trp | missense variant | - | NC_000010.11:g.121551421G>A | NCI-TCGA Cosmic |
rs1171095092 | p.Arg165Trp | missense variant | - | NC_000010.11:g.121551421G>A | gnomAD |
NCI-TCGA novel | p.Ala168Thr | missense variant | - | NC_000010.11:g.121551412C>T | NCI-TCGA |
VAR_017259 | p.Ala172Phe | Missense | Pfeiffer syndrome (PS) [MIM:101600] | - | UniProt |
NCI-TCGA novel | p.Asn173LysPheSerTerUnkUnk | frameshift | - | NC_000010.11:g.121551395_121551396insT | NCI-TCGA |
rs1477520217 | p.Asn173Ser | missense variant | - | NC_000010.11:g.121551396T>C | gnomAD |
COSM4994847 | p.Thr174Asn | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121551393G>T | NCI-TCGA Cosmic |
rs1190271376 | p.Lys176Thr | missense variant | - | NC_000010.11:g.121551387T>G | gnomAD |
rs974173968 | p.Arg178Ser | missense variant | - | NC_000010.11:g.121551382G>T | TOPMed,gnomAD |
rs141796960 | p.Arg178Leu | missense variant | - | NC_000010.11:g.121551381C>A | ESP,ExAC,TOPMed,gnomAD |
rs974173968 | p.Arg178Cys | missense variant | - | NC_000010.11:g.121551382G>A | TOPMed,gnomAD |
rs141796960 | p.Arg178His | missense variant | - | NC_000010.11:g.121551381C>T | ESP,ExAC,TOPMed,gnomAD |
rs200766273 | p.Gly182Trp | missense variant | - | NC_000010.11:g.121551370C>A | 1000Genomes,ExAC,gnomAD |
rs200766273 | p.Gly182Arg | missense variant | - | NC_000010.11:g.121551370C>T | 1000Genomes,ExAC,gnomAD |
rs200766273 | p.Gly182Arg | missense variant | - | NC_000010.11:g.121551370C>G | 1000Genomes,ExAC,gnomAD |
rs750312209 | p.Asn184Lys | missense variant | - | NC_000010.11:g.121551362G>C | ExAC,gnomAD |
rs750312209 | p.Asn184Lys | missense variant | - | NC_000010.11:g.121551362G>T | ExAC,gnomAD |
rs202212545 | p.Asn184Ile | missense variant | - | NC_000010.11:g.121551363T>A | ESP,ExAC,TOPMed,gnomAD |
COSM5074298 | p.Asn184ThrPheSerTerUnk | frameshift | Variant assessed as Somatic; HIGH impact. | NC_000010.11:g.121551365C>- | NCI-TCGA Cosmic |
rs202212545 | p.Asn184Thr | missense variant | - | NC_000010.11:g.121551363T>G | ESP,ExAC,TOPMed,gnomAD |
rs755793 | p.Met186Thr | missense variant | - | NC_000010.11:g.121551357A>G | UniProt,dbSNP |
VAR_017260 | p.Met186Thr | missense variant | - | NC_000010.11:g.121551357A>G | UniProt |
rs755793 | p.Met186Thr | missense variant | - | NC_000010.11:g.121551357A>G | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
RCV000121066 | p.Met186Thr | missense variant | - | NC_000010.11:g.121551357A>G | ClinVar |
rs55977237 | p.Met186Val | missense variant | - | NC_000010.11:g.121551358T>C | ESP,ExAC,TOPMed,gnomAD |
RCV000390607 | p.Met186Thr | missense variant | Crouzon syndrome | NC_000010.11:g.121551357A>G | ClinVar |
RCV000417413 | p.Met186Thr | missense variant | - | NC_000010.11:g.121551357A>G | ClinVar |
RCV000543983 | p.Met186Thr | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121551357A>G | ClinVar |
RCV000722541 | p.Pro187Leu | missense variant | - | NC_000010.11:g.121551354G>A | ClinVar |
rs1352732939 | p.Thr188Ala | missense variant | - | NC_000010.11:g.121551352T>C | gnomAD |
NCI-TCGA novel | p.Met189Leu | missense variant | - | NC_000010.11:g.121551349T>G | NCI-TCGA |
rs147987917 | p.Arg190Trp | missense variant | - | NC_000010.11:g.121551346G>A | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs759750319 | p.Arg190Gln | missense variant | - | NC_000010.11:g.121551345C>T | ExAC,TOPMed,gnomAD |
rs147987917 | p.Arg190Gly | missense variant | - | NC_000010.11:g.121551346G>C | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
RCV000306598 | p.Arg190Trp | missense variant | - | NC_000010.11:g.121551346G>A | ClinVar |
rs777039355 | p.Leu192Gln | missense variant | - | NC_000010.11:g.121551339A>T | ExAC |
NCI-TCGA novel | p.Asn194ThrPheSerTerUnkUnk | frameshift | - | NC_000010.11:g.121551333T>- | NCI-TCGA |
rs1474313509 | p.Gly195Arg | missense variant | - | NC_000010.11:g.121551331C>T | gnomAD |
rs1409994363 | p.Gly195Glu | missense variant | - | NC_000010.11:g.121551330C>T | TOPMed |
rs1292300276 | p.Glu197Lys | missense variant | - | NC_000010.11:g.121551325C>T | TOPMed |
rs747502397 | p.Arg203His | missense variant | - | NC_000010.11:g.121551306C>T | ExAC,gnomAD |
rs747502397 | p.Arg203His | missense variant | - | NC_000010.11:g.121551306C>T | NCI-TCGA,NCI-TCGA Cosmic |
RCV000489500 | p.Arg203His | missense variant | - | NC_000010.11:g.121551306C>T | ClinVar |
VAR_036380 | p.Arg203Cys | Missense | - | - | UniProt |
rs1234891977 | p.Gly205Glu | missense variant | - | NC_000010.11:g.121551300C>T | TOPMed |
rs773718005 | p.Gly206Ser | missense variant | - | NC_000010.11:g.121551298C>T | ExAC,gnomAD |
NCI-TCGA novel | p.Lys208Asn | missense variant | - | NC_000010.11:g.121551290C>A | NCI-TCGA |
rs1373181160 | p.Val209Leu | missense variant | - | NC_000010.11:g.121538715C>A | gnomAD |
rs1373181160 | p.Val209Leu | missense variant | - | NC_000010.11:g.121538715C>G | gnomAD |
rs1302963489 | p.Arg210Gly | missense variant | - | NC_000010.11:g.121538712G>C | TOPMed |
COSM174986 | p.Arg210Gln | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121538711C>T | NCI-TCGA Cosmic |
NCI-TCGA novel | p.Arg210Pro | missense variant | - | NC_000010.11:g.121538711C>G | NCI-TCGA |
NCI-TCGA novel | p.Arg210Ter | stop gained | - | NC_000010.11:g.121538712G>A | NCI-TCGA |
COSM2148965 | p.Gln212Lys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121538706G>T | NCI-TCGA Cosmic |
NCI-TCGA novel | p.Trp214Cys | missense variant | - | NC_000010.11:g.121538698C>A | NCI-TCGA |
rs1360830493 | p.Ile217Met | missense variant | - | NC_000010.11:g.121538689A>C | TOPMed |
rs1390042185 | p.Glu219Gly | missense variant | - | NC_000010.11:g.121538684T>C | gnomAD |
rs1390042185 | p.Glu219Gly | missense variant | - | NC_000010.11:g.121538684T>C | NCI-TCGA |
COSM3434803 | p.Ser220Cys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121538682T>A | NCI-TCGA Cosmic |
rs1216426276 | p.Ser224Pro | missense variant | - | NC_000010.11:g.121538670A>G | TOPMed |
rs537758598 | p.Asp225Glu | missense variant | - | NC_000010.11:g.121538665G>C | 1000Genomes,ExAC,gnomAD |
COSM29838 | p.Gly227Glu | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121538660C>T | NCI-TCGA Cosmic |
COSM3434799 | p.Gly227Arg | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121538661C>T | NCI-TCGA Cosmic |
rs146948953 | p.Asn228Ile | missense variant | - | NC_000010.11:g.121538657T>A | ESP,TOPMed |
rs368224180 | p.Tyr229Phe | missense variant | - | NC_000010.11:g.121538654T>A | ESP,ExAC,gnomAD |
rs1435694211 | p.Val233Met | missense variant | - | NC_000010.11:g.121538643C>T | gnomAD |
rs1432127277 | p.Glu234Ala | missense variant | - | NC_000010.11:g.121538639T>G | gnomAD |
rs779806520 | p.Glu234Gln | missense variant | - | NC_000010.11:g.121538640C>G | ExAC,gnomAD |
COSM1134980 | p.Glu236Ala | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121538633T>G | NCI-TCGA Cosmic |
COSM1134979 | p.Tyr237His | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121538631A>G | NCI-TCGA Cosmic |
rs555207905 | p.Ser239Thr | missense variant | - | NC_000010.11:g.121538625A>T | 1000Genomes,ExAC,gnomAD |
rs780846065 | p.Ser239Phe | missense variant | - | NC_000010.11:g.121538624G>A | ExAC,gnomAD |
rs751395138 | p.Ile240Met | missense variant | - | NC_000010.11:g.121538620G>C | ExAC |
rs757276690 | p.Ile240Val | missense variant | - | NC_000010.11:g.121538622T>C | ExAC,gnomAD |
rs929190618 | p.Asn241Ser | missense variant | - | NC_000010.11:g.121538618T>C | TOPMed,gnomAD |
rs1313917697 | p.Asn241Asp | missense variant | - | NC_000010.11:g.121538619T>C | TOPMed |
COSM3434792 | p.His242Tyr | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121538616G>A | NCI-TCGA Cosmic |
rs755001161 | p.Thr243Met | missense variant | - | NC_000010.11:g.121538612G>A | ExAC,gnomAD |
rs778994181 | p.Thr243Ala | missense variant | - | NC_000010.11:g.121538613T>C | ExAC,gnomAD |
rs1330602328 | p.His245Tyr | missense variant | - | NC_000010.11:g.121538607G>A | gnomAD |
NCI-TCGA novel | p.Asp247Ter | frameshift | - | NC_000010.11:g.121538601_121538602insA | NCI-TCGA |
NCI-TCGA novel | p.Asp247Tyr | missense variant | - | NC_000010.11:g.121538601C>A | NCI-TCGA |
COSM29828 | p.Arg251Gln | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121520166C>T | NCI-TCGA Cosmic |
NCI-TCGA novel | p.Arg251Ter | stop gained | - | NC_000010.11:g.121520167G>A | NCI-TCGA |
rs79184941 | p.Ser252Trp | missense variant | - | NC_000010.11:g.121520163G>C | ESP,ExAC,TOPMed,gnomAD |
rs121918498 | p.Ser252Phe | missense variant | - | NC_000010.11:g.121520162_121520163delinsAA | - |
rs121918498 | p.Ser252Phe | missense variant | Apert syndrome (APRS) | NC_000010.11:g.121520162_121520163delinsAA | UniProt,dbSNP |
VAR_004114 | p.Ser252Phe | missense variant | Apert syndrome (APRS) | NC_000010.11:g.121520162_121520163delinsAA | UniProt |
rs387907372 | p.SerPro252SerPhe | missense variant | - | NC_000010.11:g.121520160_121520162delinsAAG | - |
rs281865420 | p.SerPro252PheSer | delins | Pfeiffer syndrome (PS) | NC_000010.11:g.121520161_121520163delinsAGA | UniProt,dbSNP |
VAR_004116 | p.SerPro252PheSer | delins | Pfeiffer syndrome (PS) | NC_000010.11:g.121520161_121520163delinsAGA | UniProt |
rs79184941 | p.Ser252Leu | missense variant | - | NC_000010.11:g.121520163G>A | ESP,ExAC,TOPMed,gnomAD |
rs281865420 | p.SerPro252PheSer | missense variant | - | NC_000010.11:g.121520161_121520163delinsAGA | - |
RCV000440715 | p.Ser252Trp | missense variant | Adenocarcinoma of stomach | NC_000010.11:g.121520163G>C | ClinVar |
RCV000438603 | p.Ser252Trp | missense variant | Endometrial neoplasm | NC_000010.11:g.121520163G>C | ClinVar |
RCV000433250 | p.Ser252Trp | missense variant | Uterine Carcinosarcoma | NC_000010.11:g.121520163G>C | ClinVar |
RCV000664049 | p.Ser252Leu | missense variant | Crouzon syndrome | NC_000010.11:g.121520163G>A | ClinVar |
RCV000422979 | p.Ser252Trp | missense variant | Malignant neoplasm of body of uterus | NC_000010.11:g.121520163G>C | ClinVar |
RCV000433942 | p.Ser252Trp | missense variant | Acrocephalosyndactyly | NC_000010.11:g.121520163G>C | ClinVar |
RCV000431027 | p.Ser252Trp | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121520163G>C | ClinVar |
RCV000014202 | p.Ser252PheSer | missense variant | Pfeiffer syndrome variant | NC_000010.11:g.121520161_121520163delinsAGA | ClinVar |
rs79184941 | p.Ser252Trp | missense variant | - | NC_000010.11:g.121520163G>C | NCI-TCGA,NCI-TCGA Cosmic |
rs77543610 | p.Pro253Arg | missense variant | Apert syndrome (APRS) | NC_000010.11:g.121520160G>C | UniProt,dbSNP |
VAR_004117 | p.Pro253Arg | missense variant | Apert syndrome (APRS) | NC_000010.11:g.121520160G>C | UniProt |
COSM1139349 | p.Pro253Leu | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121520160G>A | NCI-TCGA Cosmic |
rs77543610 | p.Pro253Arg | missense variant | - | NC_000010.11:g.121520160G>C | NCI-TCGA,NCI-TCGA Cosmic |
RCV000436870 | p.Pro253Arg | missense variant | Head and Neck Neoplasms | NC_000010.11:g.121520160G>C | ClinVar |
RCV000049281 | p.Pro253Phe | missense variant | Acrocephalosyndactyly type I | NC_000010.11:g.121520160_121520162delinsAAG | ClinVar |
COSM5896063 | p.His254Tyr | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121520158G>A | NCI-TCGA Cosmic |
rs149200230 | p.Arg255Trp | missense variant | - | NC_000010.11:g.121520155G>A | ESP,ExAC,gnomAD |
rs1364891245 | p.Pro256Ser | missense variant | - | NC_000010.11:g.121520152G>A | gnomAD |
rs747171741 | p.Leu258Phe | missense variant | - | NC_000010.11:g.121520146G>A | ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Leu262Pro | missense variant | - | NC_000010.11:g.121520133A>G | NCI-TCGA |
rs779326224 | p.Pro263Leu | missense variant | - | NC_000010.11:g.121520130G>A | ExAC,gnomAD |
COSM3434781 | p.Ala264Thr | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121520128C>T | NCI-TCGA Cosmic |
rs1375799439 | p.Ala266Ser | missense variant | - | NC_000010.11:g.121520122C>A | gnomAD |
rs121918505 | p.Ser267Pro | missense variant | - | NC_000010.11:g.121520119A>G | - |
rs121918505 | p.Ser267Pro | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520119A>G | UniProt,dbSNP |
VAR_004118 | p.Ser267Pro | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520119A>G | UniProt |
RCV000690962 | p.Ser267Pro | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121520119A>G | ClinVar |
RCV000408850 | p.Ser267Pro | missense variant | Crouzon syndrome | NC_000010.11:g.121520119A>G | ClinVar |
RCV000435703 | p.Ser267Pro | missense variant | - | NC_000010.11:g.121520119A>G | ClinVar |
NCI-TCGA novel | p.Ser267IleSer | insertion | - | NC_000010.11:g.121520115_121520116insTGGAGA | NCI-TCGA |
RCV000014213 | p.Ser267Pro | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121520119A>G | ClinVar |
RCV000014214 | p.Ser267Pro | missense variant | Neoplasm of stomach | NC_000010.11:g.121520119A>G | ClinVar |
VAR_004119 | p.Thr268insThrGly | inframe_insertion | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
rs1424359588 | p.Val269Ala | missense variant | - | NC_000010.11:g.121520112A>G | gnomAD |
VAR_075856 | p.Val269_Val270del | inframe_deletion | Saethre-Chotzen syndrome (SCS) [MIM:101400] | - | UniProt |
rs183250272 | p.Gly271Arg | missense variant | - | NC_000010.11:g.121520107C>T | 1000Genomes,ExAC,gnomAD |
RCV000695392 | p.Gly271Val | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121520106C>A | ClinVar |
NCI-TCGA novel | p.Gly272ThrPheSerTerUnkUnk | frameshift | - | NC_000010.11:g.121520104_121520105insAAGTTTAGTAGTTCTTCCCCAAGTTTAGTAGT | NCI-TCGA |
VAR_042205 | p.Gly272Val | Missense | - | - | UniProt |
rs140427785 | p.Asp273Glu | missense variant | - | NC_000010.11:g.121520099G>C | ESP,ExAC,TOPMed,gnomAD |
VAR_017262 | p.Asp273del | inframe_deletion | Pfeiffer syndrome (PS) [MIM:101600] | - | UniProt |
rs1488169619 | p.Val274Ile | missense variant | - | NC_000010.11:g.121520098C>T | TOPMed,gnomAD |
rs1488169619 | p.Val274Ile | missense variant | - | NC_000010.11:g.121520098C>T | NCI-TCGA |
rs1258584689 | p.Glu275Gln | missense variant | - | NC_000010.11:g.121520095C>G | gnomAD |
RCV000544775 | p.Glu275Gln | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121520095C>G | ClinVar |
COSM1743350 | p.Phe276Cys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121520091A>C | NCI-TCGA Cosmic |
RCV000655413 | p.Phe276Val | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121520092A>C | ClinVar |
rs762937564 | p.Val277Ala | missense variant | - | NC_000010.11:g.121520088A>G | ExAC,TOPMed,gnomAD |
rs776587763 | p.Cys278Tyr | missense variant | - | NC_000010.11:g.121520085C>T | ExAC,gnomAD |
rs776587763 | p.Cys278Tyr | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520085C>T | UniProt,dbSNP |
VAR_017263 | p.Cys278Tyr | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520085C>T | UniProt |
rs1057519037 | p.Cys278Leu | missense variant | - | NC_000010.11:g.121520084_121520085delinsTA | - |
rs1554930790 | p.Cys278Trp | missense variant | - | NC_000010.11:g.121520084G>C | - |
rs776587763 | p.Cys278Phe | missense variant | - | NC_000010.11:g.121520085C>A | ExAC,gnomAD |
rs776587763 | p.Cys278Phe | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121520085C>A | UniProt,dbSNP |
VAR_004121 | p.Cys278Phe | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121520085C>A | UniProt |
RCV000255197 | p.Cys278Phe | missense variant | - | NC_000010.11:g.121520085C>A | ClinVar |
RCV000557313 | p.Cys278Phe | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121520085C>A | ClinVar |
RCV000844883 | p.Cys278Phe | missense variant | Crouzon syndrome | NC_000010.11:g.121520085C>A | ClinVar |
RCV000415498 | p.Cys278Phe | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121520085C>A | ClinVar |
RCV000655420 | p.Cys278Trp | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121520084G>C | ClinVar |
rs1057519038 | p.Tyr281Cys | missense variant | - | NC_000010.11:g.121520076T>C | - |
RCV000415488 | p.Tyr281Cys | missense variant | Crouzon syndrome | NC_000010.11:g.121520076T>C | ClinVar |
VAR_042206 | p.Asp283Asn | Missense | - | - | UniProt |
rs778094013 | p.Pro286Ser | missense variant | - | NC_000010.11:g.121520062G>A | ExAC,gnomAD |
rs1461081253 | p.His287Tyr | missense variant | - | NC_000010.11:g.121520059G>A | TOPMed |
VAR_004122 | p.His287_Gln289del | inframe_deletion | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
rs1217568539 | p.Ile288Val | missense variant | - | NC_000010.11:g.121520056T>C | gnomAD |
VAR_017265 | p.Ile288Ser | Missense | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
rs121918497 | p.Gln289Pro | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121520052T>G | UniProt,dbSNP |
VAR_004123 | p.Gln289Pro | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121520052T>G | UniProt |
rs121918497 | p.Gln289Pro | missense variant | Jackson-weiss syndrome (jws) | NC_000010.11:g.121520052T>G | - |
RCV000014197 | p.Gln289Pro | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121520052T>G | ClinVar |
RCV000014196 | p.Gln289Pro | missense variant | Crouzon syndrome | NC_000010.11:g.121520052T>G | ClinVar |
RCV000415509 | p.Gln289Pro | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121520052T>G | ClinVar |
rs121918499 | p.Trp290Cys | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121520048C>A | UniProt,dbSNP |
VAR_004124 | p.Trp290Cys | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121520048C>A | UniProt |
rs1057519039 | p.Trp290Ser | missense variant | - | NC_000010.11:g.121520049C>G | - |
rs121918501 | p.Trp290Arg | missense variant | - | NC_000010.11:g.121520050A>G | - |
rs121918501 | p.Trp290Arg | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520050A>G | UniProt,dbSNP |
VAR_004125 | p.Trp290Arg | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520050A>G | UniProt |
RCV000014206 | p.Trp290Gly | missense variant | Crouzon syndrome | NC_000010.11:g.121520050A>C | ClinVar |
RCV000655418 | p.Trp290Cys | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121520048C>A | ClinVar |
RCV000419759 | p.Trp290Cys | missense variant | Squamous cell lung carcinoma | NC_000010.11:g.121520048C>G | ClinVar |
RCV000014205 | p.Trp290Arg | missense variant | Crouzon syndrome | NC_000010.11:g.121520050A>G | ClinVar |
RCV000537718 | p.Trp290Arg | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121520050A>G | ClinVar |
rs121918501 | p.Trp290Gly | missense variant | - | NC_000010.11:g.121520050A>C | - |
rs121918501 | p.Trp290Gly | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520050A>C | UniProt,dbSNP |
VAR_017266 | p.Trp290Gly | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520050A>C | UniProt |
RCV000014218 | p.Trp290Cys | missense variant | Craniofacial-skeletal-dermatologic dysplasia | NC_000010.11:g.121520048C>A | ClinVar |
RCV000014217 | p.Trp290Cys | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121520048C>A | ClinVar |
RCV000415506 | p.Trp290Ser | missense variant | Crouzon syndrome | NC_000010.11:g.121520049C>G | ClinVar |
rs121918499 | p.Trp290Cys | missense variant | - | NC_000010.11:g.121520048C>G | NCI-TCGA,NCI-TCGA Cosmic |
rs121918500 | p.Lys292Glu | missense variant | - | NC_000010.11:g.121520044T>C | - |
rs121918500 | p.Lys292Glu | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520044T>C | UniProt,dbSNP |
VAR_004126 | p.Lys292Glu | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520044T>C | UniProt |
RCV000014204 | p.Lys292Glu | missense variant | Crouzon syndrome | NC_000010.11:g.121520044T>C | ClinVar |
rs748526473 | p.His293Tyr | missense variant | - | NC_000010.11:g.121520041G>A | ExAC,TOPMed |
rs755453106 | p.Val294Met | missense variant | - | NC_000010.11:g.121520038C>T | ExAC,gnomAD |
COSM3367926 | p.Lys296Asn | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121520030C>G | NCI-TCGA Cosmic |
rs779566502 | p.Gly298Ser | missense variant | - | NC_000010.11:g.121520026C>T | ExAC,gnomAD |
NCI-TCGA novel | p.Gly298Asp | missense variant | - | NC_000010.11:g.121520025C>T | NCI-TCGA |
rs1329431721 | p.Ser299Thr | missense variant | - | NC_000010.11:g.121520022C>G | gnomAD |
rs755570604 | p.Lys300Arg | missense variant | - | NC_000010.11:g.121520019T>C | ExAC,gnomAD |
rs1554930684 | p.Tyr301Cys | missense variant | - | NC_000010.11:g.121520016T>C | - |
rs1554930684 | p.Tyr301Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520016T>C | UniProt,dbSNP |
VAR_004127 | p.Tyr301Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121520016T>C | UniProt |
RCV000545665 | p.Tyr301Cys | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121520016T>C | ClinVar |
rs1159063118 | p.Gly302Arg | missense variant | - | NC_000010.11:g.121520014C>T | TOPMed,gnomAD |
rs374608214 | p.Pro303Arg | missense variant | - | NC_000010.11:g.121520010G>C | ESP,TOPMed,gnomAD |
rs370877537 | p.Asp304Asn | missense variant | - | NC_000010.11:g.121520008C>T | ESP,ExAC,TOPMed,gnomAD |
rs1057519040 | p.Tyr308Cys | missense variant | - | NC_000010.11:g.121519995T>C | - |
RCV000415502 | p.Tyr308Cys | missense variant | Crouzon syndrome | NC_000010.11:g.121519995T>C | ClinVar |
rs121913475 | p.Lys310Arg | missense variant | - | NC_000010.11:g.121519989T>C | - |
RCV000438031 | p.Lys310Arg | missense variant | Endometrial neoplasm | NC_000010.11:g.121519989T>C | ClinVar |
rs771158421 | p.Val311Ile | missense variant | - | NC_000010.11:g.121519987C>T | ExAC,gnomAD |
rs771158421 | p.Val311Ile | missense variant | - | NC_000010.11:g.121519987C>T | NCI-TCGA,NCI-TCGA Cosmic |
rs1358919643 | p.Ala314Thr | missense variant | - | NC_000010.11:g.121517463C>T | gnomAD |
RCV000534665 | p.Ala314Ser | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517463C>A | ClinVar |
rs1358919643 | p.Ala314Ser | missense variant | - | NC_000010.11:g.121517463C>A | gnomAD |
VAR_004128 | p.Ala314Ser | Missense | - | - | UniProt |
rs121918504 | p.Ala315Thr | missense variant | - | NC_000010.11:g.121517460C>T | ExAC,TOPMed,gnomAD |
rs121918504 | p.Ala315Ser | missense variant | - | NC_000010.11:g.121517460C>A | ExAC,TOPMed,gnomAD |
rs121918504 | p.Ala315Ser | missense variant | - | NC_000010.11:g.121517460C>A | UniProt,dbSNP |
VAR_017267 | p.Ala315Ser | missense variant | - | NC_000010.11:g.121517460C>A | UniProt |
RCV000014212 | p.Ala315Ser | missense variant | Craniosynostosis, nonsyndromic unicoronal | NC_000010.11:g.121517460C>A | ClinVar |
NCI-TCGA novel | p.Gly316Asp | missense variant | - | NC_000010.11:g.121517456C>T | NCI-TCGA |
NCI-TCGA novel | p.Thr320Met | missense variant | - | NC_000010.11:g.121517444G>A | NCI-TCGA |
rs121918510 | p.Asp321Ala | missense variant | - | NC_000010.11:g.121517441T>G | - |
rs121918510 | p.Asp321Ala | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517441T>G | UniProt,dbSNP |
VAR_004129 | p.Asp321Ala | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517441T>G | UniProt |
rs1318903454 | p.Asp321Glu | missense variant | - | NC_000010.11:g.121517440G>T | TOPMed |
RCV000014227 | p.Asp321Ala | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121517441T>G | ClinVar |
rs371141402 | p.Lys322Thr | missense variant | - | NC_000010.11:g.121517438T>G | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs371141402 | p.Lys322Arg | missense variant | - | NC_000010.11:g.121517438T>C | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs1443966407 | p.Ile324Val | missense variant | - | NC_000010.11:g.121517433T>C | TOPMed,gnomAD |
RCV000655424 | p.Ile324Val | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517433T>C | ClinVar |
NCI-TCGA novel | p.Val326Ala | missense variant | - | NC_000010.11:g.121517426A>G | NCI-TCGA |
RCV000798719 | p.Tyr328Cys | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517420T>C | ClinVar |
RCV000014189 | p.Tyr328Cys | missense variant | Crouzon syndrome | NC_000010.11:g.121517420T>C | ClinVar |
rs121918493 | p.Tyr328Cys | missense variant | - | NC_000010.11:g.121517420T>C | - |
rs121918493 | p.Tyr328Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517420T>C | UniProt,dbSNP |
VAR_004130 | p.Tyr328Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517420T>C | UniProt |
rs200204947 | p.Arg330Trp | missense variant | - | NC_000010.11:g.121517415G>A | ESP,TOPMed,gnomAD |
rs199757302 | p.Arg330Gln | missense variant | - | NC_000010.11:g.121517414C>T | 1000Genomes,ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Arg330Leu | missense variant | - | NC_000010.11:g.121517414C>A | NCI-TCGA |
VAR_004131 | p.Asn331Ile | Missense | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
rs372612885 | p.Phe334Tyr | missense variant | - | NC_000010.11:g.121517402A>T | ESP,ExAC,TOPMed,gnomAD |
COSM4012190 | p.Glu335Asp | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121517398C>A | NCI-TCGA Cosmic |
rs1057519042 | p.Asp336Gly | missense variant | - | NC_000010.11:g.121517396T>C | - |
RCV000415483 | p.Asp336Gly | missense variant | Crouzon syndrome | NC_000010.11:g.121517396T>C | ClinVar |
rs387906676 | p.Ala337Thr | missense variant | - | NC_000010.11:g.121517394C>T | - |
rs387906676 | p.Ala337Pro | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517394C>G | UniProt,dbSNP |
VAR_017268 | p.Ala337Pro | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517394C>G | UniProt |
RCV000022733 | p.Ala337Thr | missense variant | Variant of unknown significance | NC_000010.11:g.121517394C>T | ClinVar |
RCV000022732 | p.Ala337Pro | missense variant | Crouzon syndrome | NC_000010.11:g.121517394C>G | ClinVar |
VAR_004132 | p.Ala337insAlaAsnAla | inframe_insertion | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
rs1554928905 | p.Gly338Lys | missense variant | - | NC_000010.11:g.121517390_121517391delinsTT | - |
rs1057519044 | p.Gly338Glu | missense variant | - | NC_000010.11:g.121517390C>T | - |
COSM1346275 | p.Gly338IlePheSerTerUnkUnk | frameshift | Variant assessed as Somatic; HIGH impact. | NC_000010.11:g.121517385_121517391ATTCCCC>- | NCI-TCGA Cosmic |
RCV000415494 | p.Gly338Arg | missense variant | Crouzon syndrome | NC_000010.11:g.121517391C>G | ClinVar |
RCV000558696 | p.Gly338Lys | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517390_121517391delinsTT | ClinVar |
RCV000655417 | p.Gly338Trp | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517391C>A | ClinVar |
RCV000762802 | p.Gly338Glu | missense variant | Acrocephalosyndactyly type I | NC_000010.11:g.121517390C>T | ClinVar |
rs121918489 | p.Tyr340His | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517385A>G | UniProt,dbSNP |
VAR_004134 | p.Tyr340His | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517385A>G | UniProt |
rs121918489 | p.Tyr340His | missense variant | - | NC_000010.11:g.121517385A>G | - |
rs1554928884 | p.Tyr340Cys | missense variant | - | NC_000010.11:g.121517384T>C | - |
rs1554928884 | p.Tyr340Cys | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517384T>C | UniProt,dbSNP |
VAR_017269 | p.Tyr340Cys | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517384T>C | UniProt |
RCV000014175 | p.Tyr340His | missense variant | Crouzon syndrome | NC_000010.11:g.121517385A>G | ClinVar |
RCV000523700 | p.Tyr340Cys | missense variant | - | NC_000010.11:g.121517384T>C | ClinVar |
RCV000014194 | p.Thr341Pro | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121517382T>G | ClinVar |
rs121918495 | p.Thr341Pro | missense variant | - | NC_000010.11:g.121517382T>G | - |
rs121918495 | p.Thr341Pro | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517382T>G | UniProt,dbSNP |
VAR_004135 | p.Thr341Pro | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517382T>G | UniProt |
rs121918488 | p.Cys342Arg | missense variant | Jackson-weiss syndrome (jws) | NC_000010.11:g.121517379A>G | - |
rs121918488 | p.Cys342Arg | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517379A>G | UniProt,dbSNP |
VAR_004137 | p.Cys342Arg | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517379A>G | UniProt |
rs121918487 | p.Cys342Tyr | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517378C>T | UniProt,dbSNP |
VAR_004139 | p.Cys342Tyr | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517378C>T | UniProt |
rs121918487 | p.Cys342Tyr | missense variant | - | NC_000010.11:g.121517378C>T | - |
rs121918487 | p.Cys342Ser | missense variant | - | NC_000010.11:g.121517378C>G | - |
rs121918488 | p.Cys342Ser | missense variant | Jackson-weiss syndrome (jws) | NC_000010.11:g.121517379A>T | - |
rs121918488 | p.Cys342Ser | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121517379A>T | UniProt,dbSNP |
VAR_004138 | p.Cys342Ser | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121517379A>T | UniProt |
rs121918487 | p.Cys342Phe | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517378C>A | UniProt,dbSNP |
VAR_004136 | p.Cys342Phe | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517378C>A | UniProt |
rs121918487 | p.Cys342Phe | missense variant | - | NC_000010.11:g.121517378C>A | - |
rs121918488 | p.Cys342Gly | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517379A>C | UniProt,dbSNP |
VAR_017270 | p.Cys342Gly | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121517379A>C | UniProt |
rs121918488 | p.Cys342Gly | missense variant | Jackson-weiss syndrome (jws) | NC_000010.11:g.121517379A>C | - |
RCV000490034 | p.Cys342Ser | missense variant | - | NC_000010.11:g.121517379A>T | ClinVar |
RCV000014183 | p.Cys342Ser | missense variant | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (ABS2) | NC_000010.11:g.121517379A>T | ClinVar |
RCV000014174 | p.Cys342Tyr | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121517378C>T | ClinVar |
RCV000547490 | p.Cys342Tyr | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517378C>T | ClinVar |
RCV000014173 | p.Cys342Tyr | missense variant | Crouzon syndrome | NC_000010.11:g.121517378C>T | ClinVar |
RCV000762801 | p.Cys342Tyr | missense variant | Acrocephalosyndactyly type I | NC_000010.11:g.121517378C>T | ClinVar |
RCV000415499 | p.Cys342Ser | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121517378C>G | ClinVar |
rs121918496 | p.Cys342Trp | missense variant | - | NC_000010.11:g.121517377G>C | - |
rs121918496 | p.Cys342Trp | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517377G>C | UniProt,dbSNP |
VAR_017271 | p.Cys342Trp | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517377G>C | UniProt |
RCV000535651 | p.Cys342Trp | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517377G>C | ClinVar |
RCV000014179 | p.Cys342Arg | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121517379A>G | ClinVar |
RCV000655416 | p.Cys342Ser | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517379A>T | ClinVar |
RCV000014181 | p.Cys342Ser | missense variant | Crouzon syndrome | NC_000010.11:g.121517379A>T | ClinVar |
RCV000415490 | p.Cys342Phe | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121517378C>A | ClinVar |
RCV000415501 | p.Cys342Gly | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121517379A>C | ClinVar |
RCV000415484 | p.Cys342Ser | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121517379A>T | ClinVar |
RCV000815502 | p.Cys342Phe | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517378C>A | ClinVar |
RCV000534888 | p.Cys342Arg | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517379A>G | ClinVar |
RCV000014195 | p.Cys342Trp | missense variant | Crouzon syndrome | NC_000010.11:g.121517377G>C | ClinVar |
RCV000014182 | p.Cys342Ser | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121517379A>T | ClinVar |
RCV000014180 | p.Cys342Arg | missense variant | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (ABS2) | NC_000010.11:g.121517379A>G | ClinVar |
RCV000560038 | p.Cys342Ser | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517378C>G | ClinVar |
RCV000014178 | p.Cys342Arg | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121517379A>G | ClinVar |
RCV000014177 | p.Cys342Arg | missense variant | Crouzon syndrome | NC_000010.11:g.121517379A>G | ClinVar |
rs121918492 | p.Ala344Gly | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517372G>C | UniProt,dbSNP |
VAR_004140 | p.Ala344Gly | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517372G>C | UniProt |
rs121918492 | p.Ala344Gly | missense variant | Jackson-weiss syndrome (jws) | NC_000010.11:g.121517372G>C | - |
RCV000014187 | p.Ala344Gly | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121517372G>C | ClinVar |
RCV000014188 | p.Ala344Gly | missense variant | Crouzon syndrome | NC_000010.11:g.121517372G>C | ClinVar |
COSM4925043 | p.Ala344Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121517373C>A | NCI-TCGA Cosmic |
VAR_004141 | p.Ala344Pro | Missense | Pfeiffer syndrome (PS) [MIM:101600] | - | UniProt |
VAR_004141 | p.Ala344Pro | Missense | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
rs1554928838 | p.Gly345Asp | missense variant | - | NC_000010.11:g.121517369C>T | - |
COSM1346274 | p.Gly345Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121517370C>T | NCI-TCGA Cosmic |
RCV000548281 | p.Gly345Asp | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517369C>T | ClinVar |
rs121918494 | p.Ser347Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517363G>C | UniProt,dbSNP |
VAR_004142 | p.Ser347Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517363G>C | UniProt |
RCV000626619 | p.Ser347Cys | missense variant | Hypertelorism | NC_000010.11:g.121517363G>C | ClinVar |
rs121918502 | p.Ser351Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517351G>C | UniProt,dbSNP |
VAR_004143 | p.Ser351Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517351G>C | UniProt |
rs121918502 | p.Ser351Cys | missense variant | - | NC_000010.11:g.121517351G>C | - |
RCV000256107 | p.Ser351Cys | missense variant | - | NC_000010.11:g.121517351G>C | ClinVar |
RCV000528973 | p.Ser351Cys | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517351G>C | ClinVar |
RCV000014208 | p.Ser351Cys | missense variant | Pfeiffer syndrome, type III | NC_000010.11:g.121517351G>C | ClinVar |
RCV000014209 | p.Ser351Cys | missense variant | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (ABS2) | NC_000010.11:g.121517351G>C | ClinVar |
RCV000415503 | p.Ser351Cys | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121517351G>C | ClinVar |
rs1354809777 | p.His353Arg | missense variant | - | NC_000010.11:g.121517345T>C | gnomAD |
rs121918490 | p.Ser354Cys | missense variant | - | NC_000010.11:g.121517342G>C | - |
rs121918490 | p.Ser354Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517342G>C | UniProt,dbSNP |
VAR_004144 | p.Ser354Cys | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121517342G>C | UniProt |
RCV000014176 | p.Ser354Cys | missense variant | Crouzon syndrome | NC_000010.11:g.121517342G>C | ClinVar |
RCV000655419 | p.Ser354Cys | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121517342G>C | ClinVar |
RCV000623131 | p.Ser354Cys | missense variant | Inborn genetic diseases | NC_000010.11:g.121517342G>C | ClinVar |
VAR_017272 | p.Ser354Tyr | Missense | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
NCI-TCGA novel | p.Ala355Val | missense variant | - | NC_000010.11:g.121517339G>A | NCI-TCGA |
VAR_004145 | p.Trp356_Thr358del | inframe_deletion | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
rs1274989878 | p.Val359Ile | missense variant | - | NC_000010.11:g.121517328C>T | gnomAD |
VAR_004146 | p.Val359Phe | Missense | Pfeiffer syndrome (PS) [MIM:101600] | - | UniProt |
VAR_004146 | p.Val359Phe | Missense | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
rs1437948804 | p.Leu360Val | missense variant | - | NC_000010.11:g.121517325G>C | gnomAD |
rs1322410924 | p.Pro361Ser | missense variant | - | NC_000010.11:g.121517322G>A | gnomAD |
rs757846343 | p.Ala362Val | missense variant | - | NC_000010.11:g.121515319G>A | ExAC,TOPMed,gnomAD |
VAR_017273 | p.Ala362Ser | Missense | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
COSM2056264 | p.Gly364Glu | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121515313C>T | NCI-TCGA Cosmic |
rs762423026 | p.Glu366Lys | missense variant | - | NC_000010.11:g.121515308C>T | ExAC,TOPMed,gnomAD |
rs752220358 | p.Glu366Gly | missense variant | - | NC_000010.11:g.121515307T>C | ExAC,TOPMed,gnomAD |
COSM3806605 | p.Glu366Gln | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121515308C>G | NCI-TCGA Cosmic |
rs775136828 | p.Lys367Glu | missense variant | - | NC_000010.11:g.121515305T>C | ExAC,gnomAD |
rs143645832 | p.Glu368Val | missense variant | - | NC_000010.11:g.121515301T>A | ESP,TOPMed,gnomAD |
rs1434819678 | p.Glu368Lys | missense variant | - | NC_000010.11:g.121515302C>T | TOPMed |
COSM4012185 | p.Thr370Lys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121515295G>T | NCI-TCGA Cosmic |
NCI-TCGA novel | p.Thr370Ile | missense variant | - | NC_000010.11:g.121515295G>A | NCI-TCGA |
NCI-TCGA novel | p.Thr370Ala | missense variant | - | NC_000010.11:g.121515296T>C | NCI-TCGA |
rs121913477 | p.Ser372Cys | missense variant | - | NC_000010.11:g.121515289G>C | TOPMed |
rs121913477 | p.Ser372Tyr | missense variant | - | NC_000010.11:g.121515289G>T | TOPMed |
rs121913477 | p.Ser372Cys | missense variant | Beare-Stevenson cutis gyrata syndrome (BSTVS) | NC_000010.11:g.121515289G>C | UniProt,dbSNP |
VAR_017274 | p.Ser372Cys | missense variant | Beare-Stevenson cutis gyrata syndrome (BSTVS) | NC_000010.11:g.121515289G>C | UniProt |
RCV000014200 | p.Ser372Cys | missense variant | Cutis Gyrata syndrome of Beare and Stevenson (BSTVS) | NC_000010.11:g.121515289G>C | ClinVar |
rs1458741036 | p.Pro373Ser | missense variant | - | NC_000010.11:g.121515287G>A | TOPMed,gnomAD |
rs1057520028 | p.Asp374Gly | missense variant | - | NC_000010.11:g.121515283T>C | - |
rs776413718 | p.Asp374Asn | missense variant | - | NC_000010.11:g.121515284C>T | ExAC,gnomAD |
RCV000423432 | p.Asp374Gly | missense variant | Endometrial neoplasm | NC_000010.11:g.121515283T>C | ClinVar |
rs121913478 | p.Tyr375Cys | missense variant | Beare-Stevenson cutis gyrata syndrome (BSTVS) | NC_000010.11:g.121515280T>C | UniProt,dbSNP |
VAR_017275 | p.Tyr375Cys | missense variant | Beare-Stevenson cutis gyrata syndrome (BSTVS) | NC_000010.11:g.121515280T>C | UniProt |
RCV000441051 | p.Tyr375Cys | missense variant | Endometrial neoplasm | NC_000010.11:g.121515280T>C | ClinVar |
NCI-TCGA novel | p.Glu377Asp | missense variant | - | NC_000010.11:g.121515273C>A | NCI-TCGA |
rs1064796452 | p.Tyr381Cys | missense variant | - | NC_000010.11:g.121515262T>C | - |
rs387906678 | p.Tyr381Asp | missense variant | Bent bone dysplasia syndrome (BBDS) | NC_000010.11:g.121515263A>C | UniProt,dbSNP |
VAR_067977 | p.Tyr381Asp | missense variant | Bent bone dysplasia syndrome (BBDS) | NC_000010.11:g.121515263A>C | UniProt |
RCV000482209 | p.Tyr381Cys | missense variant | - | NC_000010.11:g.121515262T>C | ClinVar |
RCV000190765 | p.Tyr381Asp | missense variant | Inborn genetic diseases | NC_000010.11:g.121515263A>C | ClinVar |
RCV000424046 | p.Tyr381His | missense variant | Carcinoma of esophagus | NC_000010.11:g.121515263A>G | ClinVar |
RCV000441347 | p.Tyr381His | missense variant | Adenocarcinoma of stomach | NC_000010.11:g.121515263A>G | ClinVar |
RCV000022735 | p.Tyr381Asp | missense variant | Bent bone dysplasia syndrome (BBDS) | NC_000010.11:g.121515263A>C | ClinVar |
RCV000725446 | p.Tyr381Asp | missense variant | - | NC_000010.11:g.121515263A>C | ClinVar |
RCV000427294 | p.Tyr381His | missense variant | Endometrial neoplasm | NC_000010.11:g.121515263A>G | ClinVar |
RCV000430563 | p.Tyr381His | missense variant | Malignant neoplasm of body of uterus | NC_000010.11:g.121515263A>G | ClinVar |
RCV000585739 | p.Cys382Arg | missense variant | Adenoid cystic carcinoma | NC_000010.11:g.121515260A>G | ClinVar |
rs1057519900 | p.Cys382Tyr | missense variant | - | NC_000010.11:g.121515259C>T | - |
RCV000434751 | p.Cys382Tyr | missense variant | Malignant neoplasm of body of uterus | NC_000010.11:g.121515259C>T | ClinVar |
RCV000421261 | p.Cys382Tyr | missense variant | Carcinoma of esophagus | NC_000010.11:g.121515259C>T | ClinVar |
RCV000438442 | p.Cys382Tyr | missense variant | Adenocarcinoma of stomach | NC_000010.11:g.121515259C>T | ClinVar |
rs773178450 | p.Ile383Thr | missense variant | - | NC_000010.11:g.121515256A>G | ExAC,TOPMed,gnomAD |
rs1554927408 | p.Gly384Arg | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121515254C>T | UniProt,dbSNP |
VAR_004147 | p.Gly384Arg | missense variant | Crouzon syndrome (CS) | NC_000010.11:g.121515254C>T | UniProt |
rs1554927408 | p.Gly384Arg | missense variant | - | NC_000010.11:g.121515254C>T | - |
rs1291834042 | p.Gly384Ala | missense variant | - | NC_000010.11:g.121515253C>G | gnomAD |
NCI-TCGA novel | p.Gly384Arg | missense variant | - | NC_000010.11:g.121515254C>G | NCI-TCGA |
RCV000762798 | p.Gly384Arg | missense variant | Acrocephalosyndactyly type I | NC_000010.11:g.121515254C>T | ClinVar |
RCV000525216 | p.Gly384Arg | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121515254C>T | ClinVar |
rs780167791 | p.Phe386Val | missense variant | - | NC_000010.11:g.121515248A>C | ExAC,TOPMed,gnomAD |
rs769919776 | p.Ile388Val | missense variant | - | NC_000010.11:g.121515242T>C | ExAC,gnomAD |
rs781714766 | p.Ala389Ser | missense variant | - | NC_000010.11:g.121515239C>A | ExAC,TOPMed,gnomAD |
rs1329578117 | p.Ala389Val | missense variant | - | NC_000010.11:g.121515238G>A | gnomAD |
rs781714766 | p.Ala389Thr | missense variant | - | NC_000010.11:g.121515239C>T | ExAC,TOPMed,gnomAD |
rs751951199 | p.Met391Val | missense variant | - | NC_000010.11:g.121515233T>C | ExAC,gnomAD |
rs387906677 | p.Met391Arg | missense variant | Bent bone dysplasia syndrome (bbds) | NC_000010.11:g.121515232A>C | - |
rs387906677 | p.Met391Arg | missense variant | Bent bone dysplasia syndrome (BBDS) | NC_000010.11:g.121515232A>C | UniProt,dbSNP |
VAR_067978 | p.Met391Arg | missense variant | Bent bone dysplasia syndrome (BBDS) | NC_000010.11:g.121515232A>C | UniProt |
NCI-TCGA novel | p.Met391Ile | missense variant | - | NC_000010.11:g.121515231C>A | NCI-TCGA |
RCV000022734 | p.Met391Arg | missense variant | Bent bone dysplasia syndrome (BBDS) | NC_000010.11:g.121515232A>C | ClinVar |
RCV000493423 | p.Met391Arg | missense variant | - | NC_000010.11:g.121515232A>C | ClinVar |
COSM3721811 | p.Val392Ala | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121515229A>G | NCI-TCGA Cosmic |
rs1022488982 | p.Thr394Ala | missense variant | - | NC_000010.11:g.121515224T>C | TOPMed,gnomAD |
rs971411400 | p.Thr394Ile | missense variant | - | NC_000010.11:g.121515223G>A | gnomAD |
COSM5967160 | p.Val395Asp | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121515220A>T | NCI-TCGA Cosmic |
rs1441011501 | p.Arg399Ter | stop gained | - | NC_000010.11:g.121515209G>A | gnomAD |
rs1219597593 | p.Arg399Gln | missense variant | - | NC_000010.11:g.121515208C>T | TOPMed,gnomAD |
rs752209605 | p.Met400Lys | missense variant | - | NC_000010.11:g.121515205A>T | ExAC,gnomAD |
rs764748528 | p.Asn402Ser | missense variant | - | NC_000010.11:g.121515199T>C | ExAC,TOPMed,gnomAD |
RCV000376970 | p.Asn402Ser | missense variant | - | NC_000010.11:g.121515199T>C | ClinVar |
rs753437208 | p.Thr403Lys | missense variant | - | NC_000010.11:g.121515196G>T | ExAC,TOPMed,gnomAD |
rs753437208 | p.Thr403Met | missense variant | - | NC_000010.11:g.121515196G>A | ExAC,TOPMed,gnomAD |
rs1003638950 | p.Thr404Ile | missense variant | - | NC_000010.11:g.121515193G>A | TOPMed,gnomAD |
rs772986332 | p.Lys405Glu | missense variant | - | NC_000010.11:g.121515191T>C | ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Lys405Asn | missense variant | - | NC_000010.11:g.121515189C>A | NCI-TCGA |
NCI-TCGA novel | p.Lys405SerPheSerTerUnkUnk | frameshift | - | NC_000010.11:g.121515192_121515193insGAAGCTCACAGAA | NCI-TCGA |
NCI-TCGA novel | p.Asp408Gly | missense variant | - | NC_000010.11:g.121515181T>C | NCI-TCGA |
rs1242158155 | p.Ser410Gly | missense variant | - | NC_000010.11:g.121515176T>C | TOPMed,gnomAD |
rs372348666 | p.Pro413Leu | missense variant | - | NC_000010.11:g.121515166G>A | ESP,ExAC,TOPMed,gnomAD |
rs769880096 | p.Ala414Thr | missense variant | - | NC_000010.11:g.121515164C>T | ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Ala414GlyPheSerTerUnkUnk | frameshift | - | NC_000010.11:g.121515163_121515164insC | NCI-TCGA |
rs1295460269 | p.Val415Ala | missense variant | - | NC_000010.11:g.121515160A>G | gnomAD |
rs1355130739 | p.Lys417Arg | missense variant | - | NC_000010.11:g.121515154T>C | TOPMed |
COSM6064901 | p.Lys420Ile | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121515145T>A | NCI-TCGA Cosmic |
NCI-TCGA novel | p.Lys420Ter | stop gained | - | NC_000010.11:g.121515146T>A | NCI-TCGA |
rs1422125612 | p.Arg421His | missense variant | - | NC_000010.11:g.121515142C>T | gnomAD |
rs747449724 | p.Ile422Met | missense variant | - | NC_000010.11:g.121515138G>C | ExAC,gnomAD |
rs1291747099 | p.Pro423Leu | missense variant | - | NC_000010.11:g.121515136G>A | TOPMed |
rs1207716999 | p.Pro423Ser | missense variant | - | NC_000010.11:g.121515137G>A | TOPMed |
rs998662110 | p.Arg425Gln | missense variant | - | NC_000010.11:g.121515130C>T | TOPMed,gnomAD |
rs1483629749 | p.Ser431Leu | missense variant | - | NC_000010.11:g.121503937G>A | gnomAD |
rs1045429276 | p.Glu433Asp | missense variant | - | NC_000010.11:g.121503930C>G | TOPMed |
rs146589618 | p.Ser435Gly | missense variant | - | NC_000010.11:g.121503926T>C | ESP,ExAC,gnomAD |
rs1346945144 | p.Met438Thr | missense variant | - | NC_000010.11:g.121503916A>G | gnomAD |
rs916042003 | p.Asn439Ser | missense variant | - | NC_000010.11:g.121503913T>C | TOPMed |
NCI-TCGA novel | p.Asn439Tyr | missense variant | - | NC_000010.11:g.121503914T>A | NCI-TCGA |
COSM3434762 | p.Ser440Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121503910G>A | NCI-TCGA Cosmic |
rs1324981459 | p.Asn441His | missense variant | - | NC_000010.11:g.121503908T>G | gnomAD |
rs368002690 | p.Thr442Asn | missense variant | - | NC_000010.11:g.121503904G>T | ESP,ExAC,gnomAD |
rs757125418 | p.Pro443Leu | missense variant | - | NC_000010.11:g.121503901G>A | ExAC,TOPMed,gnomAD |
rs7078073 | p.Pro443Ala | missense variant | - | NC_000010.11:g.121503902G>C | TOPMed,gnomAD |
rs757125418 | p.Pro443Arg | missense variant | - | NC_000010.11:g.121503901G>C | ExAC,TOPMed,gnomAD |
rs776868501 | p.Val445Met | missense variant | - | NC_000010.11:g.121503896C>T | ExAC,gnomAD |
rs1372232738 | p.Arg446Gly | missense variant | - | NC_000010.11:g.121503893T>C | gnomAD |
COSM3414755 | p.Arg446Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121503891C>A | NCI-TCGA Cosmic |
NCI-TCGA novel | p.Ile447Met | missense variant | - | NC_000010.11:g.121503888T>C | NCI-TCGA |
rs1187984599 | p.Thr448Ala | missense variant | - | NC_000010.11:g.121503887T>C | TOPMed,gnomAD |
rs761012674 | p.Thr449Ala | missense variant | - | NC_000010.11:g.121503884T>C | ExAC,TOPMed,gnomAD |
rs536181987 | p.Arg450Cys | missense variant | - | NC_000010.11:g.121503881G>A | 1000Genomes,ExAC,TOPMed,gnomAD |
rs773245022 | p.Arg450His | missense variant | - | NC_000010.11:g.121503880C>T | ExAC,TOPMed,gnomAD |
rs773245022 | p.Arg450Leu | missense variant | - | NC_000010.11:g.121503880C>A | ExAC,TOPMed,gnomAD |
rs148672240 | p.Thr454Met | missense variant | - | NC_000010.11:g.121503868G>A | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs1251168391 | p.Ala455Thr | missense variant | - | NC_000010.11:g.121503866C>T | gnomAD |
rs1245946700 | p.Thr457Asn | missense variant | - | NC_000010.11:g.121503859G>T | TOPMed,gnomAD |
rs1265366960 | p.Pro458Ala | missense variant | - | NC_000010.11:g.121503857G>C | TOPMed |
rs370602437 | p.Met459Leu | missense variant | - | NC_000010.11:g.121503854T>A | ESP,ExAC,TOPMed,gnomAD |
rs370602437 | p.Met459Val | missense variant | - | NC_000010.11:g.121503854T>C | ESP,ExAC,TOPMed,gnomAD |
rs376451171 | p.Ala461Val | missense variant | - | NC_000010.11:g.121503847G>A | ESP,ExAC,TOPMed,gnomAD |
rs745349225 | p.Ala461Ser | missense variant | - | NC_000010.11:g.121503848C>A | ExAC,gnomAD |
rs756855939 | p.Gly462Arg | missense variant | - | NC_000010.11:g.121503845C>G | ExAC,gnomAD |
NCI-TCGA novel | p.Gly462Val | missense variant | - | NC_000010.11:g.121503844C>A | NCI-TCGA |
rs751433223 | p.Val463Asp | missense variant | - | NC_000010.11:g.121503841A>T | ExAC,TOPMed,gnomAD |
rs974338458 | p.Glu470Asp | missense variant | - | NC_000010.11:g.121503819C>A | - |
COSM3806597 | p.Asp471Tyr | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121503818C>A | NCI-TCGA Cosmic |
rs1459232873 | p.Pro472Leu | missense variant | - | NC_000010.11:g.121503814G>A | gnomAD |
rs1383333777 | p.Lys473Ile | missense variant | - | NC_000010.11:g.121503811T>A | gnomAD |
rs758417193 | p.Glu475Gly | missense variant | - | NC_000010.11:g.121503805T>C | ExAC,gnomAD |
rs777657579 | p.Glu475Lys | missense variant | - | NC_000010.11:g.121503806C>T | ExAC,gnomAD |
rs752644307 | p.Pro477Ala | missense variant | - | NC_000010.11:g.121503800G>C | ExAC,gnomAD |
rs765241522 | p.Pro477Leu | missense variant | - | NC_000010.11:g.121503799G>A | ExAC,gnomAD |
NCI-TCGA novel | p.Arg478Gly | missense variant | - | NC_000010.11:g.121503797T>C | NCI-TCGA |
rs760845434 | p.Asp479His | missense variant | - | NC_000010.11:g.121503794C>G | ExAC,TOPMed,gnomAD |
COSM6128304 | p.Asp479Asn | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121503794C>T | NCI-TCGA Cosmic |
NCI-TCGA novel | p.Thr482Ile | missense variant | - | NC_000010.11:g.121500942G>A | NCI-TCGA |
rs767430380 | p.Leu483Pro | missense variant | - | NC_000010.11:g.121500939A>G | ExAC,gnomAD |
NCI-TCGA novel | p.Leu483Val | missense variant | - | NC_000010.11:g.121500940G>C | NCI-TCGA |
rs149962204 | p.Lys485Asn | missense variant | - | NC_000010.11:g.121500932C>G | ESP,ExAC,TOPMed,gnomAD |
rs1400354610 | p.Glu489Lys | missense variant | - | NC_000010.11:g.121500922C>T | gnomAD |
rs1554917471 | p.Gly493Trp | missense variant | - | NC_000010.11:g.121500910C>A | - |
RCV000659648 | p.Gly493Trp | missense variant | Levy-Hollister syndrome (LADD) | NC_000010.11:g.121500910C>A | ClinVar |
rs986617010 | p.Gln494Arg | missense variant | - | NC_000010.11:g.121500906T>C | TOPMed |
rs751731391 | p.Val496Ile | missense variant | - | NC_000010.11:g.121500901C>T | ExAC,TOPMed,gnomAD |
COSM1346237 | p.Met497Ile | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121500896C>T | NCI-TCGA Cosmic |
rs1173224369 | p.Gly502Glu | missense variant | - | NC_000010.11:g.121500882C>T | gnomAD |
rs1384270958 | p.Gly502Arg | missense variant | - | NC_000010.11:g.121500883C>G | gnomAD |
rs370273049 | p.Asp504Asn | missense variant | - | NC_000010.11:g.121500877C>T | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs1429693622 | p.Asp506Tyr | missense variant | - | NC_000010.11:g.121500871C>A | TOPMed |
rs770391340 | p.Lys509Arg | missense variant | - | NC_000010.11:g.121500861T>C | ExAC,gnomAD |
rs775829173 | p.Lys509Glu | missense variant | - | NC_000010.11:g.121500862T>C | ExAC,gnomAD |
rs759906958 | p.Glu510Asp | missense variant | - | NC_000010.11:g.121500857C>A | ExAC,TOPMed,gnomAD |
rs765066758 | p.Ala511Thr | missense variant | - | NC_000010.11:g.121500856C>T | ExAC,TOPMed,gnomAD |
rs770309121 | p.Ala511Val | missense variant | - | NC_000010.11:g.121500855G>A | ExAC,gnomAD |
rs1204979359 | p.Val512Ile | missense variant | - | NC_000010.11:g.121500853C>T | gnomAD |
rs1262068931 | p.Val514Met | missense variant | - | NC_000010.11:g.121500847C>T | TOPMed,gnomAD |
NCI-TCGA novel | p.Val516Met | missense variant | - | NC_000010.11:g.121500841C>T | NCI-TCGA |
rs55689343 | p.Asp521Val | missense variant | - | NC_000010.11:g.121498605T>A | ExAC,TOPMed,gnomAD |
COSM1584816 | p.Asp521MetPheSerTerUnkUnk | frameshift | Variant assessed as Somatic; HIGH impact. | NC_000010.11:g.121500830C>- | NCI-TCGA Cosmic |
rs55689343 | p.Asp521Gly | missense variant | - | NC_000010.11:g.121498605T>C | ExAC,TOPMed,gnomAD |
rs1389986512 | p.Asp522Tyr | missense variant | - | NC_000010.11:g.121498603C>A | TOPMed |
rs756076618 | p.Asp522Val | missense variant | - | NC_000010.11:g.121498602T>A | ExAC,TOPMed,gnomAD |
rs1057520044 | p.Thr524Ala | missense variant | - | NC_000010.11:g.121498597T>C | - |
RCV000424161 | p.Thr524Ala | missense variant | Craniosynostosis syndrome | NC_000010.11:g.121498597T>C | ClinVar |
RCV000014221 | p.Lys526Glu | missense variant | Scaphocephaly, maxillary retrusion, and mental retardation | NC_000010.11:g.121498591T>C | ClinVar |
rs121918507 | p.Lys526Glu | missense variant | - | NC_000010.11:g.121498591T>C | - |
rs121918507 | p.Lys526Glu | missense variant | Familial scaphocephaly syndrome (FSPC) | NC_000010.11:g.121498591T>C | UniProt,dbSNP |
VAR_023788 | p.Lys526Glu | missense variant | Familial scaphocephaly syndrome (FSPC) | NC_000010.11:g.121498591T>C | UniProt |
RCV000014220 | p.Lys526Glu | missense variant | Crouzon syndrome | NC_000010.11:g.121498591T>C | ClinVar |
rs999092280 | p.Met535Leu | missense variant | - | NC_000010.11:g.121498564T>A | TOPMed |
rs1057519800 | p.Met535Ile | missense variant | - | NC_000010.11:g.121498562C>T | - |
rs1057519800 | p.Met535Ile | missense variant | - | NC_000010.11:g.121498562C>A | - |
rs1057519800 | p.Met535Ile | missense variant | - | NC_000010.11:g.121498562C>G | - |
RCV000417871 | p.Met535Ile | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498562C>T | ClinVar |
RCV000435530 | p.Met535Ile | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498562C>G | ClinVar |
RCV000424365 | p.Met535Ile | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498562C>A | ClinVar |
NCI-TCGA novel | p.Glu536Lys | missense variant | - | NC_000010.11:g.121498561C>T | NCI-TCGA |
rs1293868545 | p.Glu536Gln | missense variant | - | NC_000010.11:g.121498561C>G | gnomAD |
rs758628019 | p.Met537Lys | missense variant | - | NC_000010.11:g.121498557A>T | ExAC,gnomAD |
rs1057519799 | p.Met537Ile | missense variant | - | NC_000010.11:g.121498556C>G | - |
rs1057519799 | p.Met537Ile | missense variant | - | NC_000010.11:g.121498556C>A | - |
rs1057519799 | p.Met537Ile | missense variant | - | NC_000010.11:g.121498556C>T | - |
RCV000436200 | p.Met537Ile | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498556C>G | ClinVar |
RCV000442661 | p.Met537Ile | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498556C>T | ClinVar |
RCV000425939 | p.Met537Ile | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498556C>A | ClinVar |
rs1358630379 | p.Met540Ile | missense variant | - | NC_000010.11:g.121498547C>T | gnomAD |
rs1057524807 | p.Ile541Met | missense variant | - | NC_000010.11:g.121498544A>C | - |
RCV000431202 | p.Ile541Met | missense variant | - | NC_000010.11:g.121498544A>C | ClinVar |
rs752880857 | p.Gly542Arg | missense variant | - | NC_000010.11:g.121498543C>T | ExAC,gnomAD |
COSM1474415 | p.His544Gln | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121498535G>C | NCI-TCGA Cosmic |
rs765658636 | p.Asn546Thr | missense variant | - | NC_000010.11:g.121498530T>G | ExAC,TOPMed,gnomAD |
rs1375821471 | p.Ile547Met | missense variant | - | NC_000010.11:g.121498526G>C | gnomAD |
rs1057519798 | p.Ile547Val | missense variant | - | NC_000010.11:g.121498528T>C | - |
RCV000442792 | p.Ile547Val | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498528T>C | ClinVar |
rs1057519901 | p.Ile548Leu | missense variant | - | NC_000010.11:g.121498525T>G | TOPMed |
RCV000420899 | p.Ile548Leu | missense variant | Lung adenocarcinoma | NC_000010.11:g.121498525T>G | ClinVar |
RCV000441378 | p.Ile548Leu | missense variant | Neoplasm of the breast | NC_000010.11:g.121498525T>G | ClinVar |
RCV000438545 | p.Ile548Leu | missense variant | Endometrial neoplasm | NC_000010.11:g.121498525T>G | ClinVar |
RCV000423679 | p.Ile548Leu | missense variant | Malignant neoplasm of body of uterus | NC_000010.11:g.121498525T>G | ClinVar |
RCV000431121 | p.Ile548Leu | missense variant | Nasopharyngeal Neoplasms | NC_000010.11:g.121498525T>G | ClinVar |
rs1057519046 | p.Asn549Leu | missense variant | - | NC_000010.11:g.121498521_121498522delinsAG | - |
COSM4604457 | p.Asn549Asp | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121498522T>C | NCI-TCGA Cosmic |
rs121913476 | p.Asn549Lys | missense variant | - | NC_000010.11:g.121498520A>T | - |
RCV000426965 | p.Asn549Lys | missense variant | Nasopharyngeal Neoplasms | NC_000010.11:g.121498520A>T | ClinVar |
RCV000424055 | p.Asn549Lys | missense variant | Lung adenocarcinoma | NC_000010.11:g.121498520A>T | ClinVar |
RCV000425472 | p.Asn549His | missense variant | Nasopharyngeal Neoplasms | NC_000010.11:g.121498522T>G | ClinVar |
RCV000432507 | p.Asn549His | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498522T>G | ClinVar |
RCV000428300 | p.Asn549His | missense variant | Lung adenocarcinoma | NC_000010.11:g.121498522T>G | ClinVar |
rs121913476 | p.Asn549Lys | missense variant | - | NC_000010.11:g.121498520A>C | - |
RCV000433483 | p.Asn549Lys | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498520A>T | ClinVar |
RCV000434110 | p.Asn549Lys | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121498520A>C | ClinVar |
RCV000443743 | p.Asn549Lys | missense variant | Malignant neoplasm of body of uterus | NC_000010.11:g.121498520A>T | ClinVar |
RCV000441770 | p.Asn549Lys | missense variant | Neoplasm of the breast | NC_000010.11:g.121498520A>T | ClinVar |
RCV000418082 | p.Asn549His | missense variant | Neoplasm of the breast | NC_000010.11:g.121498522T>G | ClinVar |
RCV000415507 | p.Asn549His | missense variant | Crouzon syndrome | NC_000010.11:g.121498522T>G | ClinVar |
RCV000435736 | p.Asn549His | missense variant | Malignant neoplasm of body of uterus | NC_000010.11:g.121498522T>G | ClinVar |
rs1215036637 | p.Leu550Val | missense variant | - | NC_000010.11:g.121498519G>C | TOPMed |
COSM1346225 | p.Leu550Ile | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121498519G>T | NCI-TCGA Cosmic |
rs755350933 | p.Leu550Pro | missense variant | - | NC_000010.11:g.121498518A>G | ExAC,gnomAD |
NCI-TCGA novel | p.Leu551Ile | missense variant | - | NC_000010.11:g.121498516G>T | NCI-TCGA |
NCI-TCGA novel | p.Gly552Glu | missense variant | - | NC_000010.11:g.121498512C>T | NCI-TCGA |
rs1252475021 | p.Gln556Pro | missense variant | - | NC_000010.11:g.121498500T>G | TOPMed |
rs761446954 | p.Gly558Glu | missense variant | - | NC_000010.11:g.121496722C>T | ExAC,gnomAD |
NCI-TCGA novel | p.Pro559His | missense variant | - | NC_000010.11:g.121496719G>T | NCI-TCGA |
rs751077552 | p.Leu560Phe | missense variant | - | NC_000010.11:g.121496717G>A | ExAC,gnomAD |
rs957991200 | p.Tyr561Ser | missense variant | - | NC_000010.11:g.121496713T>G | TOPMed |
COSM4393097 | p.Ile563Met | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121496706T>C | NCI-TCGA Cosmic |
rs1057519797 | p.Val564Ile | missense variant | - | NC_000010.11:g.121496705C>T | - |
RCV000423825 | p.Val564Ile | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121496705C>T | ClinVar |
RCV000014219 | p.Glu565Ala | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121496701T>G | ClinVar |
rs121918506 | p.Glu565Gly | missense variant | - | NC_000010.11:g.121496701T>C | - |
rs121918506 | p.Glu565Gly | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121496701T>C | UniProt,dbSNP |
VAR_017277 | p.Glu565Gly | missense variant | Pfeiffer syndrome (PS) | NC_000010.11:g.121496701T>C | UniProt |
rs121918506 | p.Glu565Ala | missense variant | - | NC_000010.11:g.121496701T>G | - |
RCV000438913 | p.Glu565Gly | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121496701T>C | ClinVar |
RCV000415495 | p.Glu565Gly | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121496701T>C | ClinVar |
RCV000434384 | p.Glu565Ala | missense variant | Craniosynostosis syndrome | NC_000010.11:g.121496701T>G | ClinVar |
COSM4012169 | p.Gly570Arg | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121496687C>G | NCI-TCGA Cosmic |
rs371854567 | p.Leu572Phe | missense variant | - | NC_000010.11:g.121496681G>A | ESP,ExAC,TOPMed,gnomAD |
RCV000681721 | p.Arg573Ter | nonsense | - | NC_000010.11:g.121496678G>A | ClinVar |
rs1345199187 | p.Ala578Gly | missense variant | - | NC_000010.11:g.121496662G>C | gnomAD |
RCV000722571 | p.Arg579Trp | missense variant | - | NC_000010.11:g.121496660G>A | ClinVar |
rs1296941849 | p.Pro581Leu | missense variant | - | NC_000010.11:g.121496653G>A | gnomAD |
COSM3966914 | p.Pro581Gln | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121496653G>T | NCI-TCGA Cosmic |
rs138712692 | p.Gly583Arg | missense variant | - | NC_000010.11:g.121496648C>T | ESP,ExAC,TOPMed,gnomAD |
rs1287829901 | p.Gly583Ala | missense variant | - | NC_000010.11:g.121496647C>G | gnomAD |
rs759496676 | p.Met584Val | missense variant | - | NC_000010.11:g.121496645T>C | ExAC,TOPMed,gnomAD |
rs1407878017 | p.Met584Arg | missense variant | - | NC_000010.11:g.121496644A>C | gnomAD |
RCV000691056 | p.Glu585Gln | missense variant | FGFR2 related craniosynostosis | NC_000010.11:g.121496642C>G | ClinVar |
rs1554914180 | p.Tyr586Ter | stop gained | - | NC_000010.11:g.121496637_121496638delinsTC | - |
RCV000657844 | p.Tyr586Ter | nonsense | - | NC_000010.11:g.121496637_121496638delinsTC | ClinVar |
COSM1474413 | p.Ser587Cys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121496635G>C | NCI-TCGA Cosmic |
rs1173726351 | p.Ser587Ala | missense variant | - | NC_000010.11:g.121496636A>C | gnomAD |
rs770827652 | p.Tyr588Ser | missense variant | - | NC_000010.11:g.121496632T>G | ExAC,TOPMed,gnomAD |
rs770827652 | p.Tyr588Cys | missense variant | - | NC_000010.11:g.121496632T>C | ExAC,TOPMed,gnomAD |
rs768761510 | p.Arg592His | missense variant | - | NC_000010.11:g.121496620C>T | ExAC,TOPMed,gnomAD |
RCV000297633 | p.Arg592Cys | missense variant | Levy-Hollister syndrome (LADD) | NC_000010.11:g.121496621G>A | ClinVar |
RCV000289968 | p.Arg592Cys | missense variant | Acrocephalosyndactyly type I | NC_000010.11:g.121496621G>A | ClinVar |
rs141929882 | p.Arg592Cys | missense variant | - | NC_000010.11:g.121496621G>A | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
RCV000340231 | p.Arg592Cys | missense variant | Saethre-Chotzen syndrome (SCS) | NC_000010.11:g.121496621G>A | ClinVar |
RCV000396197 | p.Arg592Cys | missense variant | Isolated coronal synostosis | NC_000010.11:g.121496621G>A | ClinVar |
RCV000262246 | p.Arg592Cys | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121496621G>A | ClinVar |
RCV000305351 | p.Arg592Cys | missense variant | Cutis Gyrata syndrome of Beare and Stevenson (BSTVS) | NC_000010.11:g.121496621G>A | ClinVar |
RCV000341569 | p.Arg592Cys | missense variant | - | NC_000010.11:g.121496621G>A | ClinVar |
RCV000357145 | p.Arg592Cys | missense variant | Crouzon syndrome | NC_000010.11:g.121496621G>A | ClinVar |
RCV000404655 | p.Arg592Cys | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121496621G>A | ClinVar |
COSM3434758 | p.Glu596Lys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121496609C>T | NCI-TCGA Cosmic |
rs1201947648 | p.Met598Val | missense variant | - | NC_000010.11:g.121496603T>C | gnomAD |
rs780587674 | p.Lys601Arg | missense variant | - | NC_000010.11:g.121496593T>C | ExAC,gnomAD |
rs1485035386 | p.Lys601Gln | missense variant | - | NC_000010.11:g.121496594T>G | gnomAD |
NCI-TCGA novel | p.Ser605Leu | missense variant | - | NC_000010.11:g.121496581G>A | NCI-TCGA |
rs371395564 | p.Cys606Trp | missense variant | - | NC_000010.11:g.121496577G>C | ESP,ExAC,TOPMed,gnomAD |
COSM3434754 | p.Ala611Val | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121496563G>A | NCI-TCGA Cosmic |
VAR_046071 | p.Arg612Thr | Missense | - | - | UniProt |
VAR_015012 | p.Gly613Arg | Missense | - | - | UniProt |
rs751047267 | p.Met614Val | missense variant | - | NC_000010.11:g.121496555T>C | ExAC,TOPMed,gnomAD |
rs762545440 | p.Tyr616Cys | missense variant | - | NC_000010.11:g.121496548T>C | ExAC,TOPMed,gnomAD |
rs1057519796 | p.Leu617Met | missense variant | - | NC_000010.11:g.121496546A>T | - |
RCV000428728 | p.Leu617Met | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121496546A>T | ClinVar |
rs752349068 | p.Ala618Thr | missense variant | - | NC_000010.11:g.121496543C>T | ExAC |
rs1451548514 | p.Ser619Phe | missense variant | - | NC_000010.11:g.121496539G>A | gnomAD |
rs775697900 | p.Ile623Val | missense variant | - | NC_000010.11:g.121488110T>C | ExAC,gnomAD |
rs1466101220 | p.Arg625Ter | stop gained | - | NC_000010.11:g.121488104G>A | gnomAD |
COSM3434746 | p.Arg625Gln | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121488103C>T | NCI-TCGA Cosmic |
rs121918509 | p.Ala628Thr | missense variant | Lacrimo-auriculo-dento-digital syndrome (LADDS) | NC_000010.11:g.121488095C>T | UniProt,dbSNP |
VAR_029884 | p.Ala628Thr | missense variant | Lacrimo-auriculo-dento-digital syndrome (LADDS) | NC_000010.11:g.121488095C>T | UniProt |
rs121918509 | p.Ala628Thr | missense variant | - | NC_000010.11:g.121488095C>T | - |
RCV000414415 | p.Ala628Thr | missense variant | - | NC_000010.11:g.121488095C>T | ClinVar |
RCV000014224 | p.Ala628Thr | missense variant | Levy-Hollister syndrome (LADD) | NC_000010.11:g.121488095C>T | ClinVar |
rs1372392695 | p.Val632Ile | missense variant | - | NC_000010.11:g.121488083C>T | gnomAD |
COSM3806593 | p.Val634Ala | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121488076A>G | NCI-TCGA Cosmic |
rs1243256163 | p.Val634Ile | missense variant | - | NC_000010.11:g.121488077C>T | TOPMed |
COSM1584819 | p.Glu636Ter | stop gained | Variant assessed as Somatic; HIGH impact. | NC_000010.11:g.121488071C>A | NCI-TCGA Cosmic |
rs777169135 | p.Asn638Thr | missense variant | - | NC_000010.11:g.121488064T>G | ExAC,gnomAD |
rs1490997619 | p.Asn638Asp | missense variant | - | NC_000010.11:g.121488065T>C | gnomAD |
rs1057519854 | p.Asn638Lys | missense variant | - | NC_000010.11:g.121488063A>T | - |
rs777169135 | p.Asn638Ser | missense variant | - | NC_000010.11:g.121488064T>C | ExAC,gnomAD |
RCV000444404 | p.Asn638Lys | missense variant | Malignant neoplasm of body of uterus | NC_000010.11:g.121488063A>T | ClinVar |
RCV000442059 | p.Asn638Thr | missense variant | Craniosynostosis syndrome | NC_000010.11:g.121488064T>G | ClinVar |
RCV000426084 | p.Asn638Lys | missense variant | Neoplasm of the breast | NC_000010.11:g.121488063A>T | ClinVar |
RCV000436783 | p.Asn638Lys | missense variant | Nasopharyngeal Neoplasms | NC_000010.11:g.121488063A>T | ClinVar |
RCV000432646 | p.Asn638Lys | missense variant | Lung adenocarcinoma | NC_000010.11:g.121488063A>T | ClinVar |
RCV000420097 | p.Asn638Lys | missense variant | Endometrial neoplasm | NC_000010.11:g.121488063A>T | ClinVar |
RCV000731782 | p.Lys641Arg | missense variant | - | NC_000010.11:g.121488055T>C | ClinVar |
rs1064796413 | p.Ile642Lys | missense variant | - | NC_000010.11:g.121488052A>T | - |
RCV000478596 | p.Ile642Lys | missense variant | - | NC_000010.11:g.121488052A>T | ClinVar |
rs121918508 | p.Ala648Thr | missense variant | Lacrimo-auriculo-dento-digital syndrome (LADDS) | NC_000010.11:g.121488035C>T | UniProt,dbSNP |
VAR_029885 | p.Ala648Thr | missense variant | Lacrimo-auriculo-dento-digital syndrome (LADDS) | NC_000010.11:g.121488035C>T | UniProt |
rs121918508 | p.Ala648Thr | missense variant | - | NC_000010.11:g.121488035C>T | TOPMed |
RCV000014222 | p.Ala648Thr | missense variant | Levy-Hollister syndrome (LADD) | NC_000010.11:g.121488035C>T | ClinVar |
VAR_029886 | p.Arg649_Asp650delinsSer | deletion_insertion | Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730] | - | UniProt |
rs758829154 | p.Asp650Gly | missense variant | - | NC_000010.11:g.121488028T>C | ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Asp650Tyr | missense variant | - | NC_000010.11:g.121488029C>A | NCI-TCGA |
rs1013096035 | p.Asn653His | missense variant | - | NC_000010.11:g.121488020T>G | gnomAD |
rs1385830246 | p.Ile654Met | missense variant | - | NC_000010.11:g.121488015T>C | gnomAD |
rs747718232 | p.Ile654Val | missense variant | - | NC_000010.11:g.121488017T>C | ExAC,gnomAD |
rs1404851539 | p.Ile654Thr | missense variant | - | NC_000010.11:g.121488016A>G | gnomAD |
COSM4012164 | p.Asp655Gly | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121488013T>C | NCI-TCGA Cosmic |
rs1057520027 | p.Lys658Glu | missense variant | - | NC_000010.11:g.121488005T>C | - |
rs1057520029 | p.Lys658Asn | missense variant | - | NC_000010.11:g.121488003T>A | - |
RCV000439319 | p.Lys658Glu | missense variant | Endometrial neoplasm | NC_000010.11:g.121488005T>C | ClinVar |
RCV000433692 | p.Lys658Asn | missense variant | Endometrial neoplasm | NC_000010.11:g.121488003T>A | ClinVar |
COSM1146407 | p.Lys659Asn | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121488000C>G | NCI-TCGA Cosmic |
rs1057519795 | p.Lys659Glu | missense variant | - | NC_000010.11:g.121488002T>C | - |
RCV000417597 | p.Lys659Glu | missense variant | Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation | NC_000010.11:g.121488002T>C | ClinVar |
VAR_017279 | p.Lys659Asn | Missense | - | - | UniProt |
rs962103382 | p.Asn662Ser | missense variant | - | NC_000010.11:g.121487992T>C | TOPMed,gnomAD |
VAR_017280 | p.Gly663Glu | Missense | Pfeiffer syndrome (PS) [MIM:101600] | - | UniProt |
rs1554907364 | p.Arg664Gln | missense variant | - | NC_000010.11:g.121487420C>T | - |
rs113014479 | p.Arg664Trp | missense variant | - | NC_000010.11:g.121487421G>A | gnomAD |
RCV000624844 | p.Arg664Gln | missense variant | Inborn genetic diseases | NC_000010.11:g.121487420C>T | ClinVar |
COSM2056141 | p.Lys668Thr | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121487408T>G | NCI-TCGA Cosmic |
rs1554907337 | p.Ala674Val | missense variant | - | NC_000010.11:g.121487390G>A | - |
RCV000659649 | p.Ala674Val | missense variant | Levy-Hollister syndrome (LADD) | NC_000010.11:g.121487390G>A | ClinVar |
rs750244862 | p.Arg678Ser | missense variant | - | NC_000010.11:g.121487377T>A | ExAC,TOPMed,gnomAD |
COSM6064906 | p.Arg678Gly | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121487379T>C | NCI-TCGA Cosmic |
rs750244862 | p.Arg678Ser | missense variant | - | NC_000010.11:g.121487377T>G | ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Arg678Thr | missense variant | - | NC_000010.11:g.121487378C>G | NCI-TCGA |
VAR_017281 | p.Arg678Gly | Missense | Crouzon syndrome (CS) [MIM:123500] | - | UniProt |
rs371596204 | p.Val679Ile | missense variant | - | NC_000010.11:g.121487376C>T | ESP,ExAC,TOPMed |
rs764102895 | p.Ser684Thr | missense variant | - | NC_000010.11:g.121487360C>G | ExAC,gnomAD |
rs760895785 | p.Val686Ile | missense variant | - | NC_000010.11:g.121487355C>T | ExAC,gnomAD |
rs1311258996 | p.Gly690Arg | missense variant | - | NC_000010.11:g.121485522C>T | TOPMed |
rs774682374 | p.Met693Val | missense variant | - | NC_000010.11:g.121485513T>C | ExAC,TOPMed,gnomAD |
rs146571201 | p.Met693Thr | missense variant | - | NC_000010.11:g.121485512A>G | ESP,ExAC,gnomAD |
COSM3434738 | p.Glu695Lys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121485507C>T | NCI-TCGA Cosmic |
rs150015885 | p.Ser702Leu | missense variant | - | NC_000010.11:g.121485485G>A | ESP,TOPMed |
COSM29843 | p.Pro708Ser | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121485468G>A | NCI-TCGA Cosmic |
rs1196438732 | p.Val709Met | missense variant | - | NC_000010.11:g.121485465C>T | TOPMed |
NCI-TCGA novel | p.Glu710Gly | missense variant | - | NC_000010.11:g.121485461T>C | NCI-TCGA |
NCI-TCGA novel | p.Glu711Lys | missense variant | - | NC_000010.11:g.121485459C>T | NCI-TCGA |
rs1470951612 | p.Glu718Ala | missense variant | - | NC_000010.11:g.121485437T>G | gnomAD |
COSM3434727 | p.Glu718Lys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121485438C>T | NCI-TCGA Cosmic |
COSM3434723 | p.Met722Ile | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121485424C>T | NCI-TCGA Cosmic |
rs776188535 | p.Ala726Thr | missense variant | - | NC_000010.11:g.121485414C>T | ExAC,gnomAD |
rs1458081920 | p.Ala726Gly | missense variant | - | NC_000010.11:g.121485413G>C | TOPMed |
rs1224863755 | p.Cys728Ter | stop gained | - | NC_000010.11:g.121485406G>T | gnomAD |
rs200453002 | p.Asn730Ser | missense variant | - | NC_000010.11:g.121485401T>C | 1000Genomes,ExAC,TOPMed,gnomAD |
rs1224606327 | p.Glu731Lys | missense variant | - | NC_000010.11:g.121485399C>T | gnomAD |
rs1432567715 | p.Met735Ile | missense variant | - | NC_000010.11:g.121483794C>G | gnomAD |
rs1157875939 | p.Arg737Thr | missense variant | - | NC_000010.11:g.121483789C>G | gnomAD |
COSM3686538 | p.Arg737Gly | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121483790T>C | NCI-TCGA Cosmic |
COSM3686534 | p.Arg737Met | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121483789C>A | NCI-TCGA Cosmic |
rs1259218325 | p.Asp738Asn | missense variant | - | NC_000010.11:g.121483787C>T | TOPMed |
rs747941020 | p.Pro744Ser | missense variant | - | NC_000010.11:g.121483769G>A | ExAC,gnomAD |
rs375719482 | p.Pro744Leu | missense variant | - | NC_000010.11:g.121483768G>A | ESP,TOPMed,gnomAD |
NCI-TCGA novel | p.Ser745Tyr | missense variant | - | NC_000010.11:g.121483765G>T | NCI-TCGA |
rs116895810 | p.Gln746His | missense variant | - | NC_000010.11:g.121483761C>G | 1000Genomes |
rs754928713 | p.Thr749Ala | missense variant | - | NC_000010.11:g.121483754T>C | ExAC,TOPMed,gnomAD |
rs745947630 | p.Thr749Met | missense variant | - | NC_000010.11:g.121483753G>A | ExAC,gnomAD |
rs757501816 | p.Lys751Gln | missense variant | - | NC_000010.11:g.121483748T>G | ExAC,gnomAD |
rs751731823 | p.Val754Ile | missense variant | - | NC_000010.11:g.121483739C>T | ExAC,gnomAD |
rs777950855 | p.Val754Gly | missense variant | - | NC_000010.11:g.121483738A>C | ExAC,gnomAD |
rs1296874666 | p.Leu757Ser | missense variant | - | NC_000010.11:g.121483729A>G | gnomAD |
rs55774317 | p.Arg759Gln | missense variant | - | NC_000010.11:g.121483723C>T | 1000Genomes,ExAC,TOPMed,gnomAD |
COSM5477128 | p.Leu761Ile | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121483718G>T | NCI-TCGA Cosmic |
rs912905439 | p.Leu761Phe | missense variant | - | NC_000010.11:g.121483718G>A | TOPMed |
rs1319294677 | p.Thr762Ile | missense variant | - | NC_000010.11:g.121483714G>A | gnomAD |
NCI-TCGA novel | p.Leu763HisPheSerTerUnk | frameshift | - | NC_000010.11:g.121483710_121483711GA>- | NCI-TCGA |
COSM1584822 | p.Thr764AsnPheSerTerUnk | frameshift | Variant assessed as Somatic; HIGH impact. | NC_000010.11:g.121483708_121483709insT | NCI-TCGA Cosmic |
rs765724372 | p.Asn766Ser | missense variant | - | NC_000010.11:g.121483702T>C | ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Glu768Ter | stop gained | - | NC_000010.11:g.121480021C>A | NCI-TCGA |
rs763622845 | p.Glu768Lys | missense variant | - | NC_000010.11:g.121480021C>T | ExAC,gnomAD |
COSM1584823 | p.Tyr769Ter | missense variant | Variant assessed as Somatic; HIGH impact. | NC_000010.11:g.121480016G>T | NCI-TCGA Cosmic |
rs201752803 | p.Leu770Val | missense variant | - | NC_000010.11:g.121480015A>C | 1000Genomes,ExAC,TOPMed,gnomAD |
rs765174665 | p.Asp771Asn | missense variant | - | NC_000010.11:g.121480012C>T | ExAC,TOPMed,gnomAD |
rs759404861 | p.Asp771Glu | missense variant | - | NC_000010.11:g.121480010G>C | ExAC,TOPMed,gnomAD |
rs966805990 | p.Leu772Phe | missense variant | - | NC_000010.11:g.121480009G>A | TOPMed |
rs966805990 | p.Leu772Ile | missense variant | - | NC_000010.11:g.121480009G>T | TOPMed |
rs1032609119 | p.Pro775Leu | missense variant | - | NC_000010.11:g.121479999G>A | TOPMed |
rs1032609119 | p.Pro775Arg | missense variant | - | NC_000010.11:g.121479999G>C | TOPMed |
NCI-TCGA novel | p.Leu776ProPheSerTerUnk | frameshift | - | NC_000010.11:g.121479996_121479997insGAGG | NCI-TCGA |
rs374993905 | p.Glu777Ter | stop gained | - | NC_000010.11:g.121479994C>A | ESP,ExAC,TOPMed,gnomAD |
rs374993905 | p.Glu777Lys | missense variant | - | NC_000010.11:g.121479994C>T | ESP,ExAC,TOPMed,gnomAD |
rs374993905 | p.Glu777Gln | missense variant | - | NC_000010.11:g.121479994C>G | ESP,ExAC,TOPMed,gnomAD |
RCV000121065 | p.Glu777Lys | missense variant | - | NC_000010.11:g.121479994C>T | ClinVar |
rs1388165238 | p.Gln778Ter | stop gained | - | NC_000010.11:g.121479991G>A | gnomAD |
NCI-TCGA novel | p.Tyr779Cys | missense variant | - | NC_000010.11:g.121479987T>C | NCI-TCGA |
COSM1297002 | p.Ser780Leu | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121479984G>A | NCI-TCGA Cosmic |
rs1416453326 | p.Pro781Ala | missense variant | - | NC_000010.11:g.121479982G>C | gnomAD |
rs147439731 | p.Ser782Arg | missense variant | - | NC_000010.11:g.121479977A>C | ESP,ExAC,TOPMed,gnomAD |
rs954917585 | p.Pro784Ser | missense variant | - | NC_000010.11:g.121479973G>A | TOPMed,gnomAD |
rs1476013209 | p.Thr786Arg | missense variant | - | NC_000010.11:g.121479966G>C | gnomAD |
COSM1146406 | p.Thr786Lys | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121479966G>T | NCI-TCGA Cosmic |
rs780497781 | p.Cys790Tyr | missense variant | - | NC_000010.11:g.121479954C>T | ExAC,TOPMed,gnomAD |
NCI-TCGA novel | p.Cys790Ser | missense variant | - | NC_000010.11:g.121479954C>G | NCI-TCGA |
NCI-TCGA novel | p.Ser792Leu | missense variant | - | NC_000010.11:g.121479948G>A | NCI-TCGA |
rs1206283619 | p.Gly793Glu | missense variant | - | NC_000010.11:g.121479945C>T | TOPMed |
rs756718577 | p.Asp794Asn | missense variant | - | NC_000010.11:g.121479943C>T | ExAC,gnomAD |
rs1024846807 | p.Asp795Asn | missense variant | - | NC_000010.11:g.121479940C>T | TOPMed |
COSM3434713 | p.Ser796Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121479936G>A | NCI-TCGA Cosmic |
COSM3434711 | p.Ser799Phe | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121479927G>A | NCI-TCGA Cosmic |
rs746336453 | p.Pro800Leu | missense variant | - | NC_000010.11:g.121479924G>A | ExAC,TOPMed,gnomAD |
COSM6128319 | p.Met803Ile | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121479914C>A | NCI-TCGA Cosmic |
rs781527776 | p.Met803Val | missense variant | - | NC_000010.11:g.121479916T>C | ExAC,TOPMed,gnomAD |
rs575812178 | p.Pro804Ser | missense variant | - | NC_000010.11:g.121479913G>A | 1000Genomes,ExAC,gnomAD |
rs575812178 | p.Pro804Ala | missense variant | - | NC_000010.11:g.121479913G>C | 1000Genomes,ExAC,gnomAD |
rs763867175 | p.Tyr805Ser | missense variant | - | NC_000010.11:g.121479909T>G | ExAC,gnomAD |
rs558460047 | p.Tyr805Ter | stop gained | - | NC_000010.11:g.121479908G>T | 1000Genomes,ExAC,TOPMed,gnomAD |
rs764959117 | p.Glu806Gln | missense variant | - | NC_000010.11:g.121479907C>G | ExAC,gnomAD |
rs764959117 | p.Glu806Lys | missense variant | - | NC_000010.11:g.121479907C>T | ExAC,gnomAD |
RCV000324015 | p.Glu806Lys | missense variant | Crouzon syndrome | NC_000010.11:g.121479907C>T | ClinVar |
RCV000311542 | p.Glu806Lys | missense variant | Cutis Gyrata syndrome of Beare and Stevenson (BSTVS) | NC_000010.11:g.121479907C>T | ClinVar |
RCV000376381 | p.Glu806Lys | missense variant | Isolated coronal synostosis | NC_000010.11:g.121479907C>T | ClinVar |
RCV000337283 | p.Glu806Lys | missense variant | Acrocephalosyndactyly type I | NC_000010.11:g.121479907C>T | ClinVar |
RCV000336994 | p.Glu806Lys | missense variant | Saethre-Chotzen syndrome (SCS) | NC_000010.11:g.121479907C>T | ClinVar |
RCV000282278 | p.Glu806Lys | missense variant | Pfeiffer syndrome (ACS5) | NC_000010.11:g.121479907C>T | ClinVar |
RCV000284236 | p.Glu806Lys | missense variant | - | NC_000010.11:g.121479907C>T | ClinVar |
RCV000394935 | p.Glu806Lys | missense variant | Jackson-Weiss syndrome (JWS) | NC_000010.11:g.121479907C>T | ClinVar |
RCV000402617 | p.Glu806Lys | missense variant | Levy-Hollister syndrome (LADD) | NC_000010.11:g.121479907C>T | ClinVar |
rs759496942 | p.Cys808Trp | missense variant | - | NC_000010.11:g.121479899G>C | ExAC,TOPMed,gnomAD |
rs1430681691 | p.Cys808Phe | missense variant | - | NC_000010.11:g.121479900C>A | TOPMed |
rs368003279 | p.Leu809Pro | missense variant | - | NC_000010.11:g.121479897A>G | 1000Genomes,ESP,ExAC,TOPMed,gnomAD |
rs1315946112 | p.Pro810Thr | missense variant | - | NC_000010.11:g.121479895G>T | gnomAD |
rs1450657969 | p.Gln811Lys | missense variant | - | NC_000010.11:g.121479892G>T | gnomAD |
rs766217118 | p.Tyr812Cys | missense variant | - | NC_000010.11:g.121479888T>C | ExAC,gnomAD |
rs567030847 | p.Pro813Arg | missense variant | - | NC_000010.11:g.121479885G>C | 1000Genomes,ExAC,gnomAD |
COSM1584827 | p.Pro813HisPheSerTerUnk | frameshift | Variant assessed as Somatic; HIGH impact. | NC_000010.11:g.121479881_121479885GTGTG>- | NCI-TCGA Cosmic |
COSM2056115 | p.Pro813Thr | missense variant | Variant assessed as Somatic; MODERATE impact. | NC_000010.11:g.121479886G>T | NCI-TCGA Cosmic |
rs144176428 | p.Gly817Ser | missense variant | - | NC_000010.11:g.121479874C>T | ESP,ExAC,TOPMed,gnomAD |
rs749474548 | p.Ser818Gly | missense variant | - | NC_000010.11:g.121479871T>C | ExAC,gnomAD |
rs1183290679 | p.Val819Ile | missense variant | - | NC_000010.11:g.121479868C>T | gnomAD |
rs1183290679 | p.Val819Leu | missense variant | - | NC_000010.11:g.121479868C>G | gnomAD |
Disease ID | Disease Name | Disease Type | Source |
---|---|---|---|
C0000768 | Congenital Abnormality | group | BEFREE |
C0000772 | Multiple congenital anomalies | group | CTD_human |
C0000846 | Agenesis | disease | BEFREE |
C0000889 | Acanthosis Nigricans | disease | BEFREE;HPO |
C0001080 | Achondroplasia | disease | BEFREE |
C0001193 | Apert syndrome | disease | BEFREE;CLINVAR;CTD_human;ORPHANET;UNIPROT |
C0001418 | Adenocarcinoma | group | BEFREE;LHGDN |
C0002448 | Ameloblastoma | disease | BEFREE |
C0003090 | Ankylosis | phenotype | CTD_human |
C0003706 | Arachnodactyly | disease | HPO |
C0003803 | Arnold Chiari Malformation | disease | HPO |
C0003886 | Arthrogryposis | disease | GENOMICS_ENGLAND |
C0004114 | Astrocytoma | disease | BEFREE |
C0004936 | Mental disorders | group | BEFREE |
C0005586 | Bipolar Disorder | disease | BEFREE;PSYGENET |
C0005684 | Malignant neoplasm of urinary bladder | disease | BEFREE |
C0005695 | Bladder Neoplasm | group | BEFREE |
C0005745 | Blepharoptosis | disease | HPO |
C0005747 | Blepharospasm | disease | HPO |
C0006012 | Borderline Personality Disorder | disease | BEFREE |
C0006142 | Malignant neoplasm of breast | disease | BEFREE;CTD_human;UNIPROT |
C0006287 | Bronchopulmonary Dysplasia | disease | BEFREE |
C0006386 | Bunion | phenotype | HPO |
C0006435 | Chemical Burns | group | CTD_human |
C0006826 | Malignant Neoplasms | group | BEFREE |
C0007102 | Malignant tumor of colon | disease | BEFREE |
C0007103 | Malignant neoplasm of endometrium | disease | BEFREE;CGI |
C0007104 | Female Breast Carcinoma | disease | BEFREE |
C0007113 | Rectal Carcinoma | disease | BEFREE |
C0007114 | Malignant neoplasm of skin | disease | BEFREE |
C0007115 | Malignant neoplasm of thyroid | disease | BEFREE |
C0007131 | Non-Small Cell Lung Carcinoma | disease | BEFREE;CGI |
C0007133 | Carcinoma, Papillary | disease | BEFREE |
C0007134 | Renal Cell Carcinoma | disease | BEFREE |
C0007135 | Adenocarcinoma, Scirrhous | disease | BEFREE |
C0007137 | Squamous cell carcinoma | disease | BEFREE;LHGDN |
C0007138 | Carcinoma, Transitional Cell | disease | BEFREE |
C0007140 | Carcinosarcoma | disease | BEFREE |
C0007847 | Malignant tumor of cervix | disease | BEFREE |
C0008297 | Choanal Atresia | disease | GENOMICS_ENGLAND;HPO |
C0008479 | Chondrosarcoma | disease | BEFREE;LHGDN |
C0008487 | Chordoma | disease | BEFREE |
C0008497 | Choriocarcinoma | disease | BEFREE |
C0008924 | Cleft upper lip | disease | CTD_human |
C0008925 | Cleft Palate | disease | BEFREE;CTD_human |
C0009402 | Colorectal Carcinoma | disease | BEFREE |
C0009404 | Colorectal Neoplasms | group | LHGDN |
C0009763 | Conjunctivitis | disease | HPO |
C0010043 | Corneal Ulcer | disease | HPO |
C0010273 | Craniofacial Dysostosis | disease | BEFREE;CLINVAR;CTD_human;HPO;LHGDN;MGD |
C0010278 | Craniosynostosis | disease | BEFREE;CLINVAR;CTD_human;GENOMICS_ENGLAND;HPO;LHGDN |
C0010417 | Cryptorchidism | disease | HPO |
C0010674 | Cystic Fibrosis | disease | BEFREE |
C0010930 | Dacryocystitis | phenotype | HPO |
C0011053 | Deafness | phenotype | HPO |
C0011334 | Dental caries | disease | HPO |
C0011351 | Dental Enamel Hypoplasia | disease | HPO |
C0011570 | Mental Depression | disease | PSYGENET |
C0011581 | Depressive disorder | disease | PSYGENET |
C0011757 | Developmental Coordination Disorder | disease | CTD_human |
C0011818 | Dextraposition of aorta | disease | HPO |
C0013069 | Double Outlet Right Ventricle | disease | BEFREE |
C0013336 | Dwarfism | disease | BEFREE |
C0013377 | Dysgerminoma | disease | HPO |
C0013404 | Dyspnea | phenotype | HPO |
C0013990 | Pathological accumulation of air in tissues | phenotype | LHGDN |
C0014116 | Endocardial Cushion Defects | group | LHGDN |
C0014170 | Endometrial Neoplasms | group | CLINVAR;CTD_human |
C0014175 | Endometriosis | disease | BEFREE;LHGDN |
C0014544 | Epilepsy | disease | HPO |
C0014850 | Esophageal Atresia | disease | HPO |
C0015300 | Exophthalmos | disease | BEFREE;HPO |
C0017525 | Giant Cell Tumors | group | BEFREE |
C0017566 | Gingival Hyperplasia | phenotype | HPO |
C0017567 | Gingival Hypertrophy | disease | HPO |
C0017636 | Glioblastoma | disease | BEFREE |
C0017638 | Glioma | disease | BEFREE |
C0018099 | Gout | disease | GWASCAT;GWASDB |
C0018536 | Hallux Valgus | phenotype | HPO |
C0018553 | Hamartoma Syndrome, Multiple | disease | CTD_human |
C0018671 | Head and Neck Neoplasms | group | CGI;CLINVAR |
C0018772 | Hearing Loss, Partial | phenotype | HPO |
C0018777 | Conductive hearing loss | disease | HPO |
C0018790 | Cardiac Arrest | disease | BEFREE |
C0018798 | Congenital Heart Defects | group | BEFREE;HPO |
C0018817 | Atrial Septal Defects | group | HPO |
C0018818 | Ventricular Septal Defects | group | BEFREE;HPO |
C0019572 | Hirsutism | phenotype | HPO |
C0019829 | Hodgkin Disease | disease | BEFREE |
C0020179 | Huntington Disease | disease | BEFREE |
C0020255 | Hydrocephalus | disease | BEFREE;GENOMICS_ENGLAND;HPO |
C0020295 | Hydronephrosis | disease | HPO |
C0020302 | Hydrophthalmos | disease | HPO |
C0020534 | Orbital separation excessive | phenotype | CLINVAR;HPO |
C0020538 | Hypertensive disease | group | HPO |
C0020608 | Hypodontia | disease | HPO |
C0020796 | Profound Mental Retardation | disease | CTD_human |
C0021390 | Inflammatory Bowel Diseases | group | BEFREE |
C0021828 | Intestinal Atresia | disease | MGD |
C0022548 | Keloid | phenotype | BEFREE |
C0022596 | Palmoplantar Keratosis | disease | HPO |
C0022906 | Lacrimal Duct Obstruction | phenotype | HPO |
C0023418 | leukemia | disease | BEFREE |
C0023470 | Myeloid Leukemia | disease | BEFREE |
C0023531 | Leukoplakia | disease | BEFREE |
C0023890 | Liver Cirrhosis | disease | BEFREE;CTD_human;LHGDN |
C0023903 | Liver neoplasms | group | BEFREE |
C0024003 | Lordosis | phenotype | HPO |
C0024121 | Lung Neoplasms | group | CTD_human |
C0024623 | Malignant neoplasm of stomach | disease | BEFREE;CGI;CTD_human |
C0024636 | Malocclusion | phenotype | HPO |
C0025202 | melanoma | disease | BEFREE;LHGDN |
C0025362 | Mental Retardation | disease | HPO |
C0025363 | Mental Retardation, Psychosocial | disease | CTD_human |
C0025990 | Micrognathism | disease | HPO |
C0026106 | Mild Mental Retardation | disease | HPO |
C0026277 | Mixed Salivary Gland Tumor | disease | BEFREE |
C0026351 | Moderate mental retardation (I.Q. 35-49) | disease | HPO |
C0026613 | Motor Skills Disorders | group | CTD_human |
C0027439 | Nasopharyngeal Neoplasms | group | CLINVAR;GWASDB |
C0027443 | Natal Teeth | phenotype | HPO |
C0027627 | Neoplasm Metastasis | phenotype | BEFREE |
C0027651 | Neoplasms | group | BEFREE |
C0027719 | Nephrosclerosis | disease | HPO |
C0027819 | Neuroblastoma | group | BEFREE |
C0027962 | Melanocytic nevus | disease | HPO |
C0029124 | Optic Atrophy | disease | HPO |
C0029172 | Oral Submucous Fibrosis | disease | BEFREE |
C0029422 | Osteochondrodysplasias | group | BEFREE |
C0029434 | Osteogenesis Imperfecta | disease | GENOMICS_ENGLAND |
C0029453 | Osteopenia | disease | HPO |
C0029463 | Osteosarcoma | disease | BEFREE;LHGDN |
C0029925 | Ovarian Carcinoma | disease | BEFREE;GWASCAT |
C0030044 | Acrocephaly | disease | CTD_human;HPO |
C0030286 | Pancreatic Diseases | group | HPO |
C0030297 | Pancreatic Neoplasm | disease | LHGDN |
C0032000 | Pituitary Adenoma | disease | BEFREE |
C0032019 | Pituitary Neoplasms | group | BEFREE |
C0033578 | Prostatic Neoplasms | group | BEFREE |
C0033975 | Psychotic Disorders | group | PSYGENET |
C0034065 | Pulmonary Embolism | disease | BEFREE |
C0034194 | Pyloric Stenosis | phenotype | HPO |
C0035334 | Retinitis Pigmentosa | disease | RGD |
C0036220 | Kaposi Sarcoma | disease | LHGDN |
C0036341 | Schizophrenia | disease | BEFREE;PSYGENET |
C0036572 | Seizures | phenotype | HPO |
C0037268 | Skin Abnormalities | group | CTD_human |
C0037274 | Dermatologic disorders | group | CTD_human |
C0037286 | Skin Neoplasms | group | BEFREE |
C0037315 | Sleep Apnea Syndromes | group | HPO |
C0038219 | Status Dysraphicus | disease | CTD_human |
C0038356 | Stomach Neoplasms | group | CGI;CLINVAR;CTD_human;LHGDN |
C0038358 | Gastric ulcer | disease | BEFREE |
C0038379 | Strabismus | disease | HPO |
C0039075 | Syndactyly | disease | BEFREE;HPO;LHGDN |
C0039093 | Congenital abnormal Synostosis | disease | BEFREE |
C0039101 | synovial sarcoma | disease | BEFREE |
C0039144 | Syringomyelia | disease | BEFREE |
C0039590 | Testicular Neoplasms | group | BEFREE |
C0040034 | Thrombocytopenia | phenotype | BEFREE |
C0040136 | Thyroid Neoplasm | disease | BEFREE |
C0040427 | Tooth Abnormalities | group | CTD_human |
C0040433 | Tooth Crowding | phenotype | HPO |
C0042063 | Urogenital Abnormalities | group | BEFREE |
C0042769 | Virus Diseases | group | BEFREE |
C0042798 | Low Vision | disease | HPO |
C0043352 | Xerostomia | disease | HPO |
C0078981 | Arachnoid Cysts | disease | HPO |
C0080178 | Spina Bifida | disease | CTD_human |
C0085281 | Addictive Behavior | phenotype | BEFREE |
C0085413 | Polycystic Kidney, Autosomal Dominant | disease | LHGDN |
C0085750 | Adenosis of Breast | disease | BEFREE |
C0149782 | Squamous cell carcinoma of lung | disease | BEFREE;CGI;CLINVAR;GWASCAT;UNIPROT |
C0151468 | Thyroid Gland Follicular Adenoma | disease | BEFREE |
C0151740 | Intracranial Hypertension | disease | HPO |
C0151811 | Subcutaneous nodule | phenotype | HPO |
C0151846 | Periosteal Disorder | disease | BEFREE |
C0152013 | Adenocarcinoma of lung (disorder) | disease | BEFREE;CLINVAR;GWASCAT;UNIPROT |
C0152018 | Esophageal carcinoma | disease | BEFREE;CLINVAR |
C0152021 | Congenital heart disease | group | BEFREE;HPO |
C0152421 | Macrotia | disease | HPO |
C0152423 | Congenital small ears | disease | HPO |
C0152427 | Polydactyly | disease | GENOMICS_ENGLAND;LHGDN |
C0153574 | Malignant Uterine Corpus Neoplasm | disease | CLINVAR |
C0153690 | Secondary malignant neoplasm of bone | disease | BEFREE |
C0153943 | Benign neoplasm of stomach | disease | CGI |
C0154060 | Carcinoma in situ of stomach | disease | CGI |
C0154084 | Stage 0 Breast Carcinoma | disease | BEFREE |
C0155119 | Recurrent erosion of cornea | disease | HPO |
C0155552 | Hearing Loss, Mixed Conductive-Sensorineural | disease | HPO |
C0156394 | Hypertrophy of clitoris | disease | HPO |
C0158761 | Radioulnar Synostosis | disease | HPO |
C0162298 | Joint stiffness | phenotype | HPO |
C0175699 | Saethre-Chotzen Syndrome | disease | BEFREE;CLINVAR;CTD_human;ORPHANET |
C0175754 | Agenesis of corpus callosum | disease | HPO |
C0178874 | Tumor Progression | phenotype | BEFREE |
C0205647 | Follicular adenoma | disease | BEFREE |
C0206634 | Liposarcoma, Myxoid | disease | BEFREE |
C0206644 | Histiocytoma, Benign Fibrous | disease | LHGDN |
C0206664 | Teratocarcinoma | disease | BEFREE |
C0206698 | Cholangiocarcinoma | disease | BEFREE;CTD_human |
C0206708 | Cervical Intraepithelial Neoplasia | disease | BEFREE |
C0206762 | Limb Deformities, Congenital | group | CTD_human |
C0220620 | Gastrointestinal Carcinoid Tumor | disease | BEFREE |
C0220658 | Pfeiffer Syndrome | disease | BEFREE;CLINVAR;CTD_human;MGD;UNIPROT |
C0220668 | Congenital contractural arachnodactyly | disease | BEFREE |
C0220701 | RETINITIS PIGMENTOSA 1 | disease | RGD |
C0220724 | CONSTRICTING BANDS, CONGENITAL | disease | BEFREE |
C0220810 | Congenital defects | group | BEFREE |
C0221352 | Syndactyly of fingers | disease | HPO |
C0221354 | Frontal bossing | disease | HPO |
C0221355 | Macrocephaly | disease | HPO |
C0221356 | Brachycephaly | disease | CTD_human;HPO |
C0221357 | Brachydactyly | disease | HPO |
C0221358 | Long narrow head | phenotype | HPO |
C0233514 | Abnormal behavior | phenotype | BEFREE |
C0235653 | Malignant neoplasm of female breast | disease | BEFREE |
C0235942 | Abnormality of the skull | phenotype | BEFREE;CLINVAR;HPO |
C0235974 | Pancreatic carcinoma | disease | BEFREE |
C0238033 | Carcinoma of Male Breast | disease | BEFREE |
C0239174 | Late tooth eruption | phenotype | HPO |
C0239234 | Low set ears | phenotype | CLINVAR;HPO |
C0239337 | Deformity of limb | group | BEFREE |
C0239676 | High forehead | phenotype | CLINVAR;HPO |
C0239849 | Harlequin Fetus | disease | BEFREE |
C0239946 | Fibrosis, Liver | disease | CTD_human |
C0240310 | Hypoplasia of the maxilla | disease | HPO |
C0240538 | Convex nasal ridge | phenotype | HPO |
C0240635 | Byzanthine arch palate | disease | CLINVAR;HPO |
C0240912 | Vertical Talus | disease | HPO |
C0241074 | Hyperextensible skin | phenotype | HPO |
C0242379 | Malignant neoplasm of lung | disease | BEFREE;CTD_human |
C0242787 | Malignant neoplasm of male breast | disease | BEFREE |
C0262361 | Growth abnormality | phenotype | HPO |
C0262587 | Parathyroid Adenoma | disease | BEFREE |
C0263523 | Micronychia (disorder) | phenotype | HPO |
C0263661 | Disorder of skeletal system | group | BEFREE |
C0264303 | Laryngomalacia | disease | HPO |
C0264353 | Bronchomalacia | disease | HPO |
C0265269 | Lacrimoauriculodentodigital syndrome | disease | BEFREE;CLINVAR;CTD_human;ORPHANET;UNIPROT |
C0265326 | Bannayan-Riley-Ruvalcaba Syndrome | disease | CTD_human |
C0265529 | Plagiocephaly | disease | BEFREE;HPO |
C0265534 | Scaphycephaly | disease | BEFREE;CTD_human |
C0265535 | Trigonocephaly | disease | CTD_human |
C0265610 | Congenital clinodactyly | disease | BEFREE |
C0265660 | Syndactyly of the toes | disease | HPO |
C0265857 | Uhl anomaly | disease | BEFREE |
C0265886 | Overriding aorta | disease | BEFREE;HPO |
C0266061 | Open Bite | phenotype | HPO |
C0266122 | Cleft uvula | disease | HPO |
C0266184 | Congenital duodenal obstruction due to malrotation of intestine | disease | BEFREE |
C0266231 | Ectopic anus | disease | HPO |
C0266292 | Congenital anomaly of the kidney | group | HPO |
C0266470 | Cerebellar Hypoplasia | disease | HPO |
C0266508 | Rachischisis | disease | CTD_human |
C0266589 | Congenital ear anomaly NOS (disorder) | group | HPO |
C0266617 | Congenital anomaly of face | group | HPO |
C0269102 | Endometrioma | disease | BEFREE |
C0271441 | Chronic otitis media | disease | HPO |
C0277828 | Late fontanel closure | phenotype | HPO |
C0278488 | Carcinoma breast stage IV | disease | BEFREE |
C0278701 | Gastric Adenocarcinoma | disease | BEFREE;CLINVAR |
C0278801 | Endometrial neoplasm malignant metastatic | disease | BEFREE |
C0278802 | Recurrent Endometrial Cancer | disease | BEFREE |
C0278996 | Malignant Head and Neck Neoplasm | disease | CGI |
C0279563 | Lobular carcinoma in situ of breast | disease | BEFREE |
C0279626 | Squamous cell carcinoma of esophagus | disease | BEFREE |
C0279763 | endometrial adenoacanthoma | disease | CLINVAR |
C0280100 | Solid Neoplasm | phenotype | BEFREE |
C0280630 | Uterine Carcinosarcoma | disease | CLINVAR |
C0280725 | Adult Cholangiocarcinoma | disease | BEFREE |
C0302501 | Mandibular hyperplasia | phenotype | HPO |
C0302592 | Cervix carcinoma | disease | BEFREE |
C0332877 | Congenital premature fusion | disease | BEFREE |
C0334381 | Non-infiltrating lobular carcinoma | disease | BEFREE |
C0334579 | Anaplastic astrocytoma | disease | BEFREE |
C0339293 | Corneal Perforation | phenotype | HPO |
C0339535 | Night blindness, congenital stationary | disease | HPO |
C0339789 | Congenital deafness | disease | HPO |
C0341787 | Bifid scrotum | disease | HPO |
C0344505 | Alacrima | disease | HPO |
C0344509 | Agenesis of punctum lacrimale | disease | HPO |
C0344530 | Congenital keratoglobus | disease | HPO |
C0345354 | Radial polydactyly | disease | HPO |
C0345905 | Intrahepatic Cholangiocarcinoma | disease | BEFREE;CTD_human |
C0346153 | Breast Cancer, Familial | disease | BEFREE |
C0346163 | Endometrioid carcinoma ovary | disease | GWASCAT |
C0346191 | Carcinoma in situ of endometrium | disease | CGI |
C0346647 | Malignant neoplasm of pancreas | disease | BEFREE |
C0349204 | Nonorganic psychosis | disease | PSYGENET |
C0349588 | Short stature | phenotype | HPO |
C0376358 | Malignant neoplasm of prostate | disease | BEFREE |
C0376480 | Gingival Overgrowth | phenotype | HPO |
C0376634 | Craniofacial Abnormalities | group | BEFREE;CTD_human |
C0391826 | Lhermitte-Duclos disease | disease | CTD_human |
C0395837 | Stenosis of external auditory canal | disease | HPO |
C0399526 | Class III malocclusion | disease | HPO |
C0403592 | Chronic rejection of renal transplant | disease | BEFREE |
C0406709 | Hay-Wells syndrome | disease | BEFREE |
C0409348 | Flexion contracture of proximal interphalangeal joint | phenotype | HPO |
C0409477 | Ankylosis of the elbow joint | disease | HPO |
C0410528 | Skeletal dysplasia | disease | BEFREE |
C0423110 | Downward slant of palpebral fissure | phenotype | CLINVAR;HPO |
C0423113 | Telecanthus | phenotype | HPO |
C0423221 | Globe of eye large | phenotype | HPO |
C0423903 | Low intelligence | phenotype | HPO |
C0424503 | Dysmorphic facies | phenotype | HPO |
C0424690 | Asymmetrical skull | phenotype | HPO |
C0426414 | Small nose | phenotype | HPO |
C0426422 | Narrow nose | phenotype | HPO |
C0426790 | Narrow thorax | phenotype | HPO |
C0426799 | Congenital hypoplasia of clavicle | disease | HPO |
C0426891 | Broad thumbs | phenotype | HPO |
C0431371 | Absence of septum pellucidum | disease | HPO |
C0431483 | Simple ear | phenotype | CLINVAR;HPO |
C0432040 | Simple syndactyly of toes, first web space | disease | HPO |
C0432055 | Simple syndactyly of fingers - first web | disease | HPO |
C0432123 | Sagittal craniosynostosis | disease | HPO |
C0432124 | Unicoronal craniosynostosis | disease | BEFREE |
C0432238 | Bent bone dysplasia | disease | BEFREE |
C0432283 | Osteoglophonic dwarfism | disease | BEFREE |
C0456132 | Large fontanelle | phenotype | HPO |
C0476089 | Endometrial Carcinoma | disease | BEFREE;CGI;CLINVAR;CTD_human |
C0476273 | Respiratory distress | phenotype | HPO |
C0494165 | Secondary malignant neoplasm of liver | disease | BEFREE |
C0496905 | Neoplasm of uncertain or unknown behavior of stomach | disease | CGI |
C0497247 | Increase in blood pressure | phenotype | HPO |
C0521158 | Recurrent tumor | phenotype | BEFREE |
C0521525 | Short neck | phenotype | CLINVAR |
C0524730 | Odontome | disease | CTD_human |
C0542519 | Congenital absence of kidney | disease | BEFREE;HPO |
C0545074 | Myxoid/Round Cell Liposarcoma | disease | BEFREE |
C0546297 | Hallux Varus | phenotype | HPO |
C0549397 | Deviated nasal septum | phenotype | CLINVAR |
C0549473 | Thyroid carcinoma | disease | BEFREE |
C0554972 | Large auricle | phenotype | HPO |
C0557874 | Global developmental delay | disease | BEFREE;HPO |
C0566899 | Small labia majora | phenotype | HPO |
C0575802 | Small hand | phenotype | HPO |
C0576860 | Narrowing of ear canal | phenotype | HPO |
C0584837 | Choanal stenosis | phenotype | CLINVAR;HPO |
C0585442 | Osteosarcoma of bone | disease | BEFREE |
C0596263 | Carcinogenesis | phenotype | BEFREE |
C0600139 | Prostate carcinoma | disease | BEFREE;GWASCAT |
C0677886 | Epithelial ovarian cancer | disease | BEFREE;GWASCAT |
C0678222 | Breast Carcinoma | disease | BEFREE;CTD_human;GWASCAT;GWASDB;HPO |
C0684249 | Carcinoma of lung | disease | BEFREE;GWASCAT |
C0685381 | Congenital hypoplasia of radius | disease | HPO |
C0685409 | Congenital Camptodactyly | disease | HPO |
C0685678 | Incomplete ossification of pubis | phenotype | HPO |
C0685707 | Muscular ventricular septum defect | disease | BEFREE |
C0685938 | Malignant neoplasm of gastrointestinal tract | disease | BEFREE |
C0686619 | Secondary malignant neoplasm of lymph node | disease | BEFREE |
C0699790 | Colon Carcinoma | disease | BEFREE |
C0699791 | Stomach Carcinoma | disease | BEFREE;CGI;HPO |
C0699885 | Carcinoma of bladder | disease | BEFREE |
C0700095 | Central neuroblastoma | disease | BEFREE |
C0702166 | Acne | disease | HPO |
C0740852 | Upper airway obstruction | phenotype | HPO |
C0741916 | Cardiac defects | group | BEFREE |
C0743359 | Chronic ear infection | disease | HPO |
C0746926 | Multiple, subcutaneous nodules | disease | HPO |
C0747078 | Generalized osteopenia | disease | HPO |
C0747845 | early pregnancy | phenotype | BEFREE |
C0750929 | Arnold-Chiari Malformation, Type I | disease | BEFREE;HPO |
C0795998 | JACKSON-WEISS SYNDROME | disease | BEFREE;CLINVAR;CTD_human;ORPHANET;UNIPROT |
C0814161 | impaired motor coordination | phenotype | BEFREE |
C0846967 | Acanthoma | disease | LHGDN |
C0848558 | Hypospadias | group | BEFREE;RGD |
C0853879 | Invasive carcinoma of breast | disease | BEFREE |
C0857379 | Abnormality of the pinna | phenotype | HPO |
C0917816 | Mental deficiency | disease | CTD_human;HPO |
C0919267 | ovarian neoplasm | disease | BEFREE;LHGDN |
C0948060 | Iridocele | disease | HPO |
C0948187 | Tracheomalacia | disease | HPO |
C0949541 | Hurthle Cell Tumor | disease | BEFREE |
C0950123 | Genetic Diseases, Inborn | group | CLINVAR |
C1096616 | Contralateral breast cancer | disease | BEFREE |
C1140680 | Malignant neoplasm of ovary | disease | BEFREE |
C1153706 | Endometrial adenocarcinoma | disease | BEFREE;CGI |
C1167712 | Corneal diameter increased | phenotype | HPO |
C1168401 | Squamous cell carcinoma of the head and neck | disease | BEFREE |
C1257931 | Mammary Neoplasms, Human | group | CTD_human |
C1265996 | Large cell neuroendocrine carcinoma | disease | BEFREE |
C1269683 | Major Depressive Disorder | disease | BEFREE |
C1281931 | Obstruction of nasolacrimal duct | phenotype | HPO |
C1292120 | Extramedullary erythropoiesis | phenotype | HPO |
C1306122 | Oguchi disease | disease | HPO |
C1306459 | Primary malignant neoplasm | group | BEFREE |
C1306460 | Primary malignant neoplasm of lung | disease | BEFREE |
C1306710 | Facial asymmetry | phenotype | CLINVAR;HPO |
C1317785 | Tooth size discrepancy | phenotype | HPO |
C1321884 | Atresia of vagina | disease | HPO |
C1328504 | Hormone refractory prostate cancer | disease | BEFREE |
C1334177 | Infiltrating Cervical Carcinoma | disease | BEFREE |
C1335177 | Ovarian Serous Adenocarcinoma | disease | GWASCAT;UNIPROT |
C1335302 | Pancreatic Ductal Adenocarcinoma | disease | BEFREE |
C1336076 | Sporadic Breast Carcinoma | disease | BEFREE |
C1368683 | Epithelioma | disease | BEFREE |
C1384666 | hearing impairment | phenotype | HPO |
C1385263 | Deformity of face | phenotype | HPO |
C1394030 | Coronal hypospadias | disease | HPO |
C1398312 | Narrow palate | phenotype | HPO |
C1398325 | Absent auditory canals | disease | HPO |
C1400252 | Hypoplasia of parotid gland | phenotype | HPO |
C1405984 | Absent radius | disease | HPO |
C1450010 | Plagiocephaly, Nonsynostotic | phenotype | CTD_human;HPO |
C1458155 | Mammary Neoplasms | group | BEFREE;CLINVAR;CTD_human;LHGDN |
C1510455 | Acrocephalosyndactylia | disease | CLINVAR;CTD_human;LHGDN;MGD;ORPHANET |
C1517658 | Cervical Keratinizing Squamous Cell Carcinoma | disease | BEFREE |
C1527249 | Colorectal Cancer | disease | BEFREE;GWASCAT |
C1562113 | Fleck corneal dystrophy | disease | BEFREE |
C1623038 | Cirrhosis | disease | BEFREE |
C1691215 | Penile hypospadias | disease | BEFREE |
C1704272 | Benign Prostatic Hyperplasia | disease | BEFREE |
C1708349 | Hereditary Diffuse Gastric Cancer | disease | CTD_human |
C1737329 | Dysmorphism | disease | BEFREE |
C1833340 | Synostotic Posterior Plagiocephaly | disease | BEFREE;CTD_human;HPO |
C1833762 | Decreased calvarial ossification | phenotype | HPO |
C1836193 | Synostosis of carpal bones | phenotype | HPO |
C1836542 | Depressed nasal bridge | phenotype | HPO |
C1837218 | Cleft palate, isolated | disease | BEFREE;CTD_human |
C1837402 | Flat occiput | phenotype | CLINVAR |
C1837532 | Fused labia minora | phenotype | HPO |
C1837760 | Prominent eyes | phenotype | HPO |
C1838608 | Radial aplasia | disease | HPO |
C1838705 | Anteriorly placed anus | phenotype | HPO |
C1839758 | Narrow forehead | phenotype | CLINVAR |
C1839798 | Long nose | phenotype | HPO |
C1840077 | Anteverted nostril | phenotype | HPO |
C1840087 | Radial ray hypoplasia | phenotype | HPO |
C1840305 | Absent external auditory canals | phenotype | HPO |
C1840560 | Hidradenitis suppurativa, familial | disease | GENOMICS_ENGLAND |
C1842083 | Abnormality of the ribs | phenotype | HPO |
C1842231 | Broad metatarsal | phenotype | HPO |
C1842366 | Low anterior hairline | phenotype | HPO |
C1843108 | Short palm | phenotype | HPO |
C1843367 | Poor school performance | phenotype | HPO |
C1845447 | Cupped ears (finding) | phenotype | HPO |
C1846460 | Abnormality of the outer ear | phenotype | HPO |
C1846474 | Small thenar eminence | phenotype | HPO |
C1848103 | Narrow pelvis bone | phenotype | HPO |
C1848490 | Protruding eyes | phenotype | HPO |
C1848587 | Isolated hypoplasia of the right ventricle | disease | BEFREE |
C1848673 | Hypoplastic feet | phenotype | HPO |
C1849020 | Short metatarsal | phenotype | HPO |
C1849089 | Broad forehead | phenotype | HPO |
C1849227 | Cleft of chin | phenotype | HPO |
C1849314 | absence of radius and ulna | phenotype | HPO |
C1849538 | Delayed eruption of primary teeth | phenotype | HPO |
C1850049 | Clinodactyly of the 5th finger | disease | HPO |
C1850161 | Widened metatarsal shaft | phenotype | HPO |
C1850189 | Large pinnae | phenotype | HPO |
C1851792 | Aplasia/Hypoplasia of the earlobes | disease | HPO |
C1851797 | Palmoplantar cutis gyrata | phenotype | HPO |
C1851854 | Thin dental enamel | phenotype | HPO |
C1852406 | Cutis Gyrata Syndrome of Beare And Stevenson | disease | BEFREE;CLINVAR;CTD_human;MGD;ORPHANET;UNIPROT |
C1852407 | Prominent scrotal raphe | phenotype | HPO |
C1852411 | Preauricular skin furrow | phenotype | HPO |
C1852464 | Abnormality of the cervical spine | phenotype | HPO |
C1853241 | Flat face | phenotype | HPO |
C1853242 | Midface retrusion | phenotype | HPO |
C1854113 | Prominent nasal bridge | phenotype | HPO |
C1854114 | Short nose | phenotype | HPO |
C1856136 | Conical incisor | phenotype | HPO |
C1856266 | Coronal craniosynostosis | disease | BEFREE;HPO |
C1856409 | Dilation of lateral ventricles | phenotype | CLINVAR |
C1856714 | Palmoplantar cutis laxa | phenotype | HPO |
C1856912 | Shortening of all middle phalanges of the fingers | phenotype | HPO |
C1857079 | Atretic auditory canal | disease | HPO |
C1857108 | Limitation of joint mobility | phenotype | HPO |
C1857130 | Hypoplastic mandible condyle | phenotype | HPO |
C1857276 | Trichohepatoenteric Syndrome | disease | BEFREE |
C1857353 | Posterior fossa cyst | phenotype | HPO |
C1857484 | Brachyturricephaly | phenotype | CLINVAR;HPO |
C1857485 | Flat forehead | phenotype | HPO |
C1857486 | Low-set, posteriorly rotated ears | phenotype | HPO |
C1858036 | Periorbital fullness | phenotype | HPO |
C1858085 | Malar flattening | phenotype | HPO |
C1858569 | Absence of Stensen duct | phenotype | HPO |
C1859447 | Hypoplastic ischia | phenotype | HPO |
C1859461 | Femoral bowing | phenotype | HPO |
C1860042 | Antley-Bixler Syndrome with Disordered Steroidogenesis | disease | BEFREE;CTD_human |
C1860050 | Cloverleaf skull | phenotype | HPO |
C1860245 | Cranial asymmetry | phenotype | CLINVAR |
C1860614 | ULNAR HYPOPLASIA | phenotype | HPO |
C1860819 | Metopic synostosis | disease | CTD_human |
C1861869 | Underdeveloped supraorbital ridges | phenotype | HPO |
C1862095 | Bilateral single transverse palmar creases | phenotype | HPO |
C1862132 | Short ulnae | phenotype | HPO |
C1862425 | Prominent globes | phenotype | HPO |
C1863200 | Lacrimal gland hypoplasia | phenotype | HPO |
C1863360 | Radiohumeral synostosis of elbow | phenotype | HPO |
C1863363 | Cartilaginous trachea | phenotype | HPO |
C1863382 | Absent first metatarsal | phenotype | HPO |
C1863389 | Apert-Crouzon Disease | disease | CTD_human;UNIPROT |
C1863391 | Vogt Cephalodactyly | disease | UNIPROT |
C1863392 | Abnormal morphology of the limbic system | phenotype | HPO |
C1863395 | Acrobrachycephaly | disease | HPO |
C1863402 | Broad distal phalanx of the thumb | phenotype | HPO |
C1863403 | Broad distal hallux | phenotype | HPO |
C1863406 | Anomalous tracheal cartilage | phenotype | HPO |
C1864156 | Conjunctivitis, recurrent | phenotype | HPO |
C1864436 | Muenke Syndrome | disease | BEFREE |
C1864897 | Cognitive delay | phenotype | HPO |
C1865014 | Long philtrum | phenotype | HPO |
C1865070 | SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION | disease | CLINVAR;CTD_human;ORPHANET;UNIPROT |
C1865186 | Bell-shaped thorax | phenotype | HPO |
C1865244 | Shallow orbits | phenotype | CLINVAR;HPO |
C1865304 | Overfolding of the superior helices | phenotype | HPO |
C1865847 | Ulnar bowing | phenotype | HPO |
C1865992 | Short hallux | phenotype | HPO |
C1866134 | Wide anterior fontanel | phenotype | CLINVAR;HPO |
C1866190 | Atresia of the external auditory canal | phenotype | HPO |
C1867060 | Lacrimal Puncta, Absence of | disease | HPO |
C1867103 | Limited elbow extension | phenotype | HPO |
C1867131 | Broad hallux | phenotype | HPO |
C1867563 | CRANIOSYNOSTOSIS, NONCLASSIFIABLE AUTOSOMAL DOMINANT | phenotype | CLINVAR |
C1867564 | SCAPHOCEPHALY AND AXENFELD-RIEGER ANOMALY | phenotype | CLINVAR |
C1879344 | Biliary papillomatosis | disease | BEFREE |
C1883486 | Uterine Corpus Cancer | disease | BEFREE |
C1959582 | PTEN Hamartoma Tumor Syndrome | disease | CTD_human |
C1963137 | Hydrocephalus Adverse Event | phenotype | CLINVAR |
C1968574 | Hypoplastic lacrimal duct | phenotype | HPO |
C2145472 | Urothelial Carcinoma | disease | BEFREE |
C2227134 | mandibular excess (physical finding) | phenotype | HPO |
C2239176 | Liver carcinoma | disease | BEFREE |
C2350233 | Antley-Bixler Syndrome Phenotype | disease | CTD_human |
C2613439 | Extramedullary Hematopoiesis (disorder) | disease | HPO |
C2673410 | Small midface | phenotype | HPO |
C2674608 | Feeding difficulties in infancy | phenotype | HPO |
C2930865 | Ramer Ladda syndrome | disease | BEFREE;HPO |
C2931150 | Synostotic Anterior Plagiocephaly | disease | CTD_human |
C2931196 | Craniofacial dysostosis type 1 | disease | BEFREE;CTD_human;ORPHANET;UNIPROT |
C2931888 | Pfeiffer type acrocephalosyndactyly | disease | CTD_human |
C2936786 | Aqueductal Stenosis | disease | HPO |
C2936791 | Antley-Bixler Syndrome, Autosomal Dominant | disease | BEFREE;CLINVAR;CTD_human;ORPHANET;UNIPROT |
C2937421 | Prostatic Hyperplasia | disease | BEFREE |
C2938924 | Oestrogen receptor positive breast cancer | disease | GWASCAT |
C2981150 | Uranostaphyloschisis | disease | BEFREE;HPO |
C3150931 | Steep acetabular roof | phenotype | HPO |
C3179508 | Aplasia/Hypoplasia of the thumb | phenotype | HPO |
C3278923 | Dilated ventricles (finding) | phenotype | HPO |
C3280768 | Abnormality of the posterior cranial fossa | phenotype | CLINVAR |
C3281247 | BENT BONE DYSPLASIA SYNDROME | disease | BEFREE;CLINVAR;CTD_human;ORPHANET;UNIPROT |
C3495676 | Anorectal Malformations | group | BEFREE |
C3539878 | Triple Negative Breast Neoplasms | disease | BEFREE |
C3550546 | Depressed nasal root/bridge | phenotype | HPO |
C3551052 | Night blindness, stationary | disease | HPO |
C3552414 | Deviation of the thumb | phenotype | HPO |
C3642345 | Luminal A Breast Carcinoma | disease | BEFREE |
C3642346 | Luminal B Breast Carcinoma | disease | BEFREE |
C3665347 | Visual Impairment | phenotype | HPO |
C3714756 | Intellectual Disability | group | BEFREE;CTD_human;GENOMICS_ENGLAND;HPO |
C3805278 | Extrahepatic Cholangiocarcinoma | disease | CTD_human |
C3811653 | Experimental Organism Basal Cell Carcinoma | phenotype | BEFREE |
C3887461 | Head and Neck Carcinoma | disease | CGI |
C4016282 | BREAST CANCER, SOMATIC | disease | BEFREE |
C4016345 | PFEIFFER SYNDROME, TYPE III | phenotype | CLINVAR |
C4016346 | CRANIOSYNOSTOSIS, NONSYNDROMIC UNICORONAL | phenotype | CLINVAR |
C4020759 | Pointed incisor | phenotype | HPO |
C4020777 | Underdeveloped brows | phenotype | HPO |
C4020779 | Absence of the parotid gland | phenotype | HPO |
C4020787 | Subcoronal hypospadias | disease | HPO |
C4020847 | Abnormality of pelvic girdle bone morphology | phenotype | HPO |
C4020875 | Mental and motor retardation | phenotype | HPO |
C4020876 | Dull intelligence | phenotype | HPO |
C4020888 | Epithelial corneal erosions | phenotype | HPO |
C4020892 | Capuchin ears | disease | HPO |
C4020908 | Hypointensity of cerebral white matter on MRI | phenotype | CLINVAR |
C4021161 | Multiple suture craniosynostosis | phenotype | HPO |
C4021164 | Bicoronal synostosis | disease | BEFREE;HPO |
C4021242 | Hypoplasia of the zygomatic bone | phenotype | HPO |
C4021254 | Cutaneous finger syndactyly | disease | HPO |
C4021343 | Broad hallux phalanx | phenotype | HPO |
C4021360 | Partial duplication of the distal phalanx of the 3rd finger | phenotype | HPO |
C4021365 | Partial duplication of the distal phalanx of the 2nd finger | phenotype | HPO |
C4021377 | Prominent crus of helix | phenotype | HPO |
C4021395 | Abnormality of the antihelix | phenotype | HPO |
C4021418 | Absent proximal phalanx of thumb | phenotype | HPO |
C4021564 | Hypoplasia of the lacrimal puncta | phenotype | HPO |
C4021626 | Lethal skeletal dysplasia | phenotype | BEFREE |
C4021627 | Bilateral triphalangeal thumbs | phenotype | HPO |
C4021723 | Short middle phalanx of toe | phenotype | HPO |
C4021815 | Abnormality of the palate | phenotype | HPO |
C4021977 | Visceral angiomatosis | disease | HPO |
C4023383 | Narrow internal auditory canal | phenotype | HPO |
C4023386 | Morphological abnormality of the semicircular canal | phenotype | HPO |
C4023454 | Metopic depression | phenotype | HPO |
C4023628 | Mild fetal ventriculomegaly | phenotype | CLINVAR |
C4023749 | Abnormality of the zygomatic bone | phenotype | CLINVAR |
C4024202 | Reduced number of teeth | phenotype | HPO |
C4024215 | Aplasia of the parotid gland | phenotype | HPO |
C4024345 | Radial deviation of the 3rd finger | phenotype | HPO |
C4024589 | Aplasia/Hypoplasia of the mandible | phenotype | HPO |
C4024730 | Calcaneonavicular fusion | phenotype | HPO |
C4024822 | Lacrimal gland aplasia | phenotype | HPO |
C4025301 | Cervical C5/C6 vertebrae fusion | phenotype | HPO |
C4025414 | Radial club hand | disease | GENOMICS_ENGLAND |
C4025750 | Abnormality of the nasopharynx | phenotype | HPO |
C4025751 | Abnormality of the pancreas | phenotype | HPO |
C4025835 | Abnormality of the nasolacrimal system | phenotype | HPO |
C4025860 | Hearing abnormality | phenotype | HPO |
C4048328 | cervical cancer | disease | BEFREE |
C4048798 | Complete congenital stationary night blindness | disease | HPO |
C4049796 | Abnormality of cardiovascular system morphology | disease | HPO |
C4072820 | Large bregma sutures | phenotype | HPO |
C4072821 | Large, late-closing fontanelle | phenotype | HPO |
C4072822 | Wide bregma sutures | phenotype | HPO |
C4072823 | Broad cranium shape | phenotype | HPO |
C4072824 | Wide skull shape | phenotype | HPO |
C4072830 | Asymmetry of the posterior cranium | phenotype | HPO |
C4072832 | Distortion of face | phenotype | HPO |
C4072833 | Funny looking face | phenotype | HPO |
C4072879 | Small cheekbone | phenotype | HPO |
C4073134 | Abnormality of the periosteum | phenotype | HPO |
C4082168 | Partial duplication of thumb phalanx | phenotype | HPO |
C4082243 | Maxillary retrognathia | phenotype | HPO |
C4083050 | Tooth agenesis | phenotype | HPO |
C4083076 | Increased head circumference | phenotype | HPO |
C4230640 | Convex nasal bridge | phenotype | HPO |
C4255213 | Increased size of skull | phenotype | HPO |
C4280269 | Noncancerous mole | phenotype | HPO |
C4280320 | Hypotrophic midface | phenotype | HPO |
C4280321 | Decreased projection of midface | phenotype | HPO |
C4280341 | Pointed front tooth | phenotype | HPO |
C4280342 | Peg shaped front tooth | phenotype | HPO |
C4280368 | Hypotrophic cheekbone | phenotype | HPO |
C4280369 | Flattening of the zygomatic bone | phenotype | HPO |
C4280370 | Depressed cheekbone | phenotype | HPO |
C4280456 | Dysplasia of tooth enamel | phenotype | HPO |
C4280457 | Defective enamel matrix | phenotype | HPO |
C4280495 | Concave bridge of nose | phenotype | HPO |
C4280538 | Curvature of little finger | phenotype | HPO |
C4280562 | Malformation of skull shape | phenotype | HPO |
C4280563 | Abnormality of skull shape | phenotype | HPO |
C4280564 | Cloverleaf cranium shape | phenotype | HPO |
C4280597 | Rhomboid shaped head | phenotype | HPO |
C4280598 | Flattening of head | phenotype | HPO |
C4280613 | Angle class 3 malocclusion | phenotype | HPO |
C4280614 | Angle class 2 malocclusion | disease | HPO |
C4280617 | Tooth mass arch size discrepancy | phenotype | HPO |
C4280618 | Inadequate arch length for tooth size | phenotype | HPO |
C4280623 | Rotting teeth | phenotype | HPO |
C4280640 | Retrusion of upper jaw bones | phenotype | HPO |
C4280641 | Hypotrophic maxilla | phenotype | HPO |
C4280642 | Deficiency of upper jaw bones | phenotype | HPO |
C4280643 | Decreased projection of maxilla | phenotype | HPO |
C4280644 | Increased size of the mandible | phenotype | HPO |
C4280645 | Hypertrophy of lower jaw | phenotype | HPO |
C4280651 | Hypotrophic malar bone | phenotype | HPO |
C4280653 | Turridolichocephaly | disease | HPO |
C4280654 | Narrow skull shape | disease | HPO |
C4280655 | Narrow head shape | disease | HPO |
C4280656 | Narrow cranium shape | disease | HPO |
C4280664 | Big calvaria | phenotype | HPO |
C4280674 | Agenesis of parotid duct | phenotype | HPO |
C4280807 | Flattening of cranial vault | phenotype | HPO |
C4476522 | Oral soft tissue hyperplasia | phenotype | HPO |
C4476523 | Decreased projection of lower jaw | phenotype | HPO |
C4476524 | Decreased projection of mandible | phenotype | HPO |
C4476525 | Retrusion of lower jaw | phenotype | HPO |
C4476527 | Flat head | phenotype | HPO |
C4505262 | Oncogene Addiction | phenotype | BEFREE |
C4531022 | Breaking out | phenotype | HPO |
GO ID | GO Term | Evidence |
---|---|---|
GO:0004713 | protein tyrosine kinase activity | NAS |
GO:0004714 | transmembrane receptor protein tyrosine kinase activity | IBA |
GO:0005007 | fibroblast growth factor-activated receptor activity | IGI |
GO:0005007 | fibroblast growth factor-activated receptor activity | NAS |
GO:0005007 | fibroblast growth factor-activated receptor activity | IDA |
GO:0005007 | fibroblast growth factor-activated receptor activity | IBA |
GO:0005515 | protein binding | IPI |
GO:0005524 | ATP binding | IEA |
GO:0008201 | heparin binding | IEA |
GO:0017134 | fibroblast growth factor binding | IBA |
GO:0017134 | fibroblast growth factor binding | IPI |
GO:0017134 | fibroblast growth factor binding | IDA |
GO:0042803 | protein homodimerization activity | IPI |
GO ID | GO Term | Evidence |
---|---|---|
GO:0000122 | negative regulation of transcription by RNA polymerase II | ISS |
GO:0000165 | MAPK cascade | TAS |
GO:0001525 | angiogenesis | ISS |
GO:0001657 | ureteric bud development | ISS |
GO:0001701 | in utero embryonic development | ISS |
GO:0001837 | epithelial to mesenchymal transition | IEA |
GO:0002053 | positive regulation of mesenchymal cell proliferation | ISS |
GO:0003148 | outflow tract septum morphogenesis | ISS |
GO:0003149 | membranous septum morphogenesis | ISS |
GO:0003416 | endochondral bone growth | IEA |
GO:0006915 | apoptotic process | IEA |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | IBA |
GO:0007267 | cell-cell signaling | ISS |
GO:0007275 | multicellular organism development | IBA |
GO:0007409 | axonogenesis | ISS |
GO:0008284 | positive regulation of cell population proliferation | IMP |
GO:0008284 | positive regulation of cell population proliferation | IDA |
GO:0008284 | positive regulation of cell population proliferation | IGI |
GO:0008543 | fibroblast growth factor receptor signaling pathway | IPI |
GO:0008543 | fibroblast growth factor receptor signaling pathway | IDA |
GO:0008543 | fibroblast growth factor receptor signaling pathway | IGI |
GO:0008543 | fibroblast growth factor receptor signaling pathway | TAS |
GO:0008589 | regulation of smoothened signaling pathway | ISS |
GO:0009791 | post-embryonic development | ISS |
GO:0009880 | embryonic pattern specification | ISS |
GO:0009887 | animal organ morphogenesis | ISS |
GO:0010518 | positive regulation of phospholipase activity | IMP |
GO:0016331 | morphogenesis of embryonic epithelium | ISS |
GO:0018108 | peptidyl-tyrosine phosphorylation | IDA |
GO:0021769 | orbitofrontal cortex development | ISS |
GO:0021847 | ventricular zone neuroblast division | ISS |
GO:0021860 | pyramidal neuron development | ISS |
GO:0022612 | gland morphogenesis | ISS |
GO:0030177 | positive regulation of Wnt signaling pathway | ISS |
GO:0030282 | bone mineralization | ISS |
GO:0030324 | lung development | ISS |
GO:0030855 | epithelial cell differentiation | ISS |
GO:0030901 | midbrain development | ISS |
GO:0030916 | otic vesicle formation | ISS |
GO:0031069 | hair follicle morphogenesis | ISS |
GO:0032496 | response to lipopolysaccharide | IEA |
GO:0032808 | lacrimal gland development | ISS |
GO:0033674 | positive regulation of kinase activity | IBA |
GO:0033688 | regulation of osteoblast proliferation | TAS |
GO:0035265 | organ growth | ISS |
GO:0035602 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell | ISS |
GO:0035603 | fibroblast growth factor receptor signaling pathway involved in hemopoiesis | ISS |
GO:0035604 | fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow | ISS |
GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | ISS |
GO:0042060 | wound healing | IEA |
GO:0042472 | inner ear morphogenesis | ISS |
GO:0042476 | odontogenesis | ISS |
GO:0043410 | positive regulation of MAPK cascade | IMP |
GO:0045165 | cell fate commitment | ISS |
GO:0045471 | response to ethanol | IEA |
GO:0045667 | regulation of osteoblast differentiation | TAS |
GO:0045787 | positive regulation of cell cycle | ISS |
GO:0045944 | positive regulation of transcription by RNA polymerase II | ISS |
GO:0046777 | protein autophosphorylation | IDA |
GO:0048286 | lung alveolus development | ISS |
GO:0048333 | mesodermal cell differentiation | IEA |
GO:0048557 | embryonic digestive tract morphogenesis | ISS |
GO:0048562 | embryonic organ morphogenesis | ISS |
GO:0048565 | digestive tract development | ISS |
GO:0048568 | embryonic organ development | ISS |
GO:0048608 | reproductive structure development | ISS |
GO:0048661 | positive regulation of smooth muscle cell proliferation | IEA |
GO:0048701 | embryonic cranial skeleton morphogenesis | IMP |
GO:0048705 | skeletal system morphogenesis | TAS |
GO:0048730 | epidermis morphogenesis | ISS |
GO:0048755 | branching morphogenesis of a nerve | ISS |
GO:0048762 | mesenchymal cell differentiation | ISS |
GO:0050679 | positive regulation of epithelial cell proliferation | ISS |
GO:0050680 | negative regulation of epithelial cell proliferation | IEA |
GO:0051150 | regulation of smooth muscle cell differentiation | ISS |
GO:0051781 | positive regulation of cell division | ISS |
GO:0051897 | positive regulation of protein kinase B signaling | TAS |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | ISS |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | ISS |
GO:0060174 | limb bud formation | ISS |
GO:0060348 | bone development | ISS |
GO:0060349 | bone morphogenesis | ISS |
GO:0060442 | branching involved in prostate gland morphogenesis | ISS |
GO:0060445 | branching involved in salivary gland morphogenesis | ISS |
GO:0060449 | bud elongation involved in lung branching | ISS |
GO:0060463 | lung lobe morphogenesis | ISS |
GO:0060484 | lung-associated mesenchyme development | ISS |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | ISS |
GO:0060512 | prostate gland morphogenesis | ISS |
GO:0060523 | prostate epithelial cord elongation | ISS |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | ISS |
GO:0060529 | squamous basal epithelial stem cell differentiation involved in prostate gland acinus development | ISS |
GO:0060595 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification | ISS |
GO:0060601 | lateral sprouting from an epithelium | ISS |
GO:0060615 | mammary gland bud formation | ISS |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | ISS |
GO:0060667 | branch elongation involved in salivary gland morphogenesis | ISS |
GO:0060670 | branching involved in labyrinthine layer morphogenesis | ISS |
GO:0060688 | regulation of morphogenesis of a branching structure | ISS |
GO:0060915 | mesenchymal cell differentiation involved in lung development | ISS |
GO:0060916 | mesenchymal cell proliferation involved in lung development | ISS |
GO:0070372 | regulation of ERK1 and ERK2 cascade | ISS |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ISS |
GO:0071300 | cellular response to retinoic acid | IEA |
GO:0071560 | cellular response to transforming growth factor beta stimulus | IEA |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | ISS |
GO ID | GO Term | Evidence |
---|---|---|
GO:0005634 | nucleus | IDA |
GO:0005737 | cytoplasm | IDA |
GO:0005794 | Golgi apparatus | IEA |
GO:0005886 | plasma membrane | TAS |
GO:0005887 | integral component of plasma membrane | IDA |
GO:0005887 | integral component of plasma membrane | IBA |
GO:0005938 | cell cortex | IDA |
GO:0009986 | cell surface | IDA |
GO:0016020 | membrane | NAS |
GO:0016021 | integral component of membrane | NAS |
GO:0031410 | cytoplasmic vesicle | IEA |
GO:0043235 | receptor complex | IBA |
GO:0060076 | excitatory synapse | ISS |
GO:0062023 | collagen-containing extracellular matrix | IDA |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-109704 | PI3K Cascade | TAS |
R-HSA-112399 | IRS-mediated signalling | TAS |
R-HSA-1226099 | Signaling by FGFR in disease | TAS |
R-HSA-1226099 | Signaling by FGFR in disease | IEA |
R-HSA-1257604 | PIP3 activates AKT signaling | TAS |
R-HSA-1280215 | Cytokine Signaling in Immune system | TAS |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-1643685 | Disease | TAS |
R-HSA-1643685 | Disease | IEA |
R-HSA-168256 | Immune System | TAS |
R-HSA-1839126 | FGFR2 mutant receptor activation | TAS |
R-HSA-1839126 | FGFR2 mutant receptor activation | IEA |
R-HSA-190236 | Signaling by FGFR | TAS |
R-HSA-190241 | FGFR2 ligand binding and activation | TAS |
R-HSA-190375 | FGFR2c ligand binding and activation | TAS |
R-HSA-190377 | FGFR2b ligand binding and activation | TAS |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | TAS |
R-HSA-2023837 | Signaling by FGFR2 amplification mutants | TAS |
R-HSA-2033519 | Activated point mutants of FGFR2 | TAS |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | TAS |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | TAS |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | TAS |
R-HSA-2428924 | IGF1R signaling cascade | TAS |
R-HSA-2428928 | IRS-related events triggered by IGF1R | TAS |
R-HSA-5654221 | Phospholipase C-mediated cascade; FGFR2 | TAS |
R-HSA-5654695 | PI-3K cascade:FGFR2 | TAS |
R-HSA-5654696 | Downstream signaling of activated FGFR2 | TAS |
R-HSA-5654699 | SHC-mediated cascade:FGFR2 | TAS |
R-HSA-5654700 | FRS-mediated FGFR2 signaling | TAS |
R-HSA-5654727 | Negative regulation of FGFR2 signaling | TAS |
R-HSA-5654738 | Signaling by FGFR2 | TAS |
R-HSA-5655253 | Signaling by FGFR2 in disease | TAS |
R-HSA-5655253 | Signaling by FGFR2 in disease | IEA |
R-HSA-5663202 | Diseases of signal transduction | TAS |
R-HSA-5663202 | Diseases of signal transduction | IEA |
R-HSA-5673001 | RAF/MAP kinase cascade | TAS |
R-HSA-5683057 | MAPK family signaling cascades | TAS |
R-HSA-5684996 | MAPK1/MAPK3 signaling | TAS |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | TAS |
R-HSA-74751 | Insulin receptor signalling cascade | TAS |
R-HSA-74752 | Signaling by Insulin receptor | TAS |
R-HSA-8851708 | Signaling by FGFR2 IIIa TM | IEA |
R-HSA-8853333 | Signaling by FGFR2 fusions | TAS |
R-HSA-9006925 | Intracellular signaling by second messengers | TAS |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | TAS |
R-HSA-9607240 | FLT3 Signaling | TAS |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D019307 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dinoprost affects the localization of FGFR2 protein] | 15654655 |
D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA | 16054899 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR2 mRNA | 31009676 |
D015056 | 1-Methyl-3-isobutylxanthine | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | 16054899 |
D015056 | 1-Methyl-3-isobutylxanthine | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | 16054899 |
C548651 | 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of FGFR2 mRNA | 19933214 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FGFR2 mRNA | 27291303 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of FGFR2 mRNA | 19114083 |
C070055 | 2,3',4,4',5-pentachlorobiphenyl | 2,3',4,4',5-pentachlorobiphenyl results in increased expression of FGFR2 mRNA | 31388691 |
C013186 | 2,3-pentanedione | 2,3-pentanedione results in decreased expression of FGFR2 mRNA | 25710175 |
C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of FGFR2 mRNA | 21346803 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene results in increased expression of FGFR2 mRNA | 20406850 |
C568950 | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea results in decreased activity of FGFR2 protein | 21936542 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FGFR2 mRNA | 23196670 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FGFR2 mRNA | 20959002 |
C561052 | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one results in decreased activity of FGFR2 protein | 21608528 |
C000622214 | 6F peptide | 6F peptide results in increased expression of FGFR2 mRNA | 29899427 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FGFR2 mRNA | 19150397 |
C496492 | abrine | abrine results in decreased expression of FGFR2 mRNA | 31054353 |
D000082 | Acetaminophen | Acetaminophen affects the expression of FGFR2 mRNA | 25458485 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of FGFR2 mRNA | 29067470 |
D000082 | Acetaminophen | [Clofibrate co-treated with Acetaminophen] affects the expression of FGFR2 mRNA | 17585979 |
D000082 | Acetaminophen | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FGFR2 mRNA] | 17585979 |
D000096 | Acetone | Acetone results in increased expression of FGFR2 mRNA | 12720008 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of FGFR2 mRNA | 22100608 |
C005277 | alpha-naphthyl thiourea | alpha-naphthyl thiourea results in increased expression of FGFR2 mRNA | 10755703 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of FGFR2 mRNA | 16483693 |
D000077237 | Arsenic Trioxide | Arsenic Trioxide results in decreased expression of FGFR2 mRNA | 15761015 |
C015001 | arsenite | arsenite results in increased methylation of FGFR2 promoter | 23974009 |
D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in decreased expression of FGFR2 mRNA | 23634900 |
D001280 | Atrazine | Atrazine results in decreased expression of FGFR2 mRNA | 25929836 |
D001554 | Benzene | Benzene results in increased expression of FGFR2 mRNA | 15120971; 15122651; |
C006780 | bisphenol A | bisphenol A affects the expression of FGFR2 mRNA | 20170705 |
C006780 | bisphenol A | bisphenol A affects the expression of FGFR2 mRNA | 26063408 |
C006780 | bisphenol A | bisphenol A affects the expression of FGFR2 mRNA | 25181051; 30816183; |
C006780 | bisphenol A | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR2 mRNA | 25607892 |
C006780 | bisphenol A | bisphenol A results in increased expression of FGFR2 mRNA | 29323181 |
C006780 | bisphenol A | bisphenol A results in increased methylation of FGFR2 gene | 28505145 |
D002065 | Buspirone | Buspirone results in decreased expression of FGFR2 mRNA | 24136188 |
C027561 | butylbenzyl phthalate | butylbenzyl phthalate results in decreased expression of FGFR2 mRNA | 26472102 |
C038091 | butylparaben | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR2 mRNA | 25607892 |
C487049 | BXL628 | BXL628 inhibits the reaction [FGF7 protein results in increased phosphorylation of FGFR2 protein] | 16289173 |
D002104 | Cadmium | Cadmium results in decreased expression of FGFR2 mRNA | 21120746 |
D002104 | Cadmium | Cadmium results in decreased expression of FGFR2 mRNA | 22666406 |
D002117 | Calcitriol | Calcitriol results in increased expression of FGFR2 mRNA | 21592394 |
D002117 | Calcitriol | Calcitriol results in increased expression of FGFR2 protein | 12761878 |
D002117 | Calcitriol | [Testosterone co-treated with Calcitriol] results in increased expression of FGFR2 mRNA | 21592394 |
D002185 | Cannabidiol | Cannabidiol affects the methylation of FGFR2 gene | 30521419 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of FGFR2 mRNA | 17484886 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of FGFR2 mRNA | 31150632 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of FGFR2 mRNA | 16644059; 17692400; |
C010063 | carbonyl sulfide | carbonyl sulfide results in decreased expression of FGFR2 mRNA | 19395590 |
C084597 | chlorcyclizine | chlorcyclizine results in increased expression of FGFR2 mRNA | 21058326 |
D002713 | Chlorine | Chlorine results in decreased expression of FGFR2 mRNA | 22533443 |
D004390 | Chlorpyrifos | Chlorpyrifos affects the expression of FGFR2 mRNA | 18502319 |
C012843 | cinnamic aldehyde | cinnamic aldehyde results in decreased expression of FGFR2 mRNA | 17178418 |
D002945 | Cisplatin | Cisplatin results in decreased expression of FGFR2 mRNA | 21603599 |
D002945 | Cisplatin | FGFR2 protein affects the susceptibility to Cisplatin | 16217747 |
D002994 | Clofibrate | [Clofibrate co-treated with Acetaminophen] affects the expression of FGFR2 mRNA | 17585979 |
D002994 | Clofibrate | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FGFR2 mRNA] | 17585979 |
D003008 | Cloprostenol | Cloprostenol results in increased expression of FGFR2 mRNA | 14991729 |
D005576 | Colforsin | Colforsin results in increased expression of FGFR2 mRNA | 10320526 |
C007164 | cumene hydroperoxide | cumene hydroperoxide results in increased phosphorylation of and results in increased activity of FGFR2 protein | 12717419 |
D003471 | Cuprizone | Cuprizone results in increased expression of FGFR2 mRNA | 26577399 |
D003474 | Curcumin | Curcumin results in decreased expression of FGFR2 mRNA | 15713895 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of FGFR2 mRNA | 27989131 |
C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of FGFR2 mRNA | 23914054 |
D000077209 | Decitabine | Decitabine results in decreased expression of FGFR2 mRNA | 27915011 |
D003907 | Dexamethasone | [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA | 16054899 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FGFR2 mRNA | 31009676 |
D003907 | Dexamethasone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | 16054899 |
D003907 | Dexamethasone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | 16054899 |
D003907 | Dexamethasone | Dexamethasone results in decreased expression of FGFR2 mRNA | 20032058 |
D003907 | Dexamethasone | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of FGFR2 mRNA] | 20032058 |
D003975 | Diazepam | Diazepam results in decreased expression of FGFR2 mRNA | 19114084 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of FGFR2 mRNA | 19464577; 21266533; 25213187; 26472102; 26514922; 26948521; 27079746; 28919491; |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of FGFR2 protein | 26514922; 28919491; |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of FGFR2 mRNA | 26472102 |
C058705 | diethyl malate | diethyl malate affects the expression of FGFR2 mRNA | 24814887 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of FGFR2 mRNA | 24535843 |
D015237 | Dinoprost | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dinoprost affects the localization of FGFR2 protein] | 15654655 |
D015237 | Dinoprost | Dinoprost affects the localization of [FGF2 protein binds to FGFR2 protein] | 16365892 |
D015237 | Dinoprost | Dinoprost affects the localization of FGFR2 protein | 15654655 |
D015237 | Dinoprost | Dinoprost promotes the reaction [FGF2 protein binds to FGFR2 protein] | 16365892 |
D015237 | Dinoprost | Dinoprost results in decreased expression of FGFR2 mRNA | 15654655 |
D015237 | Dinoprost | Tetradecanoylphorbol Acetate inhibits the reaction [Dinoprost affects the localization of FGFR2 protein] | 15654655 |
C034171 | di-n-pentyl phthalate | di-n-pentyl phthalate results in decreased expression of FGFR2 mRNA | 26472102 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of FGFR2 mRNA | 30031762 |
D004317 | Doxorubicin | Doxorubicin affects the expression of FGFR2 mRNA alternative form | 15065023 |
D004726 | Endosulfan | Endosulfan results in decreased expression of FGFR2 mRNA | 29391264 |
C038939 | enzacamene | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR2 mRNA | 25607892 |
D004958 | Estradiol | ESR2 protein affects the reaction [Estradiol results in decreased expression of FGFR2 mRNA] | 14699072 |
D004958 | Estradiol | Estradiol affects the expression of FGFR2 mRNA | 14699072 |
D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in decreased expression of FGFR2 mRNA | 20660070 |
D004958 | Estradiol | Estradiol results in decreased expression of FGFR2 mRNA | 23019147 |
D004958 | Estradiol | Estradiol results in increased expression of FGFR2 mRNA alternative form | 14602803 |
D004958 | Estradiol | Estradiol results in increased expression of FGFR2 protein alternative form | 18575591 |
D004958 | Estradiol | ESR1 protein promotes the reaction [Estradiol results in increased expression of FGFR2 mRNA] | 25210133 |
D004958 | Estradiol | Estradiol results in decreased expression of FGFR2 mRNA | 30077407 |
D004958 | Estradiol | Estradiol results in increased expression of FGFR2 mRNA | 25210133 |
D004958 | Estradiol | [Polyphenols co-treated with Estradiol] results in decreased expression of FGFR2 mRNA | 30077407 |
D004958 | Estradiol | Estradiol results in decreased expression of FGFR2 mRNA alternative form | 15680359 |
D004958 | Estradiol | Estradiol results in decreased expression of FGFR2 protein alternative form | 15680359 |
C010452 | estradiol-17 beta-benzoate | estradiol-17 beta-benzoate affects the expression of FGFR2 mRNA | 15059950 |
C074283 | estradiol 3-benzoate | estradiol 3-benzoate results in decreased expression of FGFR2 mRNA alternative form | 15976484 |
C074283 | estradiol 3-benzoate | [Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of FGFR2 mRNA alternative form | 15976484 |
C024552 | estrone benzoate | estrone benzoate results in decreased expression of FGFR2 mRNA alternative form | 15120423 |
D000431 | Ethanol | Ethanol results in increased expression of FGFR2 mRNA | 12720008 |
D000431 | Ethanol | Ethanol affects the expression of FGFR2 mRNA | 30319688 |
D000431 | Ethanol | Ethanol results in increased expression of FGFR2 mRNA | 30319688 |
D000431 | Ethanol | Ethanol results in decreased expression of FGFR2 protein | 16770775 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of FGFR2 mRNA | 20170705; 26865667; |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of FGFR2 mRNA | 18936297 |
D017313 | Fenretinide | Fenretinide results in increased expression of FGFR2 mRNA | 28973697 |
D005419 | Flavonoids | Flavonoids results in increased expression of FGFR2 mRNA | 18035473 |
D005472 | Fluorouracil | FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Fluorouracil] | 18575591 |
D005472 | Fluorouracil | FGFR2 protein alternative form inhibits the reaction [FGF7 protein results in decreased susceptibility to Fluorouracil] | 18575591 |
C006326 | fluprostenol | fluprostenol results in decreased expression of FGFR2 mRNA | 15654655 |
D019833 | Genistein | ESR2 promotes the reaction [Genistein results in increased expression of FGFR2 protein] | 20884965 |
D019833 | Genistein | Genistein results in decreased expression of FGFR2 mRNA | 23019147; 26865667; |
D019833 | Genistein | Genistein results in increased expression of FGFR2 protein | 20884965 |
D006493 | Heparin | [Heparin analog binds to FGFR2 protein alternative form] which binds to and results in increased activity of FGF1 protein | 16219767 |
D006493 | Heparin | Heparin promotes the reaction [FGF10 protein binds to FGFR2 protein] | 15632068 |
D006493 | Heparin | Heparin affects the activity of FGFR2 protein | 1373495 |
D006493 | Heparin | Heparin promotes the reaction [FGFR2 protein binds to FGF2 protein] | 1373495 |
D006493 | Heparin | [Heparin binds to FGFR2 protein alternative form] which binds to FGF1 protein | 10860838 |
D006493 | Heparin | [Heparin binds to FGFR2 protein alternative form] which binds to FGF2 protein | 10860838 |
D006493 | Heparin | [Heparin binds to FGFR2 protein alternative form] which binds to FGF7 protein | 10860838 |
D006493 | Heparin | FGF1 protein binds to FGFR2 protein binds to Heparin | 15165853; 16223363; |
D006497 | Heparitin Sulfate | Heparitin Sulfate analog results in decreased activity of FGFR2 protein mutant form | 16373332 |
D006497 | Heparitin Sulfate | FGF7 protein binds to Heparitin Sulfate binds to FGFR2 protein alternative form | 16315317 |
D006497 | Heparitin Sulfate | Heparitin Sulfate analog promotes the reaction [FGF1 protein results in increased activity of FGFR2 protein alternative form] | 11714710 |
D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of FGFR2 mRNA | 15883737 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of FGFR2 mRNA | 20044591 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of FGFR2 mRNA | 17997286 |
D006861 | Hydrogen Peroxide | Sodium Selenite promotes the reaction [Hydrogen Peroxide results in decreased expression of FGFR2 mRNA] | 17997286 |
C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of FGFR2 mRNA | 21396975 |
D000077269 | Lenalidomide | Lenalidomide affects the expression of FGFR2 mRNA | 30834740 |
D000077269 | Lenalidomide | Lenalidomide results in decreased expression of FGFR2 mRNA | 30834740 |
D000077269 | Lenalidomide | Lenalidomide results in decreased expression of FGFR2 protein | 30834740 |
D000077269 | Lenalidomide | Lenalidomide results in decreased activity of FGFR2 protein | 30834740 |
C533894 | LG 100815 | LG 100815 results in increased expression of FGFR2 mRNA | 16951191 |
D008044 | Linuron | Linuron results in decreased expression of FGFR2 mRNA | 12730624 |
C482199 | lipopolysaccharide, E coli O55-B5 | lipopolysaccharide, E coli O55-B5 results in decreased expression of FGFR2 mRNA | 19524256 |
C025340 | manganese chloride | manganese chloride results in decreased expression of FGFR2 mRNA | 28801915 |
C042720 | mercuric bromide | mercuric bromide results in decreased expression of FGFR2 mRNA | 26272509 |
D008748 | Methylcholanthrene | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGFR2 mRNA | 23519560 |
C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of FGFR2 mRNA | 28001369 |
D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of FGFR2 mRNA | 26011545 |
D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of and affects the localization of FGFR2 protein | 15581186 |
D015735 | Mifepristone | Mifepristone results in decreased expression of FGFR2 mRNA | 25972201 |
D009151 | Mustard Gas | Mustard Gas affects the expression of FGFR2 mRNA | 15651846 |
D009151 | Mustard Gas | Mustard Gas results in decreased expression of FGFR2 mRNA | 18988085 |
C008588 | N-(1-naphthyl)ethylenediamine | N-(1-naphthyl)ethylenediamine results in increased expression of FGFR2 mRNA | 17311802 |
C568507 | N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide | N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide results in decreased activity of FGFR2 protein | 21888390 |
D037742 | Nanotubes, Carbon | Nanotubes, Carbon results in increased expression of FGFR2 mRNA | 15585362 |
D037742 | Nanotubes, Carbon | Nanotubes, Carbon analog results in decreased expression of FGFR2 mRNA | 25554681 |
D037742 | Nanotubes, Carbon | Nanotubes, Carbon results in decreased expression of FGFR2 mRNA | 25554681 |
C000621033 | napabucasin | napabucasin results in decreased expression of FGFR2 mRNA | 25605917 |
C051752 | nefazodone | nefazodone results in decreased expression of FGFR2 mRNA | 24136188 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in decreased expression of CCND1 protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in decreased expression of MMP2 protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in decreased expression of MMP9 protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in decreased expression of VIM protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in decreased phosphorylation of AKT1 protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in decreased phosphorylation of MAPK1 protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in decreased phosphorylation of MAPK3 protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in decreased phosphorylation of PIK3R1 protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in increased cleavage of CASP3 protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in increased cleavage of CASP9 protein] | 31207222 |
C057222 | neferine | FGFR2 protein inhibits the reaction [neferine results in increased expression of ARPC5 protein] | 31207222 |
D009532 | Nickel | Nickel results in decreased expression of FGFR2 mRNA | 24768652; 25583101; |
C029938 | nickel sulfate | nickel sulfate results in increased expression of FGFR2 protein | 12930308 |
C007350 | nitrofen | nitrofen results in decreased expression of FGFR2 mRNA | 20638522 |
C007350 | nitrofen | nitrofen results in increased expression of FGFR2 mRNA | 21994076 |
C007350 | nitrofen | nitrofen results in increased expression of FGFR2 protein | 21994076 |
D005996 | Nitroglycerin | Nitroglycerin results in increased expression of FGFR2 mRNA | 12102619 |
C100284 | norgestomet | norgestomet results in decreased expression of FGFR2 mRNA alternative form | 10954858 |
C062198 | octa-2,4,6-trienoic acid | octa-2,4,6-trienoic acid results in increased expression of FGFR2 mRNA | 16951191 |
C118580 | octylmethoxycinnamate | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR2 mRNA | 25607892 |
D009844 | Oligosaccharides | Oligosaccharides promotes the reaction [FGF1 protein results in increased activity of FGFR2 protein alternative form] | 11714710 |
D009844 | Oligosaccharides | Oligosaccharides promotes the reaction [FGF7 protein binds to and results in increased activity of FGFR2 protein alternative form] | 11714710 |
C507134 | ON 01910 | ON 01910 results in decreased phosphorylation of FGFR2 protein | 25472472 |
D000077150 | Oxaliplatin | Oxaliplatin results in increased expression of FGFR2 mRNA | 17762391 |
D000077150 | Oxaliplatin | [Oxaliplatin co-treated with Topotecan] results in increased expression of FGFR2 mRNA | 25729387 |
D000077150 | Oxaliplatin | Oxaliplatin results in increased expression of FGFR2 mRNA | 25729387 |
D010100 | Oxygen | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGFR2 mRNA | 30529165 |
D052638 | Particulate Matter | Particulate Matter results in decreased expression of FGFR2 mRNA | 17987463; 29703138; |
D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of FGFR2 mRNA | 24535843 |
D010672 | Phenytoin | Phenytoin results in increased expression of FGFR2 mRNA | 11352631 |
D010672 | Phenytoin | Phenytoin results in increased expression of FGFR2 protein | 11352631 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FGFR2 mRNA | 19710929 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of FGFR2 mRNA | 20813756; 23811191; |
C006253 | pirinixic acid | pirinixic acid results in increased expression of FGFR2 mRNA | 18301758 |
C060540 | polyhexamethyleneguanidine | polyhexamethyleneguanidine results in decreased expression of FGFR2 mRNA | 27989595 |
D059808 | Polyphenols | [Polyphenols co-treated with Estradiol] results in decreased expression of FGFR2 mRNA | 30077407 |
D059808 | Polyphenols | Polyphenols results in increased expression of FGFR2 mRNA | 30077407 |
C467566 | pomalidomide | pomalidomide results in increased expression of FGFR2 mRNA | 30834740 |
C467566 | pomalidomide | pomalidomide results in decreased activity of FGFR2 protein | 30834740 |
C545373 | ponatinib | ponatinib analog results in decreased activity of FGFR2 protein | 21561767 |
C545373 | ponatinib | ponatinib results in decreased activity of FGFR2 protein | 19878872 |
C545373 | ponatinib | ponatinib results in decreased activity of FGFR2 protein mutant form | 19878872 |
C545373 | ponatinib | ponatinib results in decreased activity of FGFR2 protein | 22238366 |
D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of FGFR2 mRNA | 23608068 |
D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in decreased expression of FGFR2 mRNA | 20660070 |
D011374 | Progesterone | Progesterone affects the expression of FGFR2 mRNA | 17251523 |
D011374 | Progesterone | [Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of FGFR2 mRNA alternative form | 15976484 |
D011374 | Progesterone | Progesterone results in decreased expression of FGFR2 mRNA alternative form | 15120423 |
D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of FGFR2 mRNA | 24780913 |
C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of FGFR2 mRNA | 27029645 |
D020849 | Raloxifene Hydrochloride | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of FGFR2 mRNA | 19059307 |
D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased phosphorylation of and results in increased activity of FGFR2 protein | 12717419 |
C052785 | rebamipide | rebamipide results in increased expression of FGFR2 mRNA | 15104358 |
C052785 | rebamipide | rebamipide results in increased expression of FGFR2 mRNA alternative form | 15104358 |
D000077154 | Rosiglitazone | [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA | 16054899 |
D000077154 | Rosiglitazone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | 16054899 |
D000077154 | Rosiglitazone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | 16054899 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of FGFR2 mRNA | 25895662 |
D012822 | Silicon Dioxide | Silicon Dioxide results in decreased expression of FGFR2 mRNA | 25351596 |
D018030 | Silver Compounds | Silver Compounds results in decreased expression of FGFR2 mRNA | 29703973 |
D012906 | Smoke | Smoke results in decreased expression of FGFR2 mRNA | 21095227 |
D018038 | Sodium Selenite | Sodium Selenite promotes the reaction [Hydrogen Peroxide results in decreased expression of FGFR2 mRNA] | 17997286 |
C105686 | SU 5402 | SU 5402 results in decreased activity of FGFR2 protein | 21517068 |
C053081 | sucrose octasulfate | sucrose octasulfate binds to FGFR2 protein | 15047176 |
D013498 | Suramin | Suramin inhibits the reaction [FGF7 protein binds to FGFR2 protein] | 15733146 |
D013629 | Tamoxifen | FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Tamoxifen] | 18575591 |
D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of FGFR2 mRNA | 19059307 |
D013739 | Testosterone | [Testosterone co-treated with Calcitriol] results in increased expression of FGFR2 mRNA | 21592394 |
D013739 | Testosterone | Testosterone results in decreased expression of FGFR2 mRNA | 21592394 |
D013739 | Testosterone | Testosterone results in decreased expression of FGFR2 mRNA | 7536664 |
D013739 | Testosterone | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of FGFR2 mRNA] | 20032058 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FGFR2 mRNA | 23152189 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of FGFR2 mRNA | 27913140 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of FGFR2 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | 16054899 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of FGFR2 mRNA | 16054899 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FGFR2 mRNA] | 16054899 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FGFR2 mRNA | 17586704; 19933214; 22666406; 24035824; |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of FGFR2 mRNA | 16054899 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of FGFR2 mRNA | 22298810 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of FGFR2 mRNA | 18796159 |
D013755 | Tetradecanoylphorbol Acetate | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGFR2 mRNA | 23519560 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [Dinoprost affects the localization of FGFR2 protein] | 15654655 |
D013792 | Thalidomide | Thalidomide results in decreased expression of FGFR2 mRNA | 30834740 |
D013792 | Thalidomide | Thalidomide results in decreased expression of FGFR2 protein | 30834740 |
D013792 | Thalidomide | Thalidomide results in decreased activity of FGFR2 protein | 30834740 |
D013849 | Thimerosal | Thimerosal results in decreased expression of FGFR2 mRNA | 27188386 |
C402769 | tipifarnib | tipifarnib results in increased expression of FGFR2 mRNA | 16403772 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased expression of FGFR2 mRNA | 30291989 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased methylation of FGFR2 intron | 31039056 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased methylation of FGFR2 promoter | 31039056 |
D019772 | Topotecan | [Oxaliplatin co-treated with Topotecan] results in increased expression of FGFR2 mRNA | 25729387 |
D019772 | Topotecan | Topotecan results in increased expression of FGFR2 mRNA | 25729387 |
D014212 | Tretinoin | Tretinoin results in decreased expression of FGFR2 mRNA | 7680553 |
D014212 | Tretinoin | Tretinoin results in decreased expression of FGFR2 protein | 15389522 |
D014241 | Trichloroethylene | Trichloroethylene results in increased methylation of FGFR2 gene | 27618143 |
D014284 | Triiodothyronine | Triiodothyronine results in increased expression of FGFR2 mRNA | 16150908 |
C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of FGFR2 mRNA | 19042947 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of FGFR2 mRNA | 26179874 |
D000077288 | Troglitazone | Troglitazone results in decreased expression of FGFR2 mRNA | 28973697 |
D014635 | Valproic Acid | Valproic Acid affects the expression of FGFR2 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of FGFR2 mRNA | 28001369; 29154799; |
C034028 | vanadyl sulfate | vanadyl sulfate results in increased expression of FGFR2 mRNA | 16330358 |
C100058 | vanillin | vanillin results in decreased expression of FGFR2 mRNA | 17178418 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased expression of FGFR2 mRNA | 17987463 |
D024483 | Vitamin K 3 | Vitamin K 3 affects the expression of FGFR2 mRNA | 20044591 |
D000077337 | Vorinostat | Vorinostat results in decreased expression of FGFR2 mRNA | 27188386 |
D014874 | Water Pollutants, Chemical | Water Pollutants, Chemical results in decreased expression of FGFR2 mRNA | 23246600 |
Keyword ID | Keyword Term |
---|---|
KW-0002 | 3D-structure |
KW-0025 | Alternative splicing |
KW-0053 | Apoptosis |
KW-0067 | ATP-binding |
KW-1003 | Cell membrane |
KW-0989 | Craniosynostosis |
KW-0968 | Cytoplasmic vesicle |
KW-0225 | Disease mutation |
KW-1015 | Disulfide bond |
KW-0038 | Ectodermal dysplasia |
KW-0325 | Glycoprotein |
KW-0333 | Golgi apparatus |
KW-0358 | Heparin-binding |
KW-0393 | Immunoglobulin domain |
KW-0418 | Kinase |
KW-0953 | Lacrimo-auriculo-dento-digital syndrome |
KW-0472 | Membrane |
KW-0991 | Mental retardation |
KW-0547 | Nucleotide-binding |
KW-0597 | Phosphoprotein |
KW-0621 | Polymorphism |
KW-0656 | Proto-oncogene |
KW-0675 | Receptor |
KW-1185 | Reference proteome |
KW-0677 | Repeat |
KW-0964 | Secreted |
KW-0732 | Signal |
KW-0808 | Transferase |
KW-0812 | Transmembrane |
KW-1133 | Transmembrane helix |
KW-0829 | Tyrosine-protein kinase |
KW-0832 | Ubl conjugation |
InterPro ID | InterPro Term |
---|---|
IPR016248 | FGF_rcpt_fam |
IPR041159 | FGFR_TM |
IPR007110 | Ig-like_dom |
IPR036179 | Ig-like_dom_sf |
IPR013783 | Ig-like_fold |
IPR013098 | Ig_I-set |
IPR003599 | Ig_sub |
IPR003598 | Ig_sub2 |
IPR011009 | Kinase-like_dom_sf |
IPR000719 | Prot_kinase_dom |
IPR017441 | Protein_kinase_ATP_BS |
IPR001245 | Ser-Thr/Tyr_kinase_cat_dom |
IPR008266 | Tyr_kinase_AS |
IPR020635 | Tyr_kinase_cat_dom |